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Abstract of Ph.D . Thesis 
PROTEIN METABOLISM IN DIABETES 
The rate of whole body protein turnover was measured in 
uncontrolled diabetic patients by c15N ] glycine administration. 
Before insulin treatment corrrnenced, protein synthesis and breakdown 
rates were within the nonnal range despite hyperglycaemia and a 
negative N-balance . Paradoxically, insulin treatment resulted in 
a decrease in protein synthesis and an improvement in negative N-ba 1 ance. 
The latter was thought to result from the even larger decrease in 
breakdown. 
Whole body protein turnover was therefore investigated in the 
streptozotocin diabetic rat. c1 14c J leucine was administered by 
constant infusion and excretion of the label was detennined in 
expired CO2. Protein oxidation was dramatically increased by 
diabetes and reduced to near normal values by pre-treatment of the 
rats with insulin. In contrast to th~ protein synthesis results in 
diabetic patients, whole body protein synthesis in these rats we~ 
significantly decreased by diabetes and nonnalized by insulin. 
However, much larger decreases were observed in parallel studies 
on protein synthesis in individual rat tissues. Tissue protein 
synthesis was measured by constant infusion of [ 14c J tyrosine in 
control and diabetic rats. The gastrocnem1us muscle showed a 
pronounced decline in fract1~nal synthesis rate, but no change was 
detected in kidney protein synthesis rate despite a state of hyper-
trophy as reflected by increased protein mass . Liver protein 
synthesis appeared to be unaffected by diabetes, and subsequently 
a more appropriate method was used for measuring protein synthesis 
in rapidly turning over tissue like liver. 
Incorporation of label was measured 10 minutes after injecting 
a large dose of t3H ]phenylalanine. Protein synthesis rates were 
detennined in liver, kidney and five muscles of control (diabetic 
rats treated with insulin) and diabetic (insulin withdrawn) groups. 
In all five muscles protein synthesis was decreased by insulin with-
drawal, with the most rapid and pronounced decline being shown by 
the gastrocnemius. Again the kidney appeared to be unaffected. 
Protein breakdown rates, calculated from the changes in protein mass 
at the time of synthesis measurement, increased progressively in all 
five muscles with the duration of diabetes. With this method it was 
demonstrated that diabetes does reduce the overall rate of liver 
protein synthesis and similarly that of albumin synthesis. Total 
liver breakdown rates were elevated after one day of insulin with-
drawal and thereafter dropped to below control values. 
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SECTION 1 
INTRODUCTION 
Severe muscle wasting and a negative nitrogen balance are only 
some of the metabolic abnonnaliti es associated with the marked 
hyperglycaemia of uncontrolled diabetes. This disease was described 
centuries ago as "a melting down of the flesh into the urine" and it 
is this protein catabolic aspect of diabetes that is the concern of 
this investigation. 
The interrelationship between protein metabolism and the essential 
anabolic role of insulin was illustrated soon after the discovery of 
this honnone in 1922 (Banting & Best, 1922). This was shown by the 
dramatic do~bling in body weight and of apparent muscle mass in 
previously untreated juvenile diabetics within days after commencement 
of insulin therapy. 
Subsequent work by Atchley et al. ( 1933), Butler et al. (1947) 
and Danowsky et al (1949) illustrated clearly that in the uncontrolled 
diabetic, a rapid deterioration of nitrogen balance takes place with 
severe losses in the ketotic state. Re-establishment of insulin therapy 
would correct the abnormalities in carbohydrate metabolism within 24 
hours, whereas nonnalization of the negative nitrogen balance required 
a few weeks. 
These effects were confi nned by Leu tscher ( 1942) , who demonstrated 
that insulin not only promoted positive nitrogen ba1ance, but also 
reduced the elevated plasma amino nitrogen 1eve1s in these untreated 
diabetic patients. Nabarro et al. (1952), reporting on patients 
recovering from severe diabetic ketosis, showed cumulative negative 
nitrogen balances of 39 grams over 8 to 12 days, despite total dietary 
intakes of 77 grams of nitrogen over this period. They predicted 
that normalization of nitrogen balance probably required several weeks. 
This was confinned by Walsh et al. (1976} who used a neutron activation 
technique to fol low the time course of nitrogen and potassium retention 
in newly diagnosed diabetics starting insulin therapy. Again, 
restoration of normal cellular potassium and nitrogen levels required up 
to 6 - 8 weeks. 
The true mechanism of this negative nitrogen balance of 
uncontrolled diabetes in man has yet to be defined. The essential 
anabolic function of insulin has been demonstrated in diabetic rats 
in vivo and with tissues from diabetic rats incubated or perfused 
in vitro. All support the view that insulin promotes protein synthesis 
and inhibits protein breakdown (Pain, 1980). 
In diabetic humans, only one preliminary study on protein 
metabolism has been reported (Wisterlow et al .• 1977 ) . By using 
techniques which measure whole body protein turnover in man, the over-
all rate at which protein is synthesized or degraded can be defined. 
Furthermore, with this method the process primarily responsible for the 
diabetic nitrogen imbalance can be identified in greater detail. 
Waterlow et al. (1977 ) measured whole body protein turnover with c15NJ• 
glycine in two diabetic patients before and after insulin treatment. 
In both subjects the rate of synthesis was depressed in the untreated 
state, and as predicted from the known anabolic effects of insulin, 
protein synthesis was enhanced by insulin therapy. 
It appears therefore that an effective insulin treatment regime 
results in improvement of both carbohydrate and protein abnormalities 
present in severe diabetes. However, on a day-to-day basis, fluctuation 
in diabetic control, despite strict insulin and dietary regimes, has 
been a cause of great concern. Improved diabetic control 1s generally 
accepted to be directly related to retardation or even prevention of 
15. 
the onset of development of microvascular complications (Hollman & 
Turner, 1977; Tchobroutsky, 1978; Molnar et al., 1979). The value of 
conventional criteria for measuring diabetic control, i.e. blood and 
urinary glucose levels.has been questioned by findings such as the 
prevalence of stunted growth or even "diabetic dwarfism" in juvenile 
diabetics (Tattersall & Pike, 1973). Alberti (1973)surm1arized this 
dilemma by stating that measurement of a single parameter such as 
plasma glucose can give only partial information on a multi-metabolite, 
multisystem disease state. 
The possibly detrimental effect of longstanding abnormalities in 
protein metabolism in diabetes and it's relationship to adequate 
control has yet to be clarified. It has been suggested that most well-
controlled diabetics on insulin probably have subnormal levels of many 
amino acids for at least some part of each day, a state which could be 
potentially hannful (Carlsten et al., 1966). In fact, the elevation of 
plasma branched-chain amino acids in uncontrolled diabetes, which may 
represent an abnormality of peripheral protein metabolism, could 
possibly be used in conjunction with plasma glucose to monitor the 
adequacy of insulin control (Berger et al., 1978). 
In 1938, Mirsky made the following statement: "An examination of 
the prevailing views concerning the influence of insulin .:>n protein 
metabolism suggests that this honnone exerts a paradoxical action". 
In the discussion that follows on data published in the 40 years since 
1938, it will be shown that our knowledge to date can only confinn 
Mirsky' s view. 
The aim of the present study was therefore to investigate the 
effect of diabetes and subsequent !nsul !n therapy on protein metabol 1sm 
in humans and animals, with more exact identification of the effects on 
protein synthesis, breakdown and oxidation . To accomplish these aims, 
several different methods were employed, each chosen for a specific 
purpose or advantage. This wi11 be i11ustrated in the following 
discussion of methods that are available for measurement of protein 
turnover in humans and animals. 
1.1 PROTEIN TURNOVER METHODOLOGY 
1.1.1 Introduction 
In muscle wasting diseases such as diabetes and starvation, 
nitrogen balance studies can provide only limited information. The 
negative nitrogen balance of these physiological states conventionally 
implies an enhanced protein breakdown rate, but this is not necessarily 
true. Certainly nitrogen excretion data alone cannot determine the 
exact nature of protein metabolism. The negative nitrogen balance 
results not only from an imbalance between dietary input and nitrogen 
excretion, but also from an imbalance between protein synthesis and 
protein breakdown (Waterlow et al., 1978al. The relationship between 
nitrogen balance and protein turnover fs illustrated in the following 
simplified model as first suggested by Sprinson and Rittenberg (1949). 
INTAKE (I) 
-------- M 
SYNTHESIS (Z) 
--- - - - --ETABOL I C p R O T E I N 
P a 
., 
0 L -
BREAKDOWN (B) P O O L 
I 
I 
I 
I 
1 EXCRETION OR I OXIDATION (E) 
t 
AMINO NtTRCGEN 
• - - - - - -- L~BELLEO AMINO 
NITROGEN 
18. 
Protein turnover is defined as a continuous dynamic state main-
tained by ongoing synthesis and breakdown of tissue proteins. Measure-
ment of the rates of these two processes is possible by introducing an 
isotopically labelled amino acid into the metabolic pool and following 
the transfer of label between the pools. Three different approaches 
have been used. Firstly, the rate of disappearance from the metabolic 
or free amino acid pool would indicate rates of synthesis and oxidation. 
This method has largely been used in studies with humans and large 
animals where tissue sampling is difficult. Secondly, uptake of label 
and incorporation into the protein pool would give an estimate of 
protein synthesis, a method suitable only if tissue samples can be 
taken. Thirdly, after incorporation into protein, subsequent dis-
appearance from the protein pool or rate of loss of label would be a 
measure of the rate of protein breakdown. 
These three approaches will be discussed. Reasons will be.given 
why some methods were chosen and others rejected. Detailed reviews on 
protein turnover methodology has recently been published by Waterlow et 
al (1978a) and Garlick (1979). 
1 .1.2 Measurement of whole body protein turnover 
The rate at which amino nitrogen enters the metabolic pool (by 
intake or breakdown) or leaves from the pool (by synthesis or oxidation) 
is termed flux (Q). If the amino nitrogen ( 14c or 15N amino acids) is 
introduced into this pool at a constant rate, the specific activity of 
the 14c amino acid or the abundance of 15N reaches a plateau value 
(5max). Flux can then be calculated from 
Q i * eqn . ( 1 l . 
5max 
where i * 1s the rate of 1 nfus 1 on of label. If measurements are made 
over a relatively short period, it can be assumed that no label wi 11 
re-enter the metabolic pool from protein breakdown. If the rate of 
food intake (I) is known and that of amino acid oxidation and excretion 
(E), rates of synthesis (Z) and breakdown (Bl can be calculated from 
flux by 
Q = Z + E B + I eqn. (2) 
Either 14c amino acids or stable isotopes of 15N labelled amino 
acids can be used to obtain Q. 
14c Amino acids: With constant infusion of a 14c amino acid, a 
plateau will be reached in the specific activity of free amino acid in 
plasma (S) and in the production of 14co 2 (e) . In man infused with 
c114cJleucine, this occurs wHhin 8 hours (.Golden & Waterlow, 1977) 
and in the rat within 2 hours (Sketcher, 1976). If it is assumed that 
the specific activity in the plasma is the same as that in the 
metabolic pool of the model, then flux can be obtained from equation 1. 
When a carboxyl labelled amino acid such as L-c1 14CJ1eucine is 
infused, leucine enters the oxidative pathway in addition to protein 
synthesis. The early decarboxylation step removes the 14c label 
14 (Adibi, 1976) and re-utilization is prevented by release of the C 
label directly into the bicarbonate pool, from which it is excreted in 
expired air as 14co2. In man approximately 20% of the label will be 
retained in the body (James et al., 1976), but in the rat 
quantitatively excreted (Sketcher, 1976). The production 
therefore an estimate of oxidation of the 14c amino acid 
the label 1s 
of 14co is 2 
(E). Protein 
synthesis can therefore be calculated from equation 2 as flux (Q) minus 
oxidation (E) . Similarly if the intake of leucine from food (I) 1s 
known, the rate of protein breakdown can be determined as flux minus 
intake. 
The use of 14c amino acids for measuring whole body protein turn-
over has the advantage of less cost in isotope and of less time 
required to reach a plateau in specific activity. However, additional 
equipment for collection of 14co2 is needed and the use of a ventilated 
hood or Douglas bag in patients who are ill adds extra complications. 
This method of constant infusion of L-[1 14cJleucine was therefore used 
in estimating whole body protein turnover only in diabetic rats. An 
additional advantage was the measurement of whole body oxidation rates 
in diabetic and insulin treated diabetic rats, information that was not 
available at the time. 
15 N labelled amino acids: In humans the use of radioactively labelled 
14c amino acids are ethically limited to patients beyond child-bearing 
age. Stable isotopes, i.e. 15N amino acids, can however be used in a 
similar way as 14c amino acids, since with a constant infusion the 
excretion of 15N in urine will aiso reach a plateau. Since urinary N 
is a product only of oxidation of amino acids in the metabolic pool, 
this plateau will be the same as that in the metabolic pool and can be 
used to calculate flux . 
The excretion of 15N in urine can be measured in either urea or 
ammonia as end product. Measurement with urinary urea as end product 
was rejected in this study since a plateau of 15N abundance is reached 
only after 2- 3 days in adults (Steffee et al., 1976). This long 
period was obviously not suitable for measurement of rapid changes in 
protein turnover which 011.! would expect to find in the acute phases of 
diabetes. In contrast, a more rapid plateau is reached with a11111onia as 
end product and measurements can be completed within 12 hours (Waterlow 
et al., 1978a). This was the end product measurement chosen in the 
present study. [ 15NJglycine was the amino acid used since it is easily 
available at a reasonable price . 
The measurement of protein turnover with C 15NJglycine and estimation 
of 15N enrichment of urinary a111Tionia requires consideration of the 
following assumptions (Waterlow et al., 1978a) : 
(a) The metabolism of the tracer amino acid must reflect that of the 
total amino nitrogen, meaning that the proportion of the dose which is 
excreted as 15N in the end product equals the proportion of flux which 
is excreted in the end-product. Given that the isotope must not 
contribute preferentially to the production of the end product, glycine 
is probably not the best amino acid to use, because it has been 
suggested to contribute to the formation of urinary a111110nia (Pitts & 
Pilkington, 1966), but there is no evidence that this invalidates the 
answer . However, availability and relative cost has determined the 
15 general use of [ NJglycine. 
(b) The synthesis of the end product and the synthesis of protein must 
occur from the same precursor pool. In the case of urea, the end 
product reflects liver urea synthesis and in the case of a111T10nia, 
synthesis in the kidney, mainly from glutamine. In practice, ammonia 
seems to give similar values to urea and to values obtainedby[1 14J-
leucine infusion (Golden & Waterlow, 1977; Garlick et al., (1980a). Even 
when different rates were obtained using anJDonia and urea as end 
products, both end products indicated the same difference between 
groups of subjects. 
In diabetes an additional problem arises in measurement of 15N 
abundance in aR1110nia as end product, namely the development of keto-
acidosis in the severely uncontrolled diabetic. This shift in acid-
base balance does influence anmonia production by the kidney, but it is 
not known how increased a111110nia production will affect 15N excretion. 
This problem was avoided by selecting only non-ketoacidotic patients. 
In fact, thedataofWaterloweta1.Ch.17(1976a)showed no apparent change 
in total ammonia excretion in diabetic patients before and after 
insulin therapy. 
In the study to be presented, [ 15NJglycine was given as a single 
oral dose and not by constant infusion, since this required the least 
involvement from the patient. Instead of a plateau, the 15N abundance 
in urinary arrmonia falls rapidly to very low values, as shown in this 
figure from Waterlow et al. (1978a) 
- I .,. .,. 1.2 iii u >( iii ... ~ 0 .8 ... 
• ammonia 
• urea 
... 
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... 0.4 
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Time course of excretion of 15N in ammonia and urea after a single 
dose of [lSNJglycine 
A time ( t) can be defined as the point when the isotope has been 
effectively eliminated from the metabolic pool, but before protein 
breakdown occurs and label re-enters the pool. From the f1gure it can 
be seen that this point occurs at about 9-12 hours. The figure also 
shows the complications involved in using urea as end product, since 
a similar point is less easily detected. Since the turnover of the 
urea pool is very slow, excretion of label 1s delayed and t 1s 
di ffi cult to define. 
With the single oral dosce, flux is then calculated from the 
following equation, which is analogous with equation (1) used to 
calculate flux from constant infusion, 
i.e. 
Q 
S.dt 
where d* is the oral dose of isotope and the integral is the area 
under the curve for 15N abundance in urinary ammonia against time. 
The integral is computed from one or more urine collections between 
times zero and t. 
Two further points have to be considered with administrating 
[ 15NJglycine as a single oral dose, i.e. the size of the dose and 
whether the isotope is given before or after a meal. The size of the 
[ 15NJglycine dose has been shown to effect the excretion of label and 
hence the calculated rates of synthesis and breakdown. With influx of 
a large amount of isotope, i_.e. more than 300mgc 15NJglycine, a high prop-
ortio:1 of the 1 abel wi 11 be excreted, since the label enters the 
metabolic pool as a single non-tracer amino acid (Waterlow et al., 
1978b). Administration of the labelled amino acid with or without food 
has also been shown to be important. If the isotope is given with a 
meal, absorption will delay entry of label into the metabolic pool, 
thus minimizing the large dose effect. In addition, there is also a 
direct effect of food intake on the rate of protein synthesis (Garlick 
et al., 1980a). Hence it is important that the rate of food intake at 
the time of measurement is accurately control led. In the present study, 
100 mg c15NJglycine was given as a single oral dose and the time of 
administration, 1.e. before or after a meal was tested and modified in 
several protocols. 
1.1.3 Measurement of the rates of protein synthesis in individual 
tissues 
An a 1 te rna ti ve method iJf determining protein syn th es 1 s 1s by 
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measurement of incorporation of label into the protein pool. Since 
this method requires removal and analysis of tissues, this approach 
has been more cormionly used in animal experiments, although the use of 
muscle biopsies for protein synthesis measurements in humans has been 
reported (Lundholm & Schersten, 1975; Halliday & McKeran, 1975}. 
Two measurements need to be made on each tissue, i.e. of the 
amount of label incorporated into protein and secondly of the specific 
activity of the free amino acid at the site of protein synthesis. The 
direct precursor of protein synthesis, i.e. the aminoacyl-tRNA can be 
measured as shown by Airhart et al. (1974) and Khairallah & Mortimore 
(1976) in liver, but this is technically difficult. For routine use 
specific activity of the free amino acids in the tissue lintracellular 
pool} has been detenained. Sometimes that in the plasma (extracellular 
pool) has also been used. However, both precursor pools present 
problems in interpretation of results, since the actual precursor pool 
is probably compartmented (Mortimore et al., 1972}. It is probably 
wise to measure the specific activity in both pools and interpret the 
results w1th the possibility of either under- or over-estimating the 
actual rate of synthesis (Garlick et al., 1973). 
In the present investigation of protein synthesis in individual 
tissues of diabetic rats, two methods were employed which minimized the 
errors involved in choice of the precursor pool, i.e. constant infusion 
of a tracer dose of labelled amino acid (Section 6) or by single 
injection of a non-tracer dose of labelled amino acid (Section 7). 
1.1.3.1 Constant infusion of a tracer dose of labe11ed amino 
acid 
If a tracer amount of a labelled amino acid is given as a single 
injection, the specific activity of the free amino acid in plasma falls 
rapidly to very low values. The intracellular specific activity 
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initially rises, but then also declines as shown in the following 
figure : 
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From: Garlick (1979) 
To determine the time course of these changes, groups of animals would 
have to be sacrificed at timed intervals, making this a tedious and 
expensive approach. 
The changes in specific activity can be more accurately defined 
with constant infusion of the tracer labelled amino acid. This is 
illustrated in the following figure : 
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W1th continuous administrat1on of the 1sotope, the spec1fic activity of 
the free amino acid pool in plasma rapidly rises to a plateau. A 
plateau is also reached in specific activity of free amino acids in the 
tissue, but this plateau 1s lower and takes longer to be reached. The 
advantage of this method is that a single measurement at the end of the 
infusion can define the entire time course of specific activity (Water-
low & Stephen, 1968). Continuous administration of the isotope can be 
achieved by giving the label as part of an agar gel diet, (Harney et 
al., 1976), but more consistent results are obtained by constent intra-
venous infusion, the method employed in this study (Section 6). 
Whereas in whole body protein measurements synthesis was defined 
as the absolute rate of grams protein synthesized per unit t i me (e.g. 
g protein per day), in single tissuesthis will be expressed as a 
fractional synthesis rate (k
5
). This is the absolute rate divided by 
the amount of protein present and represents the proportion or 
percentage of the protein content of that tissue which is replaced per 
unit time (e.g.% per day). Fractional synthesis rates are then 
calculated in the following way : 
Waterlow and Stephen (1968) showed that the rise to plateau in 
plasma can be fitted to the exponential of the form 
S (1 - t,pt) p max ( 4 ) 
where SP is the specific activity of plasma amino acid, Spmax the 
value of Sp at plateau, t the period of infusion and AP the rate 
constant. 
In tissues the specific activity of the free amino acid, which is 
assumed to be the precursor for protein synthesis, also rises to a 
plateau. This plateau is lower than that in plasma because of 
dilution by unlabelled amino acids from protein breakdown. The rate 
constant LA;) describing the time course to plateau in tissue is 
dependent on the type of tissue and the amino acid infused. With 
tyrosine as amino acid, Ai in liver can be taken to equal AP. 
In liver and kidney, tissues with rapid rates of protein turnover, 
the specific activity of free amino acid (Si) is given by 
5 
where Ai is the rate constant for the rise of specific activity to 
plateau and Si max the plateau value of Si. 
In skeletal and cardiac muscle, where the appropriate value of Ai 
is Rk
5
, the time course is given by a different function : 
6 
where R is the ratio of protein-bound to free amino acid content of 
the tissue and ks the fractional rate of protein synthesis. 
Incorporation of the free amino acid into protein, expressed as 
the specific activity of amino acid in the protein (S8), is given by 
the equation (Zilversmit, 1960) : 
( 7 l 
This equation is then solved, using the expressions shown above 
(equations 5 and 6) for s1. This gives the fractional rate of protein 
synthesis, expressed as a function of the ratio of specific activities 
of free and protein-bound amino acid (. 5~1 ) at the end of the 
infusion, i.e. for liver and kidney : 
SB 
"P (l - e -kst) ks ( 8 ) 
S; (>-p - ks) (l - e ·>.pt) (>.p - ks) 
and for skeletal and cardiac muscle : 
SB R ( 1 - e •kst) ( 9 ) 
Si R - 1 ( 1 _ e·Rkst) ( R • l ) 
These last two equations are then solved graphically for ks by 
plotting curves of ks versus s8;si at fixed values fort, "P or R. 
Va 1 ues for ks are then obtained from corresponding experimenta 1 va 1 ues 
of s8;s1 (Garlick et al., 1973), 
In this study (see Section 6) [ 14CJtyrosine was used since it 
rises rapidly to plateau in both plasma and tissues (Garlick et al., 
1973) and an enzymatic assay was available for determining the specific 
activity (Garlick & Marshall, 1972). 
1.1 .3.2 Si ngle injection of non-tracer amounts of labelled 
amino acid 
Henshaw et al. (1971) demonstrated that when a dose of labelled 
amino acid large enough to flood the endogenous free amino acid pool 
was injected, the specific activity of the amino acid rose rapidly to 
a value close to that in plasma. Over the following 20 minutes they 
found that these specific activities remained essentially constant. 
McNurlan et al. (1979) did observe a slow decline in specific activity 
over this time, but the decline was linear, as is shown in the 
follow i ng figure : 
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The mean specific acti vity of the intracellular amino acid during 
the fi rst 10 minutes (SA) can be obtained by making measurements 1n 
groups of animals killed at 2 and 10 minutes after injection. The 
fractional synthesis rate ks can then be calculated from the equation 
X 100 
where s8 is the specific activity of the free amino acid in protein at 
10 minutes, SA the mean specific activity of the amino acid in the 
precursor pool between O and 10 minutes and t, time expressed in days. 
The value for SA was obtained by plotting the decline back to zero. 
For the value of SA at zero it is assumed that the rate of decline 
between zero and 2 minutes is equal to the rate between 2 and 10 
minutes. 
Despite the larger numbers of rats required by this technique, 
there are three major advantages : 
(a) the small difference between the specific activities in tissue and 
plasma minimizes the errors involved in the correct choice of a 
precursor pool as the site of protein synthesis. 
(b) the short time of measurement of incorporation eliminates the 
problems of re-utilization of amino acids from proteolysis in tissues 
with rapid turnover such as gut and liver. 
(c) synthesis measurements during the 10 minute incorporation will 
include not only that of cellular hepatic proteins but also of the 
secretory proteins. 
This method was therefore employed in Section 7 to estimate 
changes in protein synthesis rates during the very early stages of 
diabetes. 
l. 1 .4 Measurement of the rates of protein brezkdown in i~dividual 
tissues 
1.1.4.l Decay of labelled amino acids 
[n theory it is possible to measure decay or loss of label from 
the protein pool. The decay of total label in the protein then 
estimates the fractional rate of breakdown and decay of specific 
activity, the fractional rate of synthesis. In practice however, the 
interpretation of decay curves is difficult because of the following 
two problems : 
(a) Recycling of the label: Since only 20% of amino acids are actually 
oxidized and excreted, recycling or reutilization of the remaining 80% 
for new protein synthesis will obscure measurement of the actual loss 
of label (Waterlow et al., Ch. 11, 1978a). This is a particular problem 
in measuring decay in tissues with slow turnover such as muscle, which 
continue to incorporate label released from tissues with more rapid 
turnover. Recycling can be reduced by using labels which are rapidly 
converted and excreted, e.g. [6- 14 C]arginine in liver (Swick, 1958; 
Schimke, 1964) and NaH 14co 3 in liver and muscle (Millward, 1970). 
(b) Decay in mixed proteins: In mixed proteins from whole tissues 
decay is not exponential. Only in single purified proteins will label 
be lost exponentially and decay be linear when plotted on a semi-log 
axis. It is possible to analyse decay curves in heterogeneous tissues, 
but this requires measurement over very long periods of several days 
(Garlick et al., 1976). This approach is clearly impractical for 
measurements of rapid changes in the diabetic state. 
For studying the turnover rates of individual enzymes in tissues, 
Arias et al. (1969) introduced the double label technique. This method 
involves injecting [ 14c11eucine a few days before sacrifice and c3HJ-
1eucine a few hours before the rat is killed. The 3H activity is then 
a measure of the initial labelling and the 3H; 14c ratio the rate of 
decay. This technique 1s particularly useful for comparing turnover 
rates of different proteins in the same tissue. However one of the 
major assumptions is that a steady state must be maintained when the 
t\ilo labels are injected, which is obviously difficult in diabetes. 
Dice et al. (1978) therefore had to modify the double label method to 
investigate the rate of intracellular protein degradation in liver and 
muscle of diabetic rats. They injected the c14CJ1eucine into an 
insulin treated diabetic rat, then withdrew insulin for three days and 
allowed the 14c label to degrade in vivo before sacrifice. The c3HJ-
leucine was injected into a normal animal which was killed after 4 
hours. However, even with this modification, the double label method 
can give only information about the relative turnover rates of one or 
two isolated proteins and it is difficult to extrapolate from these 
results to the rate of protein breakdown in a tissue in general. 
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Clearly the use of decay rates as measurement of protein break-
down presents major complications in investigating disease states such 
as diabetes. Most probably decay methods should be reserved for 
measurements on single purified proteins and not for measuring breakdown 
in heterogeneous whole tissue proteins. In the present study protein 
breakdown in diabetes was estimated by two methods of indirect measure-
ment. 
1.1 .4.2 Indirect estimation of rates of protein breakdown 
(a) Changes in protein mass: Fractional rates of protein breakdown 
(kd) are inferred by the difference between measured rates of fractional 
synthesis (k s ) and the fractional rate of growth of protein mass (kg) 
1.e. 
The amount of growth of protein mass in the tissue is measured over a 
period of several days. k is then derived from the gradient of the g 
growth curve divided by the protein mass of the tissue at the day that 
ks was measured. 
This time scale of difference between measurements of k5 and kg 
implies that this method of deriving breakdown is subject to some 
errors. ln muscle, where ks was measured by 6 hour constant infusion 
and kg over several days, the effect of diurnal variations in muscle 
protein mass was shown to be small enough not to invalidate the inter-
pretation of the data (Garlick et al., 1973). This method has 
been successfully used for estimating rates of breakdown in muscle 
(Turner & Garlick, 1974; Garlick et al., 1975; Millward et al., 1975, 
1976). 
In liver an additional correction must be made if k includes 
s 
synthesis of both cellular and secretory proteins (e.g. with the large 
dose method), since synthesis of the secreted proteins contribute 
very little to hepatic protein mass. Thus hepatic breakdown rates 
should be derived from the difference between growth and synthesis of 
only cellular proteins. Synthesis rates of cellular proteins can be 
estimated from the difference between that of total hepatic proteins 
and synthesis of albumin and other secreted plasma proteins. This was 
the approach used in Section 7 where total hepatic protein synthesis 
was measured by a large dose of [ 3HJphenylalanine. An alternative 
method was used by Scornik and co-workers to measure the synthesis 
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rates of cellular and secretory proteins. Total protein synthesis was 
measured by label incorporation over 5 minutes only. The export 
protein component was estimated from the proportion of incorporated 
label which was lost between 7 and 180 minutes, further incorporation 
being prevented by inhibition of protein synthesis by injection of 
pactamycin at 5 minutes (Scornik & Botbol, 1976; Conde & Scornik, 1976). 
(b) Excretion of 3-methyl histidine: Measurement of the rate of 
excretion of 3-methyl histidine is a non-isotopic approach to estimate 
muscle protein breakdown which eliminates all the probl@ms of label 
recycling. 3-Methyl histidine is present in actin of all skeletal 
muscles and in myosin of white muscle. Synthesis takes place by add1 tion 
of a methyl group to hfstidfne after formation of the actin and myosin 
peptide chains. When muscle protein is degraded, the 3-methyl 
histidine is quantitatively excreted without reutilization. Young et 
al. (1973) and Bilmazes et al .(1978b) have suggested that the measure-
ment of 3-methyl histidine in urine can provide an in vivo index of the 
rate of skeletal muscle protein breakdown. This method has not to date 
been used to measure whole body muscle protein breakdown in diabetic 
humans, but it has been employed in studies of starvation (Young et 
al., 1973; Wassner et al., 1977; Ogata et al., 1978}, in burn patients 
(Bilmazes et al., l978a)and in rats on protein free diets (Haverberg 
et al., 1975; Omstedt et al .1978). It has also been employed as an index 
of protein breakdown in perfused hindquarters of diabetic rats (Hansen 
etal., 1977). 
In the present investigation, rates of 3-methyl histidine 
excretion were measured in urine of diabetic patients before and after 
insulin treatment (Section 3). 
1.2 CHARACTERISTIC FEATURES OF DIABETIC ANIMAL MODELS 
In the published data available on the effect of diabetes on 
protein turnover in animals, various methods were used to induce 
diabetes. In the ideal situation the animal model should exhibit the 
same metabolic abnormalities of human diabetes. The abnonnalities 
present in each model are however dependent on the genetic, physical or 
chemical interventions that were employed to induce the diabetic state. 
l .2.1 Genetic diabetogenic factors 
Spontaneous diabetes occurs genetically in many animal species and 
is associated with metabolic abnormalities of hyperglycaemia, hyper• 
lnsulinaemia and obesity. However, because of species-specific 
differences in the severity of these abnonnalities, the genetic strain 
of animal must be chosen with care to enable eventual comparison with a 
specific type of human diabetes. The different Hrains cover a wide 
range of abnormalities, e.g. the 'fatty' rat with normoglycaemia 
despite hyperinsulinaemia; the Chinese hamster with severe ketosis. 
hyperglycaemia and hypoinsulinaemia and the New Zealand obese mice 
that are hyperglycaemic but do not develop ketosis or insulin 
deficiency (Herberg & Coleman, 1977). However, in some species, 
spontaneous progression towards normal glucose homeostasis can occur. 
1.2.2 Dietary and chemical diabetoQenic factors 
Dietary factors have long been suspected of being one of the 
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causes of the increase seen in diabetes in Western society. High carbo-
hydrate diets or high fat - low carbohydrate diets are known to increase 
insulin requirements in animals (Trout et al., 1978). The duration of 
the dietary treatment can reduce this animal model from a transitory 
to a pennanent form of diabetes (Somogyi & Gruenfield, 1962) . 
Temporary hyperglycaemia and glycosuria can be induced by frequent 
administration of high doses of somatotropin, prolactin, estrogen. 
the adrenal steroids or growth hormone (Williams, 1974). The injection 
of guinea-pig anti-insulin serum causes an acute but transient fonn of 
diabetes, due to irrmediate degranulation of the a-cells and binding or 
neutralization of endogenous insulin by the antibodies. However. 
repeated injections are required to matntatn the diabetic state 
(Wright. 1959, 1960; Armin et al .• 1960). 
Permanent diabetes will result from removal of more than 80% of 
the pancreas, but this obviously decreases both insulin and glucagon 
levels. Thus pancreatectomy as an animal model of diabetes is probably 
of historical importance only. 
Chemical destruction of the a-cell can be achieved by injecting 
either alloxan or streptozotocin. Until the 1960's, alloxan was 
commonly used to induce experimental diabetes. Alloxan causes 
immediate necrosis of the a-cells and atrophy of tne Islets of 
Langerhans. leaving the acinar tissue intact (Lukens, 1948). Within 
24 hours hyperglycaemia and glycosuria develops and in later stages 
ketosis with highly elevated circulating concentrations of free fatty 
acids and ketones (Mansford & Opie, 1968). 
In contrast to alloxan. streptozotocin causes hyperglycaemia and 
glycosuria without ketosis. In the present study streptozotocin was 
chosen as diabetogenic agent since the clinical population of diabetics 
that were to be investigated were of normal weight. non-ketotic and 
insulin-dependent. 
1.2.3 Streotozotocin 
Streptozotocin (N-methylni troso-carbamylglucosamine) is derived 
from Streotomyces achromogenes and has antibacterial, carcinogenic and 
cytotoxic properties. In the rat, streptozotocin will selectively 
destroy pancreatic s-cells. with the a-anomeric fonn significantly more 
effective in binding at the receptor site on the a-cell surface 
(Rossini et al.. 1977). Rossini and co-workers have suggested that it 
is this unknown a to a anomer ratio which may be the cause of' 
variation in streptozotocin potency. 
Streptozotocin causes a triphasic blood glucose response within 24 
hours of injection. Initially there is a drug related but non-speci fie 
hyperglycaemia. fa 11 owed by marked hypoglycaemia resulting from the 
release of insulin from necrotized S•cells. After 24 hours, diabetes 
with constant and severe hyperglycaemia and glycosuria will be present 
(Junod et at .• 1969). The diabetogenic action of streptozotocin can be 
prevented by pre-treatment of the rat with nicotinamide. This pro-
tection is probably due to a prevention of development of reduced 
cellular NAO concentratlons which generally follows injection wHh 
streptozotoc1n. This emphasizes the crucial role of NAO in the normal 
function of the pancreatic a-cell (Schein & Bates, 1968; Golden et al .• 
19 71). 
The diabetogenic action of streptozotocin can be directly related 
to dosage and age of the animal. with young rats markedly more 
resistant to the drug (Turner & Heard, 1972; Portha et al., 1974). 
Ketonuria can only be produced with very high doses but this also 
invariably leads to an early death. Therefore, by manipulating the 
dosage, it is possible to produce diabetes of graded severity (Schein 
et al., 1971). 
The choice of appropriate controls, Ce,g. age, weight or pair fed} 
for evaluation of results obtained from diabetic animals is complicated 
by the hyperphagia which develops within 4 to 6 days in diabetic rats 
(Booth, 1972) and insulin treated diabetic rats (Panksepp et al., 1975; 
Rezek, 1976). 
1.2.4 Changes in food intake during diabetes and insulin treatment 
Since amino acid supply has been suggested to influence protein 
synthesis (Munro, 1970), and starvation has been shown to result in 
decreased liver and gut protein synthesis (McNurlan et al., 1979), it 
was not unreasonable to expect that an increase in the supply of amino 
acids could affect protein turnover. 
Normal rats have an impressive ability to balance their food In-
take against energy expenditure. In the nonnal rat a diurnal feeding 
pattem is present, with large meals and short intervals during the 
dark cycle and small meals during the light period (Panksepp, 1973). 
Appropriate adjustments in food intake take place after long-term force 
feeding or starvation, with restoration of normal body weight by either 
hypo- or hyperphagia. This adaptability is absent in rats with 
experimental lesions of the ventromedfal hypothalamus (V~). implicating 
the hypothalamus as having a central mediator role in controlling food 
intake (Stricker, 1978). 
The ventromedial nucleus of the hypothalamus is generally accepted 
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as being the satiety center. having a dominant role in overriding the 
hunger effect of the hypothalamic lateral nucleus, or feeding center 
(Rezek, 1976). These hypothalamic centers appear to function primarily 
as integrators of incoming information via the enteroinsul ar axis. a 
concept formulated by Unger & Eisentraut in 1969. The enteroinsular 
a.xis concept proposes a peripheral, vagally mediated glucosensitive 
mechanism associated with the liver. the gastrointestinal tract and 
peripheral and central glucoreceptors. 
Exogenous insulin administered experimentally to normal humans or 
rats consistently causes hyperphagia. Instead of it's nonnal role as a 
satiety hormone, insulin now acts as a hunger-inducing honnone. Since 
exogenous insulin is injected into free-feeding animals generally 
during nonnogl ycaemi a, the effect of insulin is to cause marked hypo-
glycaemia. This stimulates the glucoreceptors and initiates feeding 
behaviour in the rat (Briese. 1971; Panksepp et al., 1975, Rezek. 1976). 
In diabetes, cellular glucoprivation resulting from the insulin 
deficiency s1mi larly stimulates glucoreceptors and thus increase food 
intake (Panksepp & Nance. 1972; Bray, 1974). Experimental diabetes can 
induce hyperphagia in rats within 5 to 7 days after administration of 
either al loxan or streptozotocin (Kumaresan & Turner, 1965. Panksepp 
et al., 1972; Booth, 1972). Food intakes vary from 30 - 50% above that 
of age and weight controls and has been shown to be strongly correlated 
with the degree of glycosuria and body weight of the diabetic rat 
(Sturtevant, 1954). 
The hyperphagia of diabetic rats al so causes changes in the actual 
feeding pattern of the rats, with disruption of the nocturnal eating 
rhythm to that of a constant intake of small meals with short interrieal 
intervals. Booth (1972), using experimental chambers with photo-
electric cells and automated feeders, determined that diabetic rats are 
much more likely to partially chew rat pellets and interrupt a meal 
feeding ti me. 
Hyperphagia of the diabetic rat may be seen as a well controlled. 
compensatory response to a lack of utilizable fuels. In fact. in 1952 
Brodsky showed that if insulin withdrawn diabetic rats were allowed to 
overeat, their survival could be prolonged despite severe glycosuria, 
polyuria and ketonuria. Decreased glucose utilization and liver 
glycogen and fat reserve depletion have all been investigated as 
possible causes of this hyperphagia. Recently Friedman (1978) 
demonstrated that diabetic rats systematically increased their food 
intake as the amount of fat in the diet was reduced. or ate normal 
amounts of high fat diets. It is interesting to note that the hyper-
phagia of exogenous insulin is also accompanied by decreased plasma 
free fa tty acid 1 eve ls. 
In these hyperphagic diabetic animals. VMH lesions will reduce 
food intake, in contrast to it's effect on nonnal rats in causing 
hyperphagia and overt obesity. This again emphasizes that the over-
eating of the diabetic animal is probably an active but fruitless 
attempt to s.tore nutrients concomitant with it's depletion of body 
stores. Furthermore, in the normal rat with VMH lesions, exogenous 
insulin will not cause hyperphagia as seen in the unoperated animal 
(Bray, 1974; Panksepp et al. 1975). 
In conclusion, in the experimental work to be presented on strep-
tozotocin diabetic and insulin treated diabetic rats, close attention 
was paid to the degree of hyperphagia. Food intakes were monitored in 
al 1 experiments. In Section 5 some experiments were performed before 
the onset of hyperphagia to exclude possible effects on protein 
turnover. 
In the following discussion of published work on the effect of 
diabetes on protein synthesis and breakdown, the various diabetic 
animal models or diabetogenic agents used will be reported in the 
context of the different effects each could induce. 
1 .3 THE EFFECT OF INSULIN ON LEVELS OF CIRCULATING AMINO ACIDS 
The early work by Mirsky (1938) on nephrectomized dogs and by 
Lotspeich (1949) on depancreatized dogs, suggested that insulin may 
stimulate protein synthesis, since they found that the same amino acids 
that disappeared from the plasma with insulin treatment, could beiden-
ti fied in the protein of skeletal muscle. Insulin release is triggered by 
intake of a mixed diet, and it is this temporary hyperinsulinaemia 
which accelerates transport of glucose and of certain amino acids across 
muscle cell membrane, followed by augmented incorporation of these 
amino acids into tissue protein (CaMll, 1971, 1976). 
In diabetes the plasma levels of amino acids are affected 
disproportionately. There is an elevation of the concentration of the 
branched-chain amino acids, i.e. valine, leucine and isoleucine and in 
contrast, a decrease in levels of alanine in man (Carlsten et al., 1966; 
Felig et al., 1970; Wahren et al., 1972, 1976) and in animals (Clark et 
al., 1968; Bloxam, 1972; Blackshear & Alberti, 1974). 
The glucose-alanine cycle: The classical work of Felig and co-workers 
on the effect of diabetes on the circulating levels of amino acids were, 
at the time, the only detailed published data available on the in vivo 
relationship of insulin to protein turnover in nonnal and diabetic man. 
Felig et al. (1970) suggested that the glucose-alanine cycle (or nitrogen 
shuttle system) was not only important for hepatic gluconeogenesis, but 
it offerred a non-toxic alternative to ammonia in the transfer of amino 
nitrogen from muscle to liver . Essentially, in the glucose-alanine 
cycle glucose is released by the liver and taken up by the muscle. 
Here it 1s converted to pyruvate and then by transamination, to alanine . 
The alanine is released from muscle, taken up by the liver and re-
converted to glucose. 
By catheterization of appropriate blood vessels. these workers 
investigated the flow of amino acids across tissues of the forearm or 
leg and from the splanchnic bed. They demonstrated changes in the 
glucose-alanine cycle during the following physiological states 
(a) In normal man in the post-absorptive state: In the fasted state 
with relatively low insulin levels, the muscle is in negative nitrogen 
balance and there is a net release of amino acids, with alanine and 
glutamine accounting for more than 50% of this amount (Pozefsky et al., 
1969, 1976). The alanine is taken up by the liver where it's carbon 
chain is converted to glucose and the amino group to urea. The 
glutamine is also extracted by the splanchnic bed, primarily by the 
gut, which converts it to alanine for subsequent uptake by liver. The 
origin of alanine in muscle can be explained only by de nova synthesis, 
since it exceeds the amount released by proteolysis. The carbon 
skeleton is derived from either transamination of pyruvate (Pozefsky et 
al., 1969; Fel ig et al., 1977) or from other amino acids (Odessey et al. 
1974; Garber et al., 1976; Goldstein & Newsho1me, 1976). The amino group 
for alanine synthesis is probably derived from oxidation of the 
branched-chain amino acids (Goldberg & Odessey, 1972; Odessey et a1 ., 
1974). 
(b) In normal man after a orotein meal: Repletion of muscle nitrogen 
results from firstly a large output of branched-chain amino acids from 
the splanchnic bed, followed by net uptake by peripheral muscle and 
synthesis of alanine. The branched-chain amino acids therefore escape 
hepatic uptake and metabolism (Wahren et al., 1976; Felig et al., 1977). 
(c) In diabetes in the post-absorptive state: [n severe diabetes the 
branched-chain amino acid levels are elevated (Cl ark P.t al. 1968; Berger et 
al., 1978), muscle oxidation of these amino acids increased and plasma 
alanine decreased (Wahren et al., 1972; Chochinov, 19781. These low 
alanine levels in di abetes results from enhancement of normal liepatic 
uptake of alanine, i.e. increased by 45'.l: in the diabetic state (_Wahren 
et al., 1972). Therefore in diabetes, depletion of glycogen stores due 
to hypoinsulinaemia switches metabolism to gluconeogenesis via enhanced 
synthesis of alanine and oxidation of branched-chain amino acids. 
(d) In diabetes after a protein meal: Diabetics respond to a protein 
~eal with an even more dramatic elevation in plasma branched-chain 
amino acids, but with only a transient net uptake by the muscle and 
reduced repletion of muscle nitrogen. In contrast to normal controls, 
alanine output frorr. the muscles is not decreased, thus reflecting on-
going branched-chain amino acid oxidation in the absence of an adequate 
insulin secretory response to food intake (_Shel'"Ni n et a 1. , 1976; Wahren 
et al., 1976}. Insulin treatment of the diabetic immediately decreases 
these elevated branched-chain amino acids levels (Carlsten et al., 1966; 
Berger et al . , 1978}. 
These findings, i.e. of enhanced oxidation of branched-chain ami no 
acids and of alanine release from muscle has led Odessey et al. (1974) 
to propose a branched-chain amino acid cycle 
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These changes in utilization and oxidation of amino acids brought 
about by a lack of insulin plus the negative nitrogen balance of 
uncontrolled diabetes, all suggest that protein turnover itself is 
altered in either rates of synthesis or breakdown. 
1.4 THE EFFECTS OF DIABETES AND INSULIN ON PROTEIN SYNTHESIS 
1.4.1 Whole body protein synthesis 
To date there appear to be only two studies published on the 
effect of diabetes on whole body protein synthesis. In 1949 
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Hobennan used c15NJglycine to measure the rate of protein turnover on 
alloxan diabetic rats. Although his experiments would appear to 
indicate that whole body protein synthesis was reduced and rates of 
protein breakdown increased, the results are difficult to interpret in 
absolute tenns. Not only were the diabetic rats starved for 3 days 
prior to the 2 day measurement of protein turnover, but this long period 
of measurement and therefore longer time for recycling of amino acids 
would also have obscured detennination of the actual rate of protein 
breakdown. 
The only study on diabetic subjects is that of Waterlow et al. 
(1977), who reported some preliminary observations on two diabetic 
patients where c15NJglycine was used to measure protein synthesis 
before and after insulin control. They observed that in the pre-
insulin period protein synthesis was severely depressed and after 4 to 
5 days of insu1in therapy, rates of synthesis were enhanced. 
1.4.2 Skeletal muscle protein synthesis 
In vivo studies : EarlyworkbyForkeretal . (1951)demonstratedthatprotein 
synthesis was decreased in muscle of eviscerated, depancreatized dogs. 
By measuring incorporation of c35SJmeth1onine into protein of skeletal 
muscle after a single injection of the isotope, they found that 
incorporation was reduced in the diabetic dog, an effect which could 
be reversed by treatment of the dogs with insulin. A more rigorous 
approach was that of Hay & Waterlow (1967) who infused c14cJlysine 
into alloxan diabetic rats and determined specific activities of the 
amino acid in plasma and in the free amino acid pools of skeletal 
muscle. They observed that protein synthesis in muscle of these 
diabetic rats was decreased by 37%. Much larger reductions in muscle 
protein synthesis of 60-70% were demonstrated in streptozotocin diabetic 
rats by Pain & Garlick (1974) and Millward et al. (_1976) who used a 
constant infusion of c14CJtyrosine. Near normal rates of protein 
synthesis could be achieved by treatment of the rats with insulin 
(Pain & Garlick, 1974). Both studies revealed a reduction in the RNA 
to protein ratios and a reduction in the rate of synthesis per unit RNA, 
suggesting that the fall in synthesis was partly the result of a loss 
of ribosomes and partly the result of ca reduced activity of remaining 
ribosomes. 
Perfusion studies: In perfusions of rat hindquarters from normal 
animals as used by Ruderman et al. (1971} or the hemicorpus preparation 
of Jefferson et al. (1974), the rate of protein synthesis declined 1f 
these muscles were perfused in the absence of insulin. An increase in 
the release of amino acids from the muscle into the perfusate could be 
measured, which could be prevented by addition of insulin. Ruderman 
et al. (_1971) identified these amino acids to be mainly alanine and 
glutamine, as was shown in in vivo studies of the release of amino acid 
from the human forearm (Pozefsky et al., 1969). Insulin addition to 
the perfusate of these normal rat hindquarters had a minimal effect on 
alanine and glutamine release. In contrast, in diabetic ruuscle where 
release of these two amino acids was greatly enhanced, addition of 
insulin resulted in a marked suppression (Ruderman & Berger, 1974). 
Jefferson and his co-workers (1972, 1974, 1977) have investigated 
the effect of insulin in perfusions of muscle preparations from normal 
or diabetic rats by measuring not only rates of protein synthesis or 
breakdown, but also the changes on a subcellular level. In the absence 
of insulin or in diabetic muscle preparations, rates of protein 
synthesis decreased in psoas and gastrocnemius muscle of the perfused 
hemicorpus . This was shown to be associated with development of a 
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block in initiation of the peptide chain, which could be prevented by 
addition of insulin (Jefferson et al., 1972, 1974). The early work in 
the 1960's by Wool and co-workers (Wool et al., 1968, 1972), had 
demonstrated that the decrease in protein synthesis observed in muscle 
was probably due to defects in polypeptide initiation. This is believed 
to be the rate-limiting step for translation, which in some tissues ts 
known to be sensitive to insulin (Manchester, 1970}. In the studies of 
Wool and other workers, the activity of ribosomes in tissues was 
investigated by analysis of polysome profiles, where a decrease in the 
monomer pool and increase in polysome size would reflect enhanced 
initiation and rate of protein synthesis (Pain, 1980). On the sub-
cellular level, Wool et al. (1972} could therefore demonstrate that ribo-
somes of skeletal muscle from diabetic rats were less able to incorporate 
labelled amino acids in vitro. They observed accumulation of dis-
aggregated polysomes and suggested that ribosomes in diabetic rat muscle 
were not less efficient, but rather contained smaller proportions of 
active polysomes. The number of polysomes could be greatly increased by 
pre-treatment of the diabetic rats with insulin (Wool et al., 1972) or 
as was shown by Jefferson et al. (1974, 1977), by addition of insulin to 
the perfusate of rat heroicorpus preparations of normal rats . 
The effect of insulin in muscle perfustons could be demonstrated to 
be specific to muscles with different types of fibres both when starved 
rats (Goodman & Ruderman, 1979) and diabetic rats (_Flaim & Jefferson, 
1979) were used. Muscles containing red fibres have been reported to 
have more rapid protein synthesis rates than those with more white 
fibres (Goldberg, 1967b; Millward et al., 19781, Short (1969) did not 
find any difference in insulin sensitivity between the two types of 
muscle. However, Goodman & Ruderman (1979) did show that addition of 
insulin to perfusates of hindquarters from starved rats increased 
glucose uptake by extensor digitorum longus muscle (predominantly white 
fibres), whereas the soleus (predominantly red fibres) was only 
marginally affected. Similar work has recently been reported by Flaim 
& Jefferson (1979) in perfused hemicorpus preparations of 48 hour 
alloxan diabetic rats. Protein synthesis was reduced in both gastroc-
nemi us and psoas (mixed fibre type) and sol eus (predominantly red 
fibres). However, in the psoas,levels of ribosomal subunits were 
enhance~ but not in the soleus, reflecting a resistance in the latter 
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red muscle to development of a block in initiation. Whereas the decrease 
in synthesis in the gastrocnemius was associated with a decrease in 
synthesis of protein per RNA unit, the decrease in soleus protein syn-
thesis resulted from the reduced levels of RNA. The addition of insulin 
caused reaggregation of subunits and increased rates of synthesis in the 
more white or mixed fibre tissues, but failed to stimulate protein 
synthesis in the soleus. 
Buse and Reid (1975) have suggested that leucine may play an 
essential role in the regulation of protein synthesis. !n perfused 
hemicorpus preparations of fasted rats, promotion of protein synthesis 
could be brought about by addition of 5 times nonnal plasma values of a 
complete amino acid mixture, with the same amount of branched-chain 
amino acids or with leucine alone (Li & Jefferson, 1979). This effect 
was associated with a reduction in ribosomal subunits, suggesting 
accelerated peptide-chain initiation. Whereas Li & Jefferson (1979) 
did not find that insulin plus the branched-chain amino acids could 
further facilitate protein synthesis, Atwell et al. (_1977) reported 
that insulin did have an additive effect on in vivo polysome fonnation. 
They suggested that the branched-chain amino acids and specifically 
leucine were essential requirements for muscles in the fasted state to 
fully respond to insulin's anabolic effect (Buse et al., 1979). 
Studies on incubated muscles: Investigations with incubated muscles 
from the early fifties and sixties has shown that labelled amino acid 
incorporation could be stimulated by addition of insulin to the 
incubation medium (Krah l, 1952. 1953; Si nex et a 1., 1952; Wool & Man chester 
1962; Kurihara & Wool, 1968). This stimulation of amino acid incorp-
oration could be brought about by increasing not only insulin, but also 
amino acid concentration. Lundholm & Schersten (1975, 1977) demon-
strated that a complete mixture of amino acids at plasma levels had a 
greater effect on incubated human skeletal muscle than insulin . Similar 
results were obtained by Buse & Reid (1975) and Fulks et al .(1975), who 
showed that addition of branched-chain amino acids and specifically 
leucine could promote prot~in synthesis in incubated diaphragms of 
nonnal rats. Fulks et al. (1975) suggested that all three branched-
chain amino acids were effective in promoting protein synthesis,whilst 
Buse & Reid (1975) indicated that the effect was more specific to 
leucine. 
In diabetic rats, where protein synthesis was decreased in incubated 
diaphragms,the effect of branched-chain amino acids was not limited to 
leucine only; all three amino acids were effective in stimulating 
protein synthesis (Buse & Weigand, 1977). Furthennore, in these studies, 
leucine also inhibited protein degradation. Buse and co-workers 
therefore suggest that the branched-chain amino acids may have an 
essential negative feedback control on protein wasting present in 
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diabetes and so function to counteract the decline in protein synthesis 
and enhancement of protein degradation (Buse & Weigand, 1977). However, 
no in vivo data has yet been produced to prove or disprove the 
regulating role of leucine in protein turnover in the normal, starved or 
diabetic state. 
1.4.3 Cardiac muscle protein synthesis 
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In vivo studies: The work of Pain & Garlick (1974) is to date the only 
published information on the in vivo rate of protein synthesis in cardiac 
muscle from diabetic rats. By constant infusion of c14cJtyrosine, they 
showed that rates of protein synthesis were decreased by 44~ in strepto-
zotocin diabetic rats. This decline was however less marked than the 
decrease of 69% in the 1110re white or mixed fibre tissues such as the 
gastrocnemius. The decrease in RNA to protein ratio that they observed 
was similarly smaller than that seen in skeletal muscle. 
In vitro studies: Perfusion of nonnal cardiac muscle requires not only 
insulin, but also high levels of amino acids to initiate and accelerate 
incorporation of labelled amino acids (Morgan et al., 1971a, b; Chain & 
Sender, 1973; Sender & Garlick, 1973). The addition of insulin appeared 
to prevent a block developing in peptide-chain initiation which would 
take place if normal cardiac muscles were perfused in the absence of 
insulin. As shown also during perfusion of skeletal muscle, addition of 
branched-chain amino acids to the perfusate promoted protein syntesis 
also in cardiac muscle (Rannels et al., 1974). 
In contrast to normal heart muscle, early work by Rannels et al. 
(1970) and Chain & Sender (1973) demonstrated that perfused cardiac 
muscle from diabetic rats responded quite differently. The rate of 
protein synthesis was not influenced by the diabetic state and normal 
numbers of polysomes and subunits were observed in perfused heart muscle 
of diabetic rats. Since in normal cardiac muscle the action of insulin 
in promoting initiation could be replaced by palmitate, Rannels et al. 
(1970) suggested that in diabetes the increased free fatty acid levels 
of this catabolic state could substitute for insuHn to maintain 
nonnal cardiac protein synthesis. This would be a possible explanation 
for the absence of cardiac muscle atrophy but presence of skeletal 
muscle wasting observed in uncontrolled diabetes. The incubated 
aorta of diabetic rats similarly appears to be resistant to changes in 
proteir.synthesis; a reduction in c14CJ1eucine incorporation could only 
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be demonstrated after at least 5 weeks of diabetes (Arnqvist & Dahlkvist, 
1979). 
However, a more recent publication from the Hershey group (Chua et 
al . , 1979) does report a 37% reduction in rates of protein synthesis in 
perfused cardiac muscle of al loxan diabetic rats studied after 3 days 
of insulin withdrawal. This decrease measured in vitro is consistent 
with the 44% decrease reported by Pain & Garlick (1974) in vivo in 5 
day s treptozotod n diabetic rats. 
1.4.4 Liver protein synthesis 
In vivo studies: Both Hay & Waterlow (.1967} and Pain & Garlick (1974) 
reported that in vivo rates of hepatic protein synthesis in diabetic 
rats were relatively unchanged. Since they used a 6 hour constant 
infusion method, these results would apply to rates of non-secretory or 
cellular hepatic proteins only. The plasma proteins would not have been 
included in the measurern@nt because these proteins are secreted within 
15 to 20 minutes after synthesis (Morgan & Peters, 1971). By contrast, 
in vivo experirn@nts using specific immunoprecipitation techniques 
demonstrated a 25 % reduction in albumin synthesis in streptozotocin 
diabetic rats (Pain et al., 1978b) and a decrease of 80% in alloxan 
diabetic rats (Peavy et al., 1978) . 
In the present study two different methods were used to 
specifically differentiate between the effect of diabetes on total 
liver proteins (Section 7) and on cellular proteins only (Section 6). 
In vitro studies: Urea production was shown to be enhanced in 
perfused livers from alloxan diabetic rats (Green & Miller, 1960) or in 
livers of normal fed rats perfused in the absence of insulin (Mondon 
& Mortimore, 1967}. Since addition of insulin to the perfusate did not 
appreciably alter protein synthesis but reduced the release of amino 
acids, the main effect of insulin in liver appears to be an inhibitory 
action of protein degradation rather than a stimulation of protein 
synthesis (Mortimore & Neely, 1975). 
Whereas in normal rats addition of insulin to the perfusate has 
1 i ttle effect on the synthesis of fixed or non-secretory proteins 
(Mortimore & Mondon, 1970), synthesis of plasma proteins can only be 
achieved if enough amino acids and insulin are added to maintain a 
positive nitrogen balance (John & Miller, 1969). In perfusionsof 
diabetic 1 ivers, the synthesis of albumin was shown to be decreased 
(Peavy et al., 1978}_. They reported tnat the reduction in albumin 
synthesis was associated with a fall in albumin mRNA content, which 
could be res to red to norma 1 1 eve 1 s by 1 nsul in treatment. 
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In the liver, polysome changes due to diabetes are less marked than 
in skeletal muscle, but even so liver ribosomes are less capable of 
incorporating amino acids into protein (Tragl & Reaven, 1971, 1972). In 
diabetic rats, disruption of the ultrastructure of the rough endoplasmic 
reticulum and a fall in the membrane-bound proportion of ribosomes in 
the liver has been demonstrated (Reaven et al., 1973; Pain et al., 1974; 
Alford et al., 1975). This ultrastructural damage could be reversed 
with in vivo insulin therapy (Reaven et al., 1973; Pain et al., 1974). 
Since the primary site of synthesis of the secretory proteins appears to 
In the present study two different methods were used to 
specifically differentiate between the effect of diabetes on total 
liver proteins (Section 7) and on cellular proteins only (Section 6). 
In vitro studies: Urea production was shown to be enhanced in 
perfused livers frorn alloxan diabetic rats (Green & Miller, 1960) or in 
livers of normal fed rats perfused in the absence of insulin (Mondon 
& Mortimore, 1967). Since addition of insulin to the perfusate did not 
appreciably alter protein synthesis but reduced the release of amino 
acids, the main effect of insulin in liver appears to be an inhibitory 
action of protein degradation rather than a stimulation of protein 
synthesis (Mortimore & Neely, 1975). 
Whereas in normal rats addition of insulin to the perfusate has 
little effect on the synthesis of fixed or non-secretory proteins 
(Mortimore & Mondon, 1970), synthesis of plasma proteins can only be 
achieved if enough amino acids and insulin are added to maintain a 
positive nitrogen balance (John & Miller, 1969). In perfusionsof 
diabetic livers, the synthesis of albumin was shown to be decreased 
(Peavy et al., 1978l. They reported that the reduction in albumin 
synthesis was associated with a fall in albumin mRNA content, which 
could be res to red to norma 1 1 eve 1 s by insulin treatment. 
so . 
In the liver, polysome changes due to diabetes are less marked than 
in skeletal muscle, but even so liver ribosomes are less capable of 
incorporating amino acids into protein (Tragl & Reaven, 1971, 1972). In 
diabetic rats, disruption of the ultrastructure of the rough endoplasmic 
reticulum and a fall in the membrane-bound proportion of ribosomes in 
the liver has been demonstrated (Reaven et al., 1973; Pain et al., 1974; 
Al ford et al., 1975). This ul tr~structural damage could be reversed 
with in vivo insulin therapy (Reaven et al., 1973; Pain et al., 1974). 
Since the primary site of synthesis of the secretory proteins appears to 
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be by ribosomes bound to the membranes of the rough endoplasmic 
reticulum (Shore & Tata, 1977), it is therefore not surprizing that the 
main effect of insulin and diabetes should be on the synthesis of some 
of these plasma proteins, as reported by Peavy et al. (1978) for 
albumin. 
In vitro studies with isolated hepatocytes prepared by collagenase 
digestion showed that incorporation of amino acids into total hepatic 
protein was reduced in hepatocytes from diabetic rats (Ingebretsen et 
al., 1972) . In vitro addition of insulin to these hepatocytes obtained 
from diabetic rats could not stimulate synthesis of albumin (Peavy et 
al., 1978). This is in contrast to the stimulation of albumin synthesis 
(Dich & Gluud, 1975; Crane & Miller, 1977), and of total liver proteins 
(Wagle & Sampson, 1975; Dich & Gluud, 1975) observed in normal hepato-
cytes. However, these discrepancies could have been due to methodo-
logical differences. Jeejeebhoy et al. (1975), using a more rigorous 
approach with more active isolated cells, demonstrated that insulin 
could maintain protein synthesis of albumin and of transferrin for up to 
2 days of incubation. 
1.4.5 Kidney protein synthesis 
In uncontrolled experimental and human diabetes, the marked poly-
uria and glycosuria is associated with enlarged kidneys and increased 
glomerular filtration rates, abnormalities which can be reversed by 
prolonged insulin treatment (Mo genson & Anderson, 1973, 1975; Rasch, 
1979). 
On a subcellular level, these hypertrophied diabetic kidneys 
demonstrated a marked increase in capacity to incorporate amino acids 
in vitro. This difference was maintained when the kidney ribosomes were 
stripped of endogenous mRNA and artificial polyuridylic acid messenger 
was added (Peterson et al., 1971). This led them to suggest that the 
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effect of insulin deficiency in enhancing amino acid incorporation was 
mostlikely due to a post-transcriptional change in protein synthesis. 
ln vivo studies by Seyer-Hansen (19771 and Fox et al. (1977) all 
show strong correlations between kidney size, protein content and base-
ment membrane thickening with p1asma glucose values and thus, the 
severity of the disease. Renal hypertrophy of diabetic kidneys was 
associated with increased total protein, increased DNA to RNA ratios and 
thus cellular growth, and in the later stages of diabetes, increased DNA 
concentration or actual cell hyperplasia (Seyer-Hansen, 1976, 1977). 
Work load hypertrophy has been suggested as a possible cause, with 
the diabetic kidney attempting to compensate for the increased demands 
of polyuria, glycosuria and ketonuria. Ross & Goldman (1970, 1971) and 
Seyer-Hansen (1978) have clearly established that compensatory renal 
hypertrophy caused by unilateral nephrectomy could be further enhanced 
by induction of diabetes. As in human diabetes, all these changes were 
reversed by insulin treatment. 
In patients with diabetes of long duration, thickening of the renal 
glomerular basement membrane is a co111T10n finding and this form of 
microangiopathy is generally accepted to be a forerunner of the later 
more severe fonn of diabet1c nephropathy (Reddi, 1978). This thickening 
of the basement membrane has been shown to correlate with increased protein 
synthesis. Basement membranes of glomeruli from diabetic r~.ts 
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demonstrated marked increases in incorporation rates of C amino acids, 
which could be reduced to normal by insulin treatment (Cohen & Vogt, 
1975; Cohen & Khalifa, 1977). 
At this time no in vivo data were available on the actual rates of 
protein synthesis in kidneys of diabetic rats. Therefore in this study, 
fractional synthesis rates were measured in rats with acute and chronic 
diabetes by constant infusion (Section 6) and by single injection of a 
large amount of labelled amino acid (Section 7). 
l.4.6 Gut and lung protein synthesis 
Although rates of protein synthesis in gut and lung were not 
measured in the present study, available data are presented here to 
complete the overall picture of the effect of diabetes on the various 
tissues and organs of the body. 
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In contrast to the catabolic effect of insulin deficiency in 
skeletal muscle, but similar to changes in the kidney, hypertrophy of 
the small intestine and particularly of the mucosa has been reported to 
be stimulated by diabetes. This hypertrophy has been suggested as 
resulting from an anatomic adaption of the gut to the marked hyper-
phagia which develops in experimental diabetes (Jervis & Levin, 1966). 
However, Miller et al. (1977) has reported that the increase in ONA 
synthesis in the mucosa that they observed was probably a more primary 
cause. The only in vivo measurements on synthesis rates of diabetic 
gut mucosa were repor-ted by McNurlan & Garlick (1980a). By using a 
single large dose method developed to measure proteins with rapid 
turnover- such as in liver and gut (McNurlan et al. 1979), no change in 
fractional synthesis rates of jejunal mucosa or ser-osa could be 
demonstrated in diabetic rats. 
In a similar way. the in vitro r-ate of protein synthesis in th'! lung 
appears to be unaffected by diabetes (.R annals et al., 1979). 
1.5 THE EFFECT OF DIABETES AND lNSULIN ON PROTEIN BREAKDOWN 
1.S. 1 Muscle protein breakdown 
In vivo studies: Ind1r-ect in vivo measurements of protein degradation 
in skeletal muscle of diabetic rats has been reported by Millward et al . 
(1976). By comparing the rate of protein synthesis with the rate of 
change of the protein mass of the muscle, a rate of protein breakdown 
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was obtained. They established that after 6 days of diabetes, both 
synthesis and breakdown rates were decreased, in contrast to the 
increase in proteolysis demonstrated in vitro if muscle was perfused in 
the absence of insulin (Jefferson et al., 1977). 
In the present study, protein breakdown in skeletal and cardiac 
muscle was determined by a similar metnod to that used by Millward et 
al. (1976). Greater emphasis was placed on minimizing the errors 
involved in measuring changes in protein mass by doing so on a day-to-
day basis irmJediately after withdrawal of insulin from diabetic rats 
(Section 7). 
The only other in vivo study of protein degradation in muscle of 
diabetic rats is that of Dice et al. (1978), who used the double label 
technique of Arias et al. (1969) to differentiate between protein 
degradation rates of different proteins in the same muscle homogenate. 
As discussed earlier in Section 1.1.4.l, Dice et al. (1978) modified 
the basic technique to accomodate for measurement of protein turnover 
in the non-steady state of diabetes. The double labelled proteins from 
diabetic muscle homogenates were separated according to subunit molecular 
weight or according to 1soelectric point. They found that the increase 
in protein breakdown in the diabetic or starved rat was quite different 
from that seen in normal protein degradation. In normal cells large 
molecular weight proteins are more rapidly degraded than smaller proteins 
and acidic proteins more rapidly than neutral or basic proteins. In 
muscles from diabetic and starved rats they found that the correlation 
between degradation and protein mo 1 ecul ar size and i soe 1 ectri c point was absent. 
In vitro studies: Although there appears to be no direct evidence that 
all cellular protein breakdown 1s mediated by lysosomes, changes in the 
activity of the proteolytic enzymes 1n these organelles can be achieved 
by the presence or absence of insulin in perfused systems. In the 
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perfused hemicorpus (Jefferson et al., 1977) and heart (Rannels et al., 
1975) of normal rats, the absence of insulin from the perfusing medium 
increased the rate of protein breakdown. This proteolysis was 
associated with greater fragility of lysosomes and with development of 
autophagi c vacuoles (Jefferson et al., 1974). If perfused over a long 
period, large amounts of alanine and glutamine were released into the 
perfusate (Rudennan & Lund, 1972). The increase in proteolysis and 
decrease in protein synthesis in these perfused hemicorpus preparations 
could be prevented by addition of insulin (Jefferson et al., 1977). 
In perfusions of nonnal cardiac muscle without insulin there was 
also a net release of amino acids and a11111onia and a decreased latency of 
the lysosomal enzymes e-acetyl-glucosaminidase and cathepsin D (Rannels 
et al., 1975). In perfusions of diabetic hearts, Chua et al. (1979) 
have reported a decrease in both protein synthesis and breakdown rates. 
The work of Fulks et al. (1975) with incubated diaphragm muscles 
from nonnal rats have indicated that insulin not only inhibits proteo-
lysis and promotes protein synthesis, but does so in the presence of 
cycloheximide. This suggests that insulin by itself can prevent 
degradation independent of any effect on protein synthesis. A similar 
inhibition of proteolysis was observed if the three branched-chain amino 
acids and specifically leucine were added to the incubation method 
(Fulks et al., 1975}. This restraining effect of the branched-chain 
amino acids on protein degradation of muscle was also demonstrated when 
diaphragm muscles of diabetic rats were incubated in the presence of 
these amino acids (Buse & Weigand, 1977). 
1.5.2 Liver protein breakdown 
In vivo studies: At the time of this study only one in vivo investigation 
of liver proteolysis had been reported by Dice et al. (1978). As was 
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shown in muscle with the double label technique, liver degradation was 
enhanced, but the correlation between protein size and degradative 
rate was abolished in proteins of liver obtained from diabetic rats. 
In vitro studies: The detailed studies of Mortimore and co-workers have 
demonstrated increased proteolysis if nonnal livers were perfused with-
out addition of insulin (Mortimore & Mondon, 1970}. As shown in 
skeletal muscle, liver proteolysis was also associated with greater 
fragility of lysosomes (_Neely et al., 1974} and the development of 
high density lysosomal particles. This was also observed 
by Pain et al. (1974) in livers of streptozotocin diabetic 
rats. Amherdt et al. (1974) also identified hepatic autophagic vacuoles 
in severely diabetic rats and showed that treatment of the rats with 
insulin could reverse these ultrastructural changes. 
1 .6 THE EFFECT OF DIABETES AND INSULIN ON PROTEIN OXIDATION 
Diabetes and starvation are both associated with increased 
mobilization of amino acids for either gluconeogenesis or com~lete 
oxidation. Adibi et al. (1974) therefore described skeletal muscle as 
having a defensive mechanism in these states in that it functions as a 
substrate depot. By increasing amino acid oxidation, the protein of 
muscle can be utilized by the liver for gluconeogenesis. 
The three branched-chain amino acids, i.e. leucine, 1soleucine and 
va11ne share a common pathway of first a reversible transamination ste~ 
which results in formation of ~-keto acids. The next step of 
decarboxylation 1s irreversible and hence the amino acids are completely 
oxidized to CO 2 and HzO (Adi bi, 1976). 
The relative rates of oxidation of various body tissues have been 
established by incubation studies in vitro, with kidney having the 
greatest oxidation capacity, followed in descending order by brain, 
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adipose tissue, skeletal muscle and liver. However, because skeletal 
muscle constitutes more than 43% of the total body mass, muscle degrades 
more than 50% of leucine (Odessey & Goldberg, 1972, 19791, providing 
energy to the muscle and probably amino groups for alanine and glutamine 
synthesis (Chang & Goldberg, 1978). 
Most of the amino acid oxidation investigations have been done with 
branched-chain amino acids and for the purpose of this discussion, the 
oxidation of leucine in diabetic tissues will be considered since this 
was also the amino acid of choice in this study. 
Leucine oxidation in diabetes: Skeletal muscle is highly adaptable to 
changes in nutrition, e.g. in starvation and diabetes the levels of 
branched-chain amino acids in plasma are increased (Carlsten et al., 
1966; Aoki et al., 1976) and oxidation of these amino acids enhanced 
(Paul & Adibi, 1978), resulting in accelerated gluconeogenesis via tne 
glucose-alanine cycle (Odessey et al., 1974). 
The anabolic role of leucine in diabetes appears to be similar to 
that of insulin and in fact, as suggested by Buse & Weigand (1977), 
leucine can substitute up to a point for the lack of insulin in promoting 
protein synthesis in vitro. It is interesting to note that leucine is 
also a potent stimulator of insulin release (Milner, 1970) and can induce 
marked hypoglycaemia (Clark et al., 1968). 
In vivo studies on leucine oxidation in diabetes have not been 
reported to date. Most of the investigations have measured oxidation 
after a single dose of 14c amino acid and presented the rate of oxidation 
only as a proportion of the dose excreted as 14co2 (McFarlane & Von Holt, 
1969; Meikle & Klain, 1972; Neale & Waterlow, 1974a,b). Without measuring 
the specific activity of the precursor at the site of oxidation, the 
absolute rate of oxidation cannot be obtained. Sketcher (1976) did 
measure the specific activity of leucine in the intracellular pool of 
muscle when a plateau was reached in output of 14co 2 during a constant 
infusion of [l- 14CJleucine. This enabled him to calculate the absolute 
rate of protein synthesis from flux as described in Section 1 .1.2. 
Sketcher (.1976} showed that in protein depleted animals, the rate of 
protein oxidation was reduced. rn the work to be presented, a similar 
approach was used for measuring the rate of oxidation of carboxyl 
labelled leucine from the output of 14co2 in expired air and from the 
specific activity of the leucine in both plasma and tissue free amino 
acid pools (Section 5). 
The only data available on leucine oxidation in diabetes is that 
obtained by in vitro incubation studies on individual tissues. Buse 
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and her colleagues have systematically studied the effect of diabetes on 
leucine oxidation in various tissues, and found increased rates of 
oxidation in rat hemidiaphragms (Buse et al., 1976a), sciatic nerves 
(Buse et al., 1976b) and rat retina (Frayser & Buse, 1978). In the hemi-
diaphragm, oxidation was increased by 46%, and could be brought down to 
near normal values by treatment of the diabetic rats with insulin (Buse 
et al., 1976a). Paul & Adibi (1978) established the rates of decarboxyl-
ation of leucine in homogenates prepared from liver, kidney and gastroc-
nemius muscle. rn contrast to starvation in which leucine oxidation 
was enhanced in only muscle, in diabetes leucine oxidation was enhanced 
in liver, kidney and gastrocnemius muscle incubated in vitro. 
rn the work to be presented the rate of whole body protein oxidation 
was measured in diabetic rats 4 or 8 days after the streptozotocin 
injection and in insulin treated diabetic rats. [114 Jleucine was given 
by constant infusion, flux was obtained and hence whole body protein 
synthesis and breakdown could be calculated (Section 5). 
1.7 THE AIMS OF THIS WORK 
(a) To investigate the exact mechanism of the negative nitrogen balance 
present in uncontrolled, insulin dependent diabetic patients. 
(b) To follow the changes in protein metabolism in these patients 
59 . 
during the initial stages of insulin therapy and again after several 
months of treatment. 
(c) To measure whole body protein synthesis, breakdown and oxidation 
in diabetic rats, and to determine the rate at which each of these 
parameters of protein metabolism could be normalized by insulin 
treatment. 
(d) To identify the effect of diabetes in animals at the tissue level, 
i .e. to measure changes in tissue composition and rates of protein 
synthesis and breakdown in acute and chronic diabetic rats and in 
diabetic rats well controlled by insulin. 
SECTION 2 
GENERAL EXPERIMENTAL TECHNIQUES 
2.1 MATERIALS 
Most of the reagents used in the following experiments were of 
Ana 1 ar grade, obtained from B DH ( Poo 1 e, Dorset, UK) or Sigma Chemicals 
Limited (Poole, Dorset, UK). All radioactive isotopes were purchased 
from The Radiochemical Centre (Amersham, Bucks., UK) and enzymes fl"'om 
Sigma Chemicals. 
2.2 SYMBOLS 
SA ~ specific activity of precursor amino acid 
s6 • specific activity of protein amino acid 
s1 • specific activity of intracellular free amino acid 
Sp ~ specific activity of plasma free amino acid 
ks • fractional synthesis rate of protein 
kd • fractional breakdown rate of protein 
k • g fractional yrowth rate of protein 
z • absolute rate of protein synthesis 
B • absolute rate of protein breakdown 
E • absolute rate of protein oxidation 
2.3 RADIOACTIVITY COUNTING 
Two liquid scintillation counters were used, namely a Beckman 
LS 150 and a Nuclear Chicago Delta 300. Samples were counted until 
10,000 counts were accumulated (SE • l i ). Counting efficiency for 14c 
60. 
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labelled samples varied from 80-85% and for 3tt samples from 19-23% . 
The counts were corrected for quenching by the automatic external 
standard (AES) method. Appropriate quench curves were constructed with 
commercial calibrated standards of [ 3HJ or [ 14cJn-hexadecane (The Radio-
chemical Centre, Amersham, Bucks., UK), (Dyer, 1974). 
Two scintillation cocktails were used: 
(a) 0.4% 2,5 di phenyloxazole (PPOl in toluene, for counting of 
14co2 trapped in 3 ml of a hyami ne hydroxide: ethanol (_1: 2) 
solution. 
(b) a Triton-X100/xylene based scintillant containir:; ;i~r litre: 3g 
2 ,5 di phenyloxazole, 357 ml Triton, 37 ml ethanediol, 106 ml 
ethanol,500 ml xylene (_Fricke, 1975); for counting of radioactivity 
in all samples other than expired 14co2. 
2.4 PRESENTATION OF RESULTS 
All results in tables and figures are given as mean values! 
standard error of the mean (SEM). In the clinical work (Section 3) the 
mean difference between pre- and post-insulin values were obtained by 
paired comparison. Significance levels were assessed by the Student's 
't' test and 'p' was the probability that any difference between two 
groups of va 1 ues was due to chance al one, with 'p' va 1 ues of O. 05 or 
less considered to be significant. 
The sequence of experiments to be presented is not necessarily in 
the same order in which they were carried out. The animal experiments 
were done simultaneously with the clinical work which spanned 20 
months. 
SECTION 3 
',HOLE BODY PROTEIN TURNOVER IN DIABETIC PATIENTS MEASURED WITH 
c15NJ GLYCINE 
3. l INTRODUCTION 
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The anabolic role of insulin in promoting protein synthesis and 
inhibiting protein breakdown has been demonstrated in vivo and in vitro 
in experimentally diabetic animals. A preliminary study in this 
department on two diabetic patients indicated a similar response, 
namely that uncontrolled diabetes is associated with very low rates of 
protein synthesis, which can be increased by treating these patients 
for 3 to 5 days with insulin (Waterlow et al., 1977). 
The aim of the present study was to investigate further the effect 
of insulin on protein synthesis in patients with uncontrolled diabetes, 
by modified methods and protocols which had been perfected for this 
type of investigation in the two years following the first study, 
Whole body protein turnover measurements were made using an oral dose 
of c15NJ glycine, with determination of the excretion of 15N in urinary 
ammonia. This method relies on a basic two-pool model discussed in 
the Introduction (see Section 1 .1.1). 
The protocol for the present study was approved by the Ethical 
Committee of King's College Hospital, Denmark Hill, London. 
3.2 EXPERIMENT 
3.2. 1 Subjects 
A total of six male diabetic patients participated in this 
investigation. They were selected for this study by a consultant or 
registrar at the Diabetic Clinic, King's College Hospital, during the 
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patients' routine 3 or 6 monthly visits. All six had been on oral hypo-
glycaemic agents (sulfonylureas) for at least 3 months but required 
insulin to achieve better diabetic control. Their symptoms at this 
time included hyperglycaemia, glycosuria, mild ketosis, some weight 
loss and generalized weakness. All six patients were within the nonnal 
weight range for their age and height . Details on age, duration of 
diabetes and weight are given in Table 3-1. 
The basic details and aims of the study were explained to each 
patient at the clinic and if they agreed to participate, they were 
admitted to the diabetic ward of King's College Hospital for a period 
of at least 7 to 8 days. During this time protein turnover measure-
ments were made using c15NJ glycine during the period before insulin 
treatment comnenced and repeated 4 to 5 days later after insulin 
control had been established (Figure 3-1). At the time of measurement 
the patients were on controlled diets containing no meat. 
The first four patients were studied using the following protocol 
(Experiment I), which was subsequently modified for the measurement of 
protein turnover in the last two patients (Experiment II). 
3.2.2 Dietary protocol 
Each patient was admitted 24 hours before the actual c
15
NJ-
glycine experiment for stabilization on a controlled diet prepared 
under supervision in the hospital diet kitchen. This diet excluded 
all meat products to pennit measurement of 3-methyl histidine 
excretion in urine. Each diet contained gram protein and 30 kcal 
(126 kJ) per kg body weight, provided as 3 meals and 3 snacks . The 
carbohydrate content and distribution was similar to the patients' 
own diet at home. Details of a 24 hour patient protocol are shown 1n 
Figure 3-2. 
TABLE 3 - 1 CLINICAL DATA OF PATIENTS AT TIME OF PROTEIN 
TURNOVER 1£ASUREMENTS 
Patient AGE WEIGHT Duration 
(Male) (yrs) ( Kg) of diabetes 
1. R.H. 42 56 5 years 
2. N.A. 45 60 10 years 
3. A.P. 51 60 18 years 
4. S.S. 25 70 3 months 
5. F.E. 40 60 4 months 
6. A.S. 65 62 3 years 
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3.2.3 c15NJglycine administration 
An oral dose of 100 mg ~5NJglycine (95.2 atoms percent excess, 
Prochem division of British Oxygen Company, London) was administered 
at exactly 08.00 hrs on the day of the study. The tracer was preceded 
by 100 ml of milk and was followed by breakfast 30 minutes later. The 
cumulative excretion of 15N was determined in urinary anmonia during 
the first 12 hours (Exp. I) or 9 hours (Exps. II and III). 
3.2.4 Urine and blood sample collection 
A 24-hour urine collection was made on the day preceding c15NJ-
glycine and analyzed for total nitrogen and creatinine excretion. For 
the first 12 hours il1111E!diately after the oral 15N dose, uri ne was 
collected at exactly timed intervals of 3 hours and thereafter one 12 
hour collection was made to determine N-balance (Figure 3-2) . The 
urine collection bottles contained a 2i solution of Hibitane (chlor-
hexidene gluconate) in 6N HCl, which effectively prevented bacterial 
growth in urine samples stored at room temperature. 
Blood samples of 10 ml each were collected before each meal for 
plasma glucose and insulin determinations. 
3.2.5 Sample analysis 
Plasma glucose: Plasma glucose was determined in the Diabetic Clinic 
Laboratory using the glucose oxidase method as automated for a 
Technicon Autoanalizer Colorimeter. 
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Plasma insulin: Plasma insulin was estimated by the radioirnnunoassay 
method of Hales and Randle (.1963), using a kit from the Radiochemical 
Centre, Amersham, U.K. This method is based on competitive binding 
between insulin in plasma and added radioactive insulin (1251-insulin), 
with an antibody specific to insulin . The insoluble insulin-antibody 
complex which fonued was then counted for radioactivity using a well· 
type, gamma scintillation counter (EKCO Electronics Limited, U.K.) . The 
level of radioactivity was related in an inverse manner to the amount 
of insulin present in the plasma. 
Plasma urea: Boehringer Mannheim,(Londoaj provided a urease kit for 
plasma urea measurement. The ammonium carbonate formed from urea, 
split by urease, was reacted with first phenol and then hypochlorite 
to give a coloured complex. The absorbance was read at 550 nm on a 
Gilford 240 spectrophotometer. 
Urinary creatinine: Crea ti nine was measured in urine as an indication of 
the completeness of urine collections. For this purpose urine was 
reacted with alkaline picric acid and after colour development, the 
OD read at 520 nm. 
3-Methyl histidine: The excretion of 3-methyl histidine was used as 
index of protein breakdown in muscle (Bil mazes et al., 1978a). The 
concentration of 3-methyl histidine in urine was determined with an 
automated amino acid analyzer (Locarte Co., London W14, U.K.). The 
samples were loaded onto a column (23 cm x 0.9 cm) containing a cation 
exchange resin (LA/49, Locarte Co., London W14, U.K.) and was eluted 
first with 0.2 M sodium citrate buffer, pH 3.44 for 75 minutes, then 
with 1.0 M sodium citrate buffer, pH 4.55 for 175 minutes, at a 
temperature of 45°c and flow rate of 30 ml per hour. A standard 
sample of 1 rrl4 3-methyl histidine was run each day with the urine 
samples. The analyzer was routinely operated by Mr Philtp Broadbent. 
Urinary nitrogen: Total nitrogen was assayed by the micro-Kjeldahl 
method by which the urine was digested in concentrated sulphuric acid 
plus a copper catalyst for 12-20 hours, followed by distillation with 
a Markham still into 2% (w/v} boric acid and t1trat1on to determine 
concentration. 
Urinary amnonta and 15N abundance: Anlnonia was collected by aeration 
of strongly alkaline urine 1nto saturated boric acid. After titration, 
ammonia was red1stilled into 1 N HCl. The distillate was then assayed 
15 for N abundance by the method of Sp ri nson & Ri ttenbe rg ( 1949) . A 
single collector MS 20 mass spectrometer (AEI Scientific Apparatus 
Limited, Manchester, U.K.) was used as described by Golden & Waterlow 
(1977) and was routinely operated by Miss Hilda Sheppard. A standard 
solution of 15 NH4Cl (0.30 atoms percent excess 
15N) and of unlabelled 
NH 4Cl was measured in duplicate each day with each set of samples. 
3.2.6 Calculation of protein synthesis and breakdown 
Flux, which is the rate at which amino-nitrogen enters or leaves 
the metabolic pool, was measured after a single oral dose of c15NJ 
glycine (see Section 1.1. l for detail of 2 pool-model and calculations). 
Flux was obtained by measurement of the area under the curve for 15N 
excretion between time zero and 12 hours (t). From 
Q d1/ rt 
oJ S.dt 
synthesis (Z) and breakdown (B) rates were calculated, since 
Q = Z + E • B + I 
Excretion of total amino nitrogen (E) was measured over 24 hours. 
3.2.7 Results and Discussion - Experiment I 
Effect of insulin treatment on diabetic control: On admission to the 
ward and whilst still on oral hypoglycaemic agents, all patients were 
in poor diabetic control as shown by the large amounts of glucose 
excreted in the urine (Table 3-2). After 4 to 5 days of insulin, 
glycosur1a was considerably reduced, though it was still present in 
all four patients. Similarly, plasma glucose, which was elevated 
pre-insulin, was still above nonnal control values post-insulin 
(Table 3-3), although a mean glucose value of 10.6 t 1 . O 1111101/litre is 
not an uncommon finding in insulin treated diabetics. 
Plasma insulin was assayed before the insulin treatment regime 
conwnenced. The mean val ues at 08 . 00, 15 .00 and 18 .00 hours were 
TABLE 3- 2 £XCR£TION Of URINARY GLUCOSE AND CR£ATININ£* PR£- AND POST-INSULIN (g/day) 
Patient Urinary glucose Urinary creatinine 
Pre-insulin Post-insulin Pre-insulin Post-insulin 
1. (R.H.) 14 . 1 3. 5 1.32 1.19 
2. (N.A.) 12.8 4.0 1.66 1.24 
3. (A.P.) 18 . 2 16.4 1.28 1.27 
4. (8.S.) 21.0 10 .1 1.37 1.52 
--
ll ! S£M 16.5 t 1.9 8.5 ! 3.0 1.41 ! 0.09 1.31 ! 0.07 
Mean difference 
! SOI -8.0 ! 2.1 -0 . 10 ! 0.12 
(Post-insulin - pre-insulin) 
*Creatinine used as test for c011pleteness of urine collections. 
TA8L£ 3- 3 Pl.AW G.UCQS£ CONCENTRATl<Jf* (aoles/1 l. NITROOEN BALANCE lo N/dl AND URINARY AtHJNIA 
EXCR£TIII fag/ 12 hours) BEFORE AND AFTER INSULIN TREAMNT 
Patient Glucose Nitrogen balance Aaonia 
Pre-insulin Post-insulin Pre-insulin Post-insulin Pre-insulin Post-insulin 
------
1. (R.H.) 13.3 9 .6 + 0.9 t 1.5 277 242 
2. (N.A.) 16 .5 ll.2 - 7.8 t 2. l 480 195 
3. (A.P . ) 13.4 13.0 - 0.1 + 0.5 331 214 
4. (B.S.) 15.4 8.5 - 1.5 - l.4 446 293 
i ! SOI 14.7 ! 0.8 10.6 ! 1.0 -2.1 ! 2.0 +-0 . 7 ~ 0.8 383 ± 47 236 ± 21 
Mean difference -4. l ! 1.4 t2.8 ! 2. 4 -148 ± 52 
! SEN (Post-insulin - pre-1nsulin) 
* Mean value for 3 aeasureaents per day before each 11c1in aeal. 
14.7 "!: 6.6, 17.6 ! 5.4 and 12.2 ! 3.7 lilnits per ml. Although the 
mean values appear to be within the normal range, the usual response of 
insulin secretion to food intake was insignificant (Holman & Turner, 
1977). This lack of response fits with the diagnosis of these patients, 
namely that they no longer responded to oral hypoglycaemic agent treat-
ment and required insulin to restore diabetic control. 
All the patients were in negative nitrogen balance before insulin 
treatment. The response to insulin was poor in that N-balance was 
improved in some but not all patients (Table 3-3). This slow response 
in normalization of N-balance was not unexpected, given that the work 
of Walsh et al. (1976) suggested that the accumulation of total body 
nitrogen lost during uncontrolled diabetes would require up to 8 weeks 
for restoration. Unfortunately the neutron activation analysis 
technique used by Walsh and co-workers does not allow expression of 
nitrogen changes in absolute terms and therefore one cannot predict 
what the amount of nitrogen accumulation per day could be in these 
patients after only 4 days of insulin treatment. Oddoye et al. (1979) 
have shown that a maximum nitrogen accretion of 1.6 g per day can be 
achieved on extremely high protein diets of 36g N per day. 
None of the patients showed any evidence of ketone excretion in 
the urine before or after insulin treatment. However, total anmonia 
excretion was decreased with insulin treatment (Table 3-3) in contrast 
to the very small drop in excretion reported by Waterlow et al., Ch. 17, 
1978a, in the pilot study. 
Effect of insulin treatment on 15N excretion and protein turnover: 
Figure 3-3 shows the time course of the cumulative excretion of 15N 
in arm,onia in the four patients before and after insulin treatment. 
The two excretion curves both have a sharp inflexion at about 12 hours. 
at which µoint the cumulative excretion of the label in the armKlnia 
end-product had reached a maximum. 
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The effect of insulin treatment on protein synthesis and break-
down rates is given in Table 3-4. In the pre-insulin period rates of 
protein synthesiswerewell within the normal range despHe hyper-
glycaemia and negative N-balance. In the pilot study Waterlow et al. 
(1977) reported that protein synthesis rates were extremely low in the 
two diabetic patients measured during the pre-insulin period, i.e. 
0. 77 and 1.57 g protein/kg/day. In that study insulin treatment 
resulted in a highly significant increase in protein synthesis, but in 
the present study, protein synthesis in fact decreased on the average 
by 16%. This result was contrary to what one would expect, given the 
known anabolic role of insulin in promoting protein synthesis as 
demonstrated in diabetic patients (Waterlow et al., 1977) and in 
diabetic rats (Sections 6 and 7). Insulin, which is thought to inhibit 
protein degradation in perfused 1 iver tissue (Mortimore & Neely, 1975), 
did in fact decrease the average rate of protein breakdown by 25%. 
However, the excretion of 3-methyl histidine did not differ 
significantly before (338 :t 2B -µmole~/d) and after (326 t 29 -µmoles/D) 
insulin treatment. Therefore 3-methyl histidine gave no indication 
that there was a change on a tissue level of rates of muscle protein 
breakdown. The decrease in whole body protein breakdown suggests 
that, where there was an improvement in N-balance, it appeared to 
result mainly from a decrease in protein breakdown and not from any 
change in protein synthesis. 
Possible explanations for these surprizing results in protein 
synthesis were sought by comparing the differences between protocols 
used in the present and in the pilot study. 
(a) Size of c15NJglycine dose: In the pilot study large non-tracer 
amounts of 238 and 315 mg [ 15NJ glycine were administered compared to 
the 100 mg used in this experiment. Since a non-tracer dose leads to 
excess excretion of isotope (Waterlow et al., 197Bb) this could explain 
TABLE 3- 4 PROTEIN FLUX*, SYNTHESIS ANO BREAKOCMN (g protein/Kg/d) IN DIABETIC PATIENTS BEFORE ANO 
AFTER INSULIN TREATfl:NT 
Patient Pre-insulin 
Flux 
l. (R.H.) 4.0 
2. (N.A.) 4.9 
3. (A.P.) 5.6 
4. (8.S.) 5.6 
Mean difference t S£M. 
(Post-insulin - Pre-insulin) 
Synthesis Breakdown 
3.1 3.0 
3.0 3.8 
4.6 4.6 
4.5 4.6 
P o s t - i n s u 1 i n 
Flux Synthesis Breakdown 
3.4 2.4 2.3 
4 .0 3.2 3.0 
3.8 2.8 2.3 
5.3 4.2 4 .3 
-0 .90 ! 0.32 -0.65 ! 0.43 -1.03 ± 0.44 
*flux calculated froa 12 hour excretion of 15N, total N output was aeasured over 24 hours. 
the very low pre-insulin values obtained in the pilot study for 
synthesis i.e. 1.2 g protein/kg/d and the higher rates of 3.5 g 
protein/kg/d with 100 mg c15NJglycine in the present study. 
(b) Time of [ 15NJ glycine administration: In this study the patients 
received their daily oral hypoglycaemic agent (or insulin injection in 
the post-insulin period) with 100 ml of milk 10 minutes before the 
oral 15N dose, which was followed by breakfast 30 minutes later. In 
the pilot study the patients were also treated with insulin just 
before breakfast, but 15N administration was delayed for 2 hours there-
after. However, it has s i nee come to light that in the pilot study 
oral hypoglycaemics were actually withdrawn for 48 hours before the 
pre-insulin measurement. This did not result in very high glucose 
values (11 mmoles/1), but probably insulin levels were lower than in 
the present study, since the sulfonylureas that were used are thought 
to increase a-cell function (Shen & Bressler, 1977a,b). This presents an 
alternative suggestion why the pre-insulin synthesis rates in the 
pilotstudywereso low, in that the speculated lower plasma insulin 
concentrations could have resulted in lower protein synthesis. 
However, this fact was unknown at the time of this study and in 
a following study in one patient (Mr R.H.), only one change in protocol 
was tested, namely that of the time of [ 15NJ glycine administration. 
10 months post-insulin follow-up study: Two measurements of protein 
turnover were made within 3 days of each other on Mr R.H. (patient 1, 
Table 3-1), who returned after 10 months of insulin treatment. At 
this time he was feeling well and his diabetes was well controlled. 
The two a1rns of this study were : 
(a) to establish the effect of 10 months of insulin treatment on 
protein turnover as compared with 4 days of insulin (Protocol as 
in Exp. I}, 
76. 
(b) to detennine the effect of giving the oral dose ofc15NJglycine 2 
hours after breakfast and his daily injection (Protocol II). 
The results in Table 3-5 demonstrate that after 10 months of 
insulin treatment, synthesis rates were increased back to pre-insulin 
values and protein breakdown was now even further reduced by 57%. In 
the 10 month period he had gained 5 kg in body weight and was at the 
time of measurement in a highly positive nitrogen balance. Furthennore, 
it is clear that administration of c15NJ glycine 30 minutes before or 
2 hours after breakfast had no different effect on protein turnover. 
This follow-up study therefore did not clarify in any way why the 
results of the pilot study differed from the present investigation. 
A further two patients were studied using a modified dietary 
protocol (Experiment II). One of the patients was also investigated 
after 8 weeks of insulin treatment with again a further dietary 
modification (Experiment III). 
3.3 EXPERIMENT II 
3.3.1 Modified protocol 
Diet: Two changes were made in the dietary intake and distribution of 
food : 
(a) The energy value of the diet was increased from 30 to 40 kcal/kg/ 
day (126 to 168 kJoules). This was to test if the energy content 
of the diet could limit protein synthesis or it's response to 
insulin. 
(b) An approximately continuous food intake and absorption was 
accomplished by feeding the total intake in 6 meals every 2 hours, 
each containing equal amounts of protein. Since completion of the 
first experiment, Garlick et al. (1980a) have demonstrated that 
protein synthesis fell rapidly after cessation of food given 
hourly over 12 hours. This dietary modification of a 6 meal 
TABLE 3-5 PROTEIN SYNTHESIS AND BREAKDOWN RATES (g protein/Kg/ 
day) AFTER 10 MONTHS OF INSULIN TREATMENT 
PATIENT PROTOCOL SYNTHESIS BREAKDOWN 
1. (R.H.) 
Pre-insulin 3. l 3.0 
4 days 
Post-insulin 2.4 2.3 
10 months 
Post-insulin 3.2 1.3 
10 months 
Post-insulin II 3.0 l.3 
Protocol I Normal meal pattem, 30 Kcal/day 
100 mg clSNJ glycine 30 minutes before breakfast 
Protocol II Normal meal pattern, 30 Kcal/day 
100mg [ 15NJglycine 2 hours after breakfast 
pattern and its effect on protein turnover was tested in both pre-
and post-insulin periods. 
Isotope administration: [ 15NJ glycine was given at the same time as 
in the pilot study of Waterlow et al. (1977), i.e. 2 hours after break-
fast, the time at which the patients also received their oral hypo-
glycaemics or insulin. Furthennore, the 100 mg [ 15NJ glycine was given 
as an oral dose in 500 ml water which the patient sipped slowly, so 
that influx of the isotope into the metabolic pool could be delayed. 
Calculation of protein turnover: Calculation of flux was modified 
from that used in Experiment I, since urine collection times were now 
changed to encompass the total feeding time. The first 0-3 hour 
collection was started when [ 15NJ glycine was given and hence 2 hours 
after the first meal. The last collection was completed one hour 
after the 6th meal. Therefore the cummulative excretion of 15N in 
arrmonia was now measured over 9 hours, whereas in Experiment I 
excretion of isotope was measured over 12 hours and that of unlabelled 
amino nitrogen over 24 hours. In this experiment both isotope and 
unlabelled nitrogen were detennined over 9 hours. This latter change 
required a modification in calculation of total amino nitrogen 
excretion (E in eqn 2, Experiment I). Since the urea pool of the 
body ts large and turns over slowly, it could effectively delay 
nitrogen excretion. Hence, excretion (E) over 9 hours would not be a, 
accurate estimatfon of the true excretion rate of amino nitrogen 
(Waterlow et al., 1978a). A correction factor for amino nitrogen was 
thus calculated from changes in the urea pool between 0 and 9 hours. 
Plasma samples for urea analysis were taken when 15N was given and 
exactly 9 hours later. The size of the urea pool was calculated from 
total body water as percent of body weight, using a value of 60.2i (for 
malesl of body water determined by urea (Scientific Tables, Docun:enta 
Geigy), The corrected amino nitrogen was then calculated as total 
nitrogen excreted over 9 hours plus or minus the change in urea pool 
size over that time. 
3.3.2 Results and Discussion - Experiment II 
Two patients (No.5, F.E. and No.6, A.S. of Table 3-1) were studied 
using this modified protocol. A.S. responded to insulin in the same 
fashion as the patients in Experiment I, i.e. plasma glucose was 
reduced and the negative N-balance improved. Similarly, his protein 
synthesis rate was slightly reduced by insulin treatment (Table 3-6) 
and breakdown was decreased by 23 %. Unfortunately the severe diabetic 
state of F.E. was not improved by only 4 days of insulin treatment and 
as will be discussed in Section 3.4, after 8 weeks his diabetes was 
still poorly controlled despite many changes in insulin type and 
dosage and investigations at the Diabetic Clinic. His negative N-
ba 1 ance and hyperglycaemia we re hardly improved by 4 days of insulin and 
similarly, there was no change detectable in protein synthesis or 
breakdown rates. 
In total, the synthesis and breakdown rates measured with this 
modified protocol differ strikingly from those of Experiment I, namely 
with synthesis rates of 6.6 g protein/kg per day versus much lower 
rates of 3.8 in Experiment I (Table 3-4}. Possible explanations for 
this difference could be : 
(a) The practically continuous intake of food during the time that 
c15NJglycfne excretion was measured. Waterlow et al.(1978b) have 
reported a 34 to 48t decrease fn synthesis with 15N given without 
food as compared to 15N given with food. In the present study 
rates of protein synthesis in Experiment I were decreased by 42i as 
compared with Experiment II. 
(b) Sfnce 15N and total nitrogen excretionwererueasured over only nfne 
hours, the tfme in which all food was eaten, ft 1s not surprising 
that the flux estimation would be larger and therefore the 
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TABLE 3 - 6 PROTEIN SYNTHESIS AND BREAKDOWN (g protein/Kg/day) 
AND NITROGEN BALANCE ( gN/d) IN DIABETIC PATIENTS 
BEFORE AND AFTER INSULIN TREATMENT IN EXPERIMENT II 
Patient Pre-insu ; n 
Synthesis Breakdown N-bal ance ( g protein I kg / d} ( gN/d ) 
5. ( F. E.) 6.2 6.3 - 6 .8 
6. (A. S.) 6.9 6.4 - 2.5 
p 0 s t - i n s u 1 i n 
5. ( F. E.) 6.0 6.3 - 6 .6 
6. (A. S.) 5.4 4.9 + 0. 5 
Protocol: 6 meals with equal protein content 40 Kcal/Kg/day, 
[15N J glycine 2 hours after breakfast. 
calculated synthesis and breakdown rates higher. 
The results of Experiment II still did not change the conclusion 
reached with the first experiment, namely that insulin treatment of 
diabetic patients in poor control resulted in a slight decrease in 
protein synthesis and an even larger reduction in protein breakdown. 
A follow-up study was conducted in one of the patients and a further 
modification of caloric content was tested (Experiment III). 
3.4 EXPERIMENT III 
3.4. l Protocol 
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Mr F.E. (patient No. 5 in Table 3-6) returned after 8 weeks on 
insulin treatment. At this point his diabetes was still very unstable 
although he had regained 5 of the 13 kg body weight lrss with onset of 
diabetes 6 months previously. The protocol of Experiment II (6 meals 
given 2 hourly and [ 15NJg1yci ne 2 hours after first mea 1) was reported in this 
patient to determine the effect of 8 weeks of insulin treatment. Three 
days later a further modified diet was tested, namely an increase of 
energy content of the diet which was increased from 40 to 60 kcal/kg/ 
day. 
3.4.2 Results and Discussion 
Table 3-7 shows the effect of 4 days and 8 weeks of insulin treat-
ment on protein turnover in this patient. Protein synthesis was 
slightly increased and breakdown reduced by 221, as were breakdown rates 
in the first 4 patients studied. The increased calories did not 
appreciably affect protein synthesis or breakdown, therefore a lack of 
energy content of the diet could not have been the cause of the delayed 
response of synthesis to insulin or lack of weight gain. 
The effect of fnsulfn after 8 weeks on protein turnover (Table 3-7) 
and after 10 months (Table 3-5} appear to suggest that protein breakdown 
fs more sensitive to long term insulin treatment than protein synthesis. 
TABLE 3 - 7 PROTEIN SYNTHESIS AND BREAKDOWN RATES AND PLASMA 
GLUCOSE VALUES AFTER 8 WEEKS OF INSULIN TREATMENT 
Protocol 
II 
Protocol I 
Protocol JI 
Patient Plasma Synthesis Breakdown 
No. 5 (F .E.) glucose (g protein / Kg / day) 
(mmole/1) 
Pre-insulin l S.O 6.2 6.3 
4 days 
Post-insulin 10.4 6.0 6.3 
8 weeks 
Post-insulin 13.0 6.6 4.9 
8 weeks 
Pos t-i nsul in 8.5 6.6 4.3 
6 meals with equal protein content, 
40 Kcal/Kg/day, c15NJ glycine 2 hours after 
breakfast. 
6 meals with equal protein content, 
60 Kcal/Kg/day, [ 15NJ glycine 2 hours after 
breakfast. 
3.5 SUMMARY ANO CONCLUSIONS 
In conclusion, the data of the two experiments and follow-up 
studies suggest that short-term insulin treatment results in a slight 
decrease in protefo synthesis rate and that the improved negative 
nitrogen balance is a result of a larger decrease in breakdown. These 
conclusions are not effectively changed by manipulation of dietary 
intake, meal pattern or [ 15NJ glycine administration. Insulin treat-
ment for 8 weeks and longer results in a return of synthesis rate to 
pre-insulin values with a very large reduction in protein breakdown. 
The results of this study not only contrast with that of 
Waterlow et al. (1977) on diabetic patients,but also with in vivo data 
on tissues from experimentally diabetic rats, 1.e. that d1abetes 
decreased protein synthesis and this could be normalized by insulin 
treatment of the animal (Pain & Garlick, 1974, Section 7) . 
At this time no published data were avail ab-le on the effect of 
diabetes on whole body protein synthesis and breakdown in rats. The 
next step was therefore to design a suitable animal model which would 
enable comparison with the diabetic patients, i.e. a nonketotic, 
acutely diabetic rat, requiring insulin treatment, which could be 
studied also in the chronic phase of the disease. The following 
chapter describes the method followed in choice and dose of diabeto-
genic agent and the characterization of this model in terms of changes 
in body and tissue weight. food and water intake and lastly, tissue 
composition. 
3.5 SUMMARY ANO CONCLUSIONS 
In conclusion, the data of the two experiments and follow-up 
studies suggest that short-term insulin treatment results in a slight 
decrease in protein synthesis rate and that the improved negative 
nitrogen balance is a result of a larger decrease in breakdown. These 
conclusions are not effectively changed by manipulation of dietary 
intake, meal pattern or [ 15NJ glycine administration. Insulin treat-
ment for 8 weeks and longer results in a return of synthesis rate to 
pre-insulin values with a very large reduction in protein breakdown. 
The results of this study not only contrast with that of 
Waterlow et al. (1977) on diabetic patients.but also with in vivo data 
on tissues from experimentally diabetic rats, i.e. that diabetes 
decreased protein synthesis and this could be normalized by insulin 
treatment of the animal (Pain & Garlick, 1974, Section 7). 
At this time no published data were availaltle on the effect of 
diabetes on whole body protein synthesis and breakdown in rats. The 
next step was therefore to design a suitable animal model which would 
enable comparison with the diabetic patients, i.e. a nonketotic, 
acutely diabetic rat, requiring insulin treatment, which could be 
studied also in the chronic phase of the disease. The following 
chapter describes the method followed in choice and dose of diabeto-
genic agent and the characterization of this model in terms of changes 
in body and tissue weight, food and water intake and lastly, tissue 
composition. 
SECTION 4 
CHARACTERISTIC FEATURES OF THE STREPTOZOTOCIN DIABETIC RAT 
4. 1 INTRODUCTION 
In all the studies. the choice of a diabetic animal model was 
governed by the fact that ft had to facfl itate comparisons with the 
clinical work that was being carried out simultaneously. The adult 
human diabetics were insulin-dependent.non-ketotic and of normal body 
weight at the time of protein-turnover measurements (see Section 3). 
These patient characteristics inmediately excluded the use of 
genetically diabetic animals, because of the obesity factor which 
generally accompanies the diabetic gene (Herberg & Coleman, 1977). 
Alloxan was also rejected owing to it's known effect of causing a 
ketotic fonn of diabetes (Mansford & Opie, 1968). Streptozotocin, a 
cytotoxic ant1-bacter1 a 1 agent was therefore chosen as a chemi ca 1 agent 
for a-cel 1 destruction, since ft is thought to cause no other bio-
chemi ca 1 or metabol 1 c abnonna 1 f ti es than hypoi nsul f naemi a and hyper-
glycaemia. 
Streptozotocin. which is prepared from Streptomyces acromo9enes, 
is composed of a cytotoxic moiety, 1-methyl 1-nitrosurea attached to 
carbon-2 of glucose. It can ex1 st in the pyranose form as either an 
a or B anomer. with the a-anomer having a much greater a-cell 
destruction ability at lower doses (Rossini et al,, 1977). The strepto-
zotocin used in this study (Sigma Chemical Company Limited, Poole, 
Dorset. U.K,) contained an unknown distribution of anomers. However, 
Rossini et al. (1977) have shown that at high doses ( > 50 mg/kg body 
we1qht)there 1s no difference 1n a or 6 anomer action on the a-cell. 
4. 2 METHOD 
Male albino Wistar rats of 90-lOOg were used in all studies and 
were obtained from Charles River, Margate, Kent, U.K. On arrival 
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they were housed in wire bottom cages, usually singly, and had free 
access to water and a cubed diet (Oxoid Limited, Basingstoke, U.K.), 
containing 23% (w/w) crude protein. The animal house lighting was set 
on 12 hours light - dark cycles whilst a thenooneutral temperature of 
25°c (77°F) was maintained throughout. 
Young growing rats are known to be resistant to streptozotocin 
(Turner & Heard, 1972) and the dosage was increased accordingly 
(Portha et al., 1974). However, even a high dose does not necessarily 
always destroy all a-cells and hence the success rate in each 
experiment was approximately 80%. 
A dose of 130 mg streptozotocin per kgram body weight was used. 
Since the weights of the rats were close enough to 95-100 gm, 13 mg of 
streptozotocin was dissolved in 0.3 ml of 0.05 M citrate buffer (pH 
4.5), i11111ediately before it was injected via the lateral tail vein of 
the rats. Because of the low pH, rats were anaesthetized with ether 
30-60 seconds before the injection. In the first few studies, control 
rats were also anaesthetized and injected with citrate buffer to 
minimize the immediate effect of ether on food intake. However, this 
effect was found to be minimal and the procedure was not repeated in 
control groups of later experiments. 
The effectiveness of this streptozotocin dosage to create an 
acceptable animal model was tested against known published criteria for 
plasma glucose and insulin, and changes in concentration of protein, 
RNA and DNA in various tissues. 
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4.3 EFFECT OF STREPTOZOTOCIN ON PLASMA GLUCOSE AND INSULIN 
Base-line data on the physiological response to streptozotocin 
wereobtained by measuring and analyzing blood and urine collected from 
rats placed in metabolic cages. Glucose was measured enzymatically 
using the glucose oxidase method and kit of Boehringer Corporation 
(London). Plasma insulin was estimated by the radioilllllunoassay method 
of Hales & Randle (1963), using a kit from the Radiochemical Centre, 
Amersham, U.K. and following the same procedure as in detennination of 
plasma insulin of diabetic patients. 
By withdrawing small amounts (50 1,11) of blood from the tip of the 
tai 1, it was possible to show that rats were severely diabetic 48 hours 
after injection with streptozotocin (Figure 4-1). Rats w1 th plasma 
glucose values below 350-400 mg/100 ml were rejected and this selection 
procedure resulted in mean plasma concentrations of 450-600 mg per 100 
ml in all experiments. That streptozotocin did not destroy all a-cells 
in the Islets of Langerhans was apparent from the still measurable 
insulin in plasma. Insulin values were very low (2-6 1.1Units/ml) in all 
experiments, but this appeared to be sufficient to maintain life, 
certainly up to 8 weeks after streptozotocin injection. 
Severe diabetes was also reflected in the dramatically enhanced 
glucose excretion in the urine i.e. 6 ± 1.6 grams per day. Similarly, 
urine volumes were increased from control amounts of 14 ml to 66 ml per 
day. This polyuria resulted in a spontaneous increase in water intake 
i.e. from 24 t 3 mls per day in controls to 94 ± 14 ml per day after 4 
to 5 days of diabetes. Similar results on urine volume and water 
intake have been reported by Rasch et al. (1979). 
The above mentioned symptoms of severe diabetes could all be 
reversed by an insulin treatment regime. Protamine Zinc Insulin (PZI) 
was chosen, since it is a long acting insulin (24-36 hours) and if 
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All rats treated with 4 U PZI/day except received 
+ 3 U PZI/d on day ·5. Mean - SEM for 5 rats per group 
injected at 10.00 hrs each day, would probably achieve peak action at 
approximately 18.00 - 20.00 hrs and so coincide with the dark cycle of 
food intake by the rat. 
A treatment regime of 4 uni ts PZI per day, injected subcutaneously 
as a single dose, was found to be highly effective in restoring normal 
blood glucose values within 48 hours (Figure 4-1). There appeared to 
be no advantage in a split dose injected twice a day and 3 units was 
found to have a diminished effect, which is clearly illustrated in 
Figure 4-1. This figure also demonstrates the rate of onset of 
diabetes after insulin withdrawal. 
4.4 EFFECT OF STREPTOZOTOCIN AND lNSULlN TREATMENT ON GROWTH RATES 
Normal growth rates of each set of rats were established in the 
5 - 8 days preceding each experiment. Therefore, rats were ordered at 
50- 60 grams and used in experiments only after reaching 90 - 100 grams 
in weight. Generally, growth rates were severely depressed in the 
first 24 - 48 hours il'llllediately after the streptozotocin injection, but 
thereafter became stabilized at rates of approximately 3 - 4 grams per 
day in diabetic rats compared to 7 - 8 grams of growth in nonnal rats. 
This is shown in Figure 4-2. 
For comparative purposes this figure also demonstrates the loss of 
weight which occurs in rats fed a protein free diet. Loss of weight in 
a streptozotocin diabetic rat will only be observed in older, non-
growing rats, whereas in young diabetic rats growth will continue but 
at a much lower rate. 
Treatment with insulin resulted in accelerated growth rates of 
8 - 9 grams per day and control body weight was generally regained 
within 4 to 6 days of treatment. More detailed results w111 be 
illustrated in the actual experiments (see Section 7} where insulin 
treated rats were used as controls to insulin withdrawn diabetic rats. 
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4.5 EFFECT OF STREPTOZOTOCIN DIABETES AND INSULIN TREATMENT ON 
FOOD INTAKE 
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Hyperphagia in diabetic and insulin treated rats has been 
reported by various workers (Booth, 1972; Panksepp et al., 1975). In 
our pilot studies the published degree of hyperphagia could not be 
demonstrated after 6 days of diabetes, the time at which most of the 
experiments that follow were tenninated. A detailed study of the 
onset and magnitude of hyperphagia in diabetes and the effect of 
insulin treatment was therefore initiated. 
4 .5. I Method 
90 - 100g male Wis tar rats on a cubed diet were injected with 13mg 
streptozotocin. The rats were housed singly in wire-bottom cages 
with paper instead of wood chips in the bottom tray to facilitate 
weighing of spilled food . At approximately the same time each day the 
rats were weighed and food intake estimated from left-over diet and 
spillage. Because of the large urine volume produced by diabetic rats 
and their habit of partially chewing the pelleted diet (Booth, 1972), 
the much larger spillage from these rats was heavily contaminated with 
urine. Therefore, 1 eft-over food p 1 us spil 1 age from both control and 
diabetic rats were dried to constant weight in an oven at 110°c. Food 
intake, growth rate and plasma glucose values (as obtained from the 
tip of the tail) were detennined for 10 days of diabetes, and there-
after for 10 days in which each rat was treated with 4 units PZI/day. 
4.5.2 Results and Discussion 
The influence of streptozotocin diabetes on growth rate and food 
intake is shown in Figure 4-3. The depressed growth rate caused by 
diabetes and marked acceleration after insulin treatment is clearly 
illustrated, as is the day-to-day var1abilfty of this measurement in 
control and experimental groups. 
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Immediately after injection with streptozotocin, food intake was 
generally suppressed, but as the disease state progressed, so food 
intake increased. At 4 days, food intake of diabetics equalled that 
ofcontrols and thereafter hyperphagia became firmly established 
(26.2 ± 0.4 g diet/day in diabetic rats versus 19.1? 0.5 g/day in 
control rats) with only a slight decrease after insulin treatment. 
However, if we express food intake per gram of growth (Figure4-4), 
the hyperphagia of the diabetic rat can be interpreted as a 
compensatory response to a lack of utilizable fuel. In contrast, the 
hyperphagia of the insulin treated rat appears to be a purely 
physiological adaptation to the highly accelerated catch-up growth. 
The sensitivity of this adaptation is illustrated in Figure 4-4. On 
day 14 the insulin dose was reduced from 4 to 3 units PZI per day. 
Plasma glucose inrnediately increased to 289 mg/100 ml and similarly, 
food intake was enhanced and growth rate suppressed on that and the 
following day. 
4 .6 EFFECT OF STREPTOZOTOCIN ANO INSULIN ON TISSUE PROTEIN, RNA AND 
DNA CONCENTRATIONS 
The following investigation was a pilot study for the planned 
measurement of protein tumover by constant infusion of c14cJ tyrosine 
(Section 6). Rats were killed after acute and chronic diabetes, i.e. 
5 and 56 days after streptozotocin. In addition, a further group of 
diabetic rats were treated with insulin for 4 days to test the effect-
iveness of insulin in normalization of these tissue results. 
4.6. 1 Methods 
Rats were housed, fed and diabetes was induced with streotozotocin 
as described. At the appropriate days after streptozotocin, rats were 
decapitated and bled from the neck. The liver, kidneys and gastroc-
nem1us muscles were quantitatively but rapidly removed, blotted, 
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weighed and frozen in liquid nitrogen and stored at -1s0 c. The mixed 
venous blood was spun at 1200 x g for 10 minutes at 4°c and the plasma 
removed for glucose and insulin assays. 
The frozen tissues were homogenized in 2% (w/v) perchloric acid 
(PCA) using an ultrasonic tissue homogenizer (Polytron, The Northern 
Media Supply Limited, Hull, U.K.) in two 10-second periods at top 
speed, whilst keeping the tissue in the tube cold on ice. In later 
experiments, the frozen tissues were pulverized to a fine consistency 
by placing the tissue in a plastic bag between two aluminium blocks 
previously cooled on dry ice, the top of which was then harrmered. 
Both methods achieved an effective tissue homogenate from which protein, 
RNA and DNA could be extracted, in the sequence of steps as described 
in Figure 4-5. 
The procedure outlined in this figure is a modification of the 
method of Schmidt-Thannhauzer as described by Munro & rleck (1969). 
The protein fraction was estimated by the automated procedure of Lowry 
et al. (1951), using a Technicon Autoanalyzer. Each set of protein 
assays were run with standard solutions of bovine serum albumin in 
O.lN NaOH. The RNA concentration was determined by measuring optical 
absorption at 260nm using a Gilford 240 spectrophotometer. A 
correction for peptide contamination was made by reading absorption 
also at 232nm and applying the equation of Munro & Fleck (1969) 
RNAphosphorus ■ (3.4 x 00260nm) - (1 .44 x 00232nm) 1,19/ml 
RNA is obtained from RNAphosphorus by multiplying by 10.53 (the average 
ratio by molecular weight of RNA to RNA phosphorus). 
The DNA content of tissues was estimated by the diphenylamine 
method as modified by Giles and Myers (1965), in which the ONA extract 
is reacted with di phenyl amine in glacial acetic acid to yield a blue 
colourafterl8 to 24 hours. Optical absorption was read at 595nm and 
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corrected for possible turbidity by reading also at 700nm. DNA 
concentration was obtained from a standard curve using deoxyribonucleic 
acid (Type 1. calf thymus, Sigma Chemicals Limited, Poole, Dorset, U.K). 
4.6.2 Results and Discussion 
The presence of overt diabetes 5 days after induction with strep-
tozotocin was characterized by hyperglycaemia (481 ± 21 v 148 ± 3.5 mg 
glucose/100 ml plasma in controls) and hypoinsulinemia (2.7 ± 0.7 v 
19.5 ! 2.4 uUnits insulin/ml plasma in controls). This high plasma 
glucose value was maintained for 56 days (583 ± 12.4 mg/100 ml) despite 
even lower insulin production (1.8 t 0.6 uUnits/ml). It would appear 
that the residuals-cell function was sufficient to prevent ketosis and 
death but could not maintain growth (Table 4-1). Severe weight loss of 
50% was observed in the chronic diabetic rats and loss of 18% in the 
acutely ill rats. 
Muscle composition chanQes with diabetes: On a tissue level similar 
changes were shown with a 35% decrease in total gastrocnemiusweight in 
acute diabetes and an even greater reduction of 66i in weight after 56 
days of diabetes (Table 4-1). 
The decrease in gastrocnemius weight was paralleled by a drop 
in total protein and total RNA. Since in most tissues ribosomal RNA 
accounts for at least 80% of total RNA (Young. 1970). a change in RNA 
content or in the RNA:protein ratio may be a good index of the rate of 
protein synthesis (Millward et al .• 1973). In this study the RNA to 
protein ratio of muscle (also defined as the capacity of protein 
synthesis, Millward et al. 1975) was unchanged in the chronic diabetic rats 
and nonsignificantly lower at 5 days of diabetes. A larger and 
significant decrease of 32% has been reported by Pain & Garlic~ (1974) 
and subsequent studies (see Table 4-4) have confirmed this. 
Total ONA was decreased in both acute and chronically diabetic 
groups, with a very significant reduction in the protein to D~A ratio. 
TABLE 4 - l THE EFFECT OF ACUTE AND CHRONIC DIABETES ON GASTROCNEMIUS 
MUSCLE RNA, DNA AND PROTEIN CONCENTRATIONS 
Control Acute Control Chroni C diabetes diabetes 
(6 rats) (13 rats) ( 5 rats) (8 rats) 
Total body weight (g) l 38±2 113:t4 421±13 212±28 
Total tissue weight (g) 1.14:t0.04 o. 74±0.05 4.17:t0.08 l .40:tO. 31 
Protein (g/lOOg) 13.22:t0.92 14.83:t0.42 19 .45:tO. 71 19 .05_:tO. 35 
Tota 1 protein (mg) lShl 1 110:tl 3 811 :t30 267:t38 
RNA (mg/g) 1 .05:t0.14 0.97:t0.04 0.92:t0.03 0.8~0.03 
Total RNA (mg) l .20:tO. ll 0. 72:tO. 13 3. 84:tO. 71 1.25:t0.22 
RNA/Protein (mg/g) 7 .9:tl .O 6.5:t0.3 4.6:t0.3 4.8:t0.2 
DNA (mg/g) 0.89:t0.05 1 . l O:tO. 06 0.31:t0.02 0.49:t0.09 
Total DNA (mg) 1.01:t0.09 0.81:t0.09 l . 29:tO. 13 0.69:t0.08 
Protein/DNA ( mg/mg) 152±14 l 39:t7 620:t:22 4 74:tSO 
""an va 1 ues :1: SEM. Acute diabetes 5 days pos t-s treptozotoci n and 
chronic diabetes 56 days post-streptozotocin. Protein, RNA and OOA 
concentrations mg/g wet tissue. 
Cheek et al. (1971) defined a DNA-unit as an imaginary volume of cyto-
plasm managed by a single nucleus. The protein to DNA ratio would then 
be an indication of the size of these DNA-units, an increase 
i n which would suggest cellular hypertrophy. 
Liver composition changes with diabetes: The effect of short and long-
tenn diabetes on liver is shown in Table 4-2. Both at 5 and 56 days, 
diabetes resulted in reduced tissue weight and protein, RNA and DNA 
content. The 34% decrease in RNA to protein ratio in acute diabetes 
and 21% i n chronic diabetes is comparable to the results of Pain & 
Garlick (1974) in 6 day diabetic rats. This fall would appear to 
suggest a decrease in capacity of hepatic protein synthesis, as will 
be shown in Section 7 where rates of both cellular and secretory 
protein synthesis were measured in diabetic rats. 
Kidney composition changes with diabetes: Enlarged kidneys with 
increased glomerular filtration rates have been reported to be 
associated with the polyuria and glycosuria of untreated diabetes in 
humans and rats (Mogenson & Anderson, 1973, 1975; Seyer-Hansen, 1977). 
The results of this study on kidney weight and composition is shown in 
Table 4-3. The enlarged kidneys and increased protein content in 
acutely diabetic rats confirm the published data of Seyer-Hansen 
(1976) . The increase in RNA and DNA was much less than the protein 
changes and no change could be detected in the protein to DNA ratio in 
acute diabetes. However, a 28i increase in this ratio and hence, 
cellular growth, was observed after 56 days of diabetes. Similarly, 
Seyer-Hansen (1976) has reported a 20% enhancement of protein to DNA 
ratios after 42 days of diabetes. 
Effect of insulin treatment on tissue weights and composition: Insulin 
treatment is known to prevent the onset of these kidney abnormalities 
or to reverse the aevelopment if already established (Seyer-~ansen, 
TABLE 4 - 2 THE EFFECT OF ACUTE AND CHRONIC DIABETES ON LIVER RNA, DNA 
AND PROTEIN CONCENTRATIONS 
Control Acute Control Chronic diabetes diabetes 
(6 rats) ( 13 rats) ( 5 rats) ( 8 rats) 
Total tissue weight (g) 7.2:t0.2 S .1:tO. 3 16. 7±1.0 11.6:tl ,2 
100. 
Protein ( g/1 OOg) 13 .59: 0. 35 16 .55t0. 30 22.21:tl .83 26.00tl .01 
Total Protein (mg) 973:t28 836±37 3716:tl71 3013±244 
RNA (mg/g) 6.76:t0.38 5.57:t0.21 7.36:t0.45 7 .00:tO. 16 
Total RNA (mg) 48. 7:t2.9 28.1:tJ,l 123. l:tS. 3 81.1:8. 7 
RNA/Protein (mg/g) 50.0:t3.5 33.4:tl .6 33.6:t3.6 27.2:tl.1 
DNA (mg/g) 2. 95:tO. 29 3.25:t0.13 1 . 06:tO . 08 1.37:t0.04 
Total DNA (mg) 21 • 2:t2. S 16 ,4:t2. 7 17. 7:t2. 3 1S.9:t2.8 
Protein/ONA (mg/mg) 48.4:t4,7 51.9:t2.2 209:t7 179:t 11 
Mean values t SEM. Acute diabetes 5 days post-streptozotocin and 
chronic diabetes 56 days post-streptozotocin. Protein, RNA and DNA 
concentrations mg/g wet tissue. 
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TABLE 4 - 3 THE EFFECT OF ACUTE ANO CJ-iRONIC DIABETES ON KIIJ~EY PROTEIN, 
RNA ANO ONA CONCENTRATIONS 
Control Acute Control Chronic di abeti C di abeti C 
(6 rats) ( 13 rats) (5 rats) (B rats) 
Total tissue weight (g) l .31::0.04 1.53.t0.06 3.07:tO. 16 3.091:0. 24 
Protein (g/lOOg) 11. 37:t0.18 10. 7lt0.20 11 .26:tO. 74 11.431:0. 34 
Total protein (mg) 1491: B 164±9 348:t6 359±7 
RNA (mg/g) 3.34±0.26 3.09±0.12 3.09:tO. 21 2.28±0 . 16 
Total RNA (mg) 4.38:tO.ll 4.73±0.09 9.86:t0.12 7. l 0:tO. 17 
RNA/Protein (mg/g) 26.3:tJ.3 29.0.tl .1 27 .6:tl.2 19 .8±1 .1 
ONA (mg/g) 5.52±0.33 5. 19:tO. 22 4.48±0.30 3. 72±0. 37 
Total ONA (mg) 7 .23.tO. 71 7.94:t0.58 13. 71:tO. 82 11.52±0.63 
Protein/ONA (mg/mg) 21.0±1 .3 21.2:t0.8 25.1:t0.8 32 .0±3 .0 
Mean va 1 ues ? SEM. Acute diabetes 5 days pos t-s treptozotoci n and 
chronic diabetes 56 days post-streptozotocin. Protein, RNA and ONA 
concentrations mg/g wet tissue. 
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1976). T'iis was examinedinastudyinwhich4 day diabetic rats were 
treated for a further 4 days with PZI (4 units/day). As is shown in 
Table 4-4, this short duration of insulin treatment was ineffective in 
normalizing kidney protein and RNA content, despite increased growth 
rates and control plasma glucose values in the insulin treated rats. 
The gastrocnemius muscle responded to insulin with an increase in RNA 
content and RNA to protein ratios, but only partially so as was 
reported also by Pain & Garlick (1974). In contrast, the liver 
demonstrated a marked increase in total tissue weight, namely from 
6.4 g in control and 4.9 g in diabetic rats to 9.1 g in insulin 
treated rats. This pronounced enlargement of the liver in response to 
insulin has been noted by other workers (Steiner & Williams~ 1959; 
Peavy et al., 1978) and is probablypartlyduetoan ir.tnsitoryaccumulation 
of glycogen and fat in the liver since glycogen deposition, as 
measured by activity of UDPglucose glycogen glucosyl-transferase, is 
increased within hours of insulin administration (Steiner & King, 
1964). 
4.7 CONCLUSION 
From this series of experiments it was concluded that in young 
(90-lOOg) rats,a streptozotocin dose of 13 mg effectively destroyed 
enough B-cel ls of the Islets of Langerhans to result in a severe 
diabetic state. The results of the effect of diabetes on growth, food 
intake, plasma glucose and tissue protein, RNA and DNA content, are 
all similar to published data. Furthermore, the insulin treatment 
regime as tested was found to be an efficient method of normalizing 
the physiological abnormalities caused by diabetes. 
This diabetic model and insulin treatment regime was used 
throughout in the experiments to be discussed. 
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TABLE 4 - 4 THE EFFECT OF INSULIN TREATMENT ON PROTEIN AND RNA CONTENT 
OF LIVER, GASTROCNEMIUS AND KIDNEY 
Control Di abeti C 
Insulin 
treated 
( 5 rats) (5 rats) (4 rats) 
Body weight (g) 137 ± 2 115 :t 4 128 :t 4 
Plasma glucose (mg/100 ml) 178 :t 16 633 ± 26 108 :t 12 
Total protein (mg) - Liver 1036 :t 36 1033 :t 46 1320 :t 73 
- Gastrocnemius 222 .± 10 156 :t 13 164 :t 19 
- Kidney 174 :t 10 198 :t 14 190 :t 13 
Total RNA (mg) - Liver 55 :t 3 42 .± 3 66 :t 3 
- Gas trocnemi us 2. 5 :t o. 1 1.3 :t 0.2 1.9 :t 0.2 
- Kidney 5.9 :t 0.3 6. 3 :t 0.5 6.0 :t 0.4 
RNA/Protein (mg/g) - Liver 53. 3 :t 1.1 40.8 :t 3.2 50.0 :t 3.6 
- Gas trocnemi us 12. 4 :t 1.3 9. 1 :t 0.6 11.9 :t 0.8 
- Kidney 34.6 :t 2.1 31 . 9 :t O. 5 31.9 :t 1.4 
01 abetfc rats were 5 days post-streptozotocin. 
Insulin treatment (4 U PZI / d11y) of 4 day diabetic rats for a further 
4 days. 
SECTION 5 
WHOLE BODY PROTEIN TURNOVER IN DIABETIC AND INSULIN TREATED 
RATS 
5. 1 INTRODUCTION 
l 04. 
The investigation of protein metabolism in adult diabetics failed 
to show any differences between rates of whole-body protein synthesis 
before and after short periods of insulin treatment (Section 3), which 
contrasted with the large decrease in muscle-protein synthesis found in 
streptozotocin diabetic rats (Pain & Garlick, 1974; Millward et al., 
1976, and Sections 6 and 7). Since no published data was available on 
whole-body protein turnover in diabetic animals, the following study 
was planned : 
(a) to detenuine whole-body protein synthesis and breakdown rates by 
constant infusion with L-[l- 14cJ leucine in diabetic (4 and 8 days 
post-streptozotocin), insulin treated diabetic and age control rats. 
(b) to determine whole-body protein oxidation rates in these three 
experimental groups and their controls during the same infusion by 
measurement of the proportion of the 14c 1 abel excreted in res pi ra tory 
From the two-pool model discussed in Section 1.1. 1 it is evident 
that the loss of label of a 14c amino acid via oxidation and the 
excretory pathway can be determined from the output of 
14
co2 . If 
measurements are made over a short time and so exclude re-entry of 
tracer from the breakdown pathway of this model, the two main routes 
of disposal of amino acids are by synthesis and oxidation. Therefore, 
the proportion of label appearing in respiratory co2 should give an 
estimate of the relative flow of amino acids along the pathway of 
oxidation compared with that of synthesis to protein. 
Most published in vivo data, us i ng closed systems for 
14
co2 
collection, have expressed amino acid oxidation only as proportion of 
14co
2 
output, without measurement of flux which enables calculation of 
synthesis rates (McFarlane & von Holt, 1969 ; Meikle & Klain, 1972; 
Neale & Waterlow, 1974 a, b). 
5.2.1 Calculation of protein turnover 
Flux was determined from the specific acitivy of the free amino 
acid in plasma when a plateau was achieved during constant infusion 
with c1-14cJ leucine. At plateau the input and outflow of radio• 
activity would be equal, hence 
i .. 
Q ( 1 ) 
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where i* is the rate of isotope infused (dpm/minute), Smax the specific 
activity of plasma at p 1 a teau ( dpm/umol el and Q the flux ( umoles/mi nute). 
Oxidation (E, umoles/minute) was obtained from 
E e " (2) 
5max 
where e* is the rate of excretion of 14co2 (dpm/minute). 
Protein synthesis (Z), oxidation (E) and breakdown (B) rates were 
obtained from 
Q • Z+E • B+I (J) 
The calculation of breakdown required precise information on diet 
intake (I) and on the leucine content of the rat diet. From automated 
106. 
amino acid analysis, the Oxoid diet was found to contain 1.17g leucine 
per 100 gram diet. Alternatively, breakdown was calculated from total 
body growth (G) 
8 Z - G (4) 
where grams of body weight gained per day was converted to leucine, 
using a value of 88.6 lllllOles leucine per gram body weight (Fern, 1975) . 
In all the experiments flux was determined from the plasma 
specific activity of leucine, with the plasma extracellular pool 
therefore used as a representative of the precursor pool from which 
protein synthesis and oxidation take place. In Section 5.4.4, a 
comparison will be made with the same results calculated from the 
tissue free amino acid pool. 
Al 1 va I ues for synthesis oxidation and breakdown were expressed 
as umoles leucine per minute per lOOg rat weight to accommodate for 
the difference in final body weight between diaoetic: and control groups. 
5.2.2 Tissue and respiratory co, collection and analysis 
5.2.2.1 Apparatus for 14co., collection 
.. 
c1- 14cJ leucine was Infused over a period of 4 hours and 14co2 
in expired air collected by an apparatus designed to overcome the 
complexicity and problems of a closed air collection system. 
A diagram of the system used is shown in Figure 5-1. c14cJ-
leucine was infused into the rat via a tail vein by a slow speed 
constant infusion pump. The rat, wrapped in a restraining cloth, was 
placed In a glass tube (25cm x 6 cm) closed at one end with a rubber 
stopper pierced by an outlet bore hole. The outlet was connected to 
translucent polythene tubing (9.52 Jllll 00 x 6.35 11111 [D) leading to a 
system of scintillation vials containing 3 ml of a 1:2 (v/v) mixture 
of hyamine hydroxide and ethanol, a mixture which effectively trapped 
CO2 , At precisely timed intervals, air was sequentially bubbled 
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amino acid analysis, the Oxoid diet was found to contain 1. 17g leucine 
per 100 gram diet. Alternatively, breakdown was calculated from total 
body growth (G) 
8 = Z - G (4) 
where grams of body weight gained per day was converted to leucine, 
using a value of 88.6 \.lmoles leucine per gram body weight (Fern, 1975). 
In all the experiments flux was determined from the plasma 
specific activity of leucine, with the plasma extracellular pool 
therefore used as a representative of the precursor pool from which 
protein synthesis and oxidation take place. In Section 5.4.4, a 
comparison will be made with the same results calculated from the 
tissue free amino acid pool. 
All values for synthesis oxidation and breakdown were express@d 
as 1Jmoles leucine per minute per 100g rat weight to accommodate for 
the difference in final body weight between diabetic and control groups. 
5.2.2 Tissue and resciratory co2 collection and analysis 
5.2.2 . 1 Aooaratus for 14co2 collection 
c1- 14CJ leucine was infused over a period of 4 hours and 14co2 
in expired air collected by an apparatus designed to overcome the 
complexicity and problems of a closed air collection system. 
A di a gram of the system used is shown in Figure 5-1 . [ 14cJ -
leucine was infused into the rat via a tail vein by a slow speed 
constant infusion pump, The rat, wrapped in a restraining cloth, was 
placed fn a glass tube (25cm x 6 cm) closed at one end with a rubber 
stopper pierced by an outlet bore hole. The outlet was connected to 
translucent polythene tubing (9.52 nm OD x 6.35 11111 ID) leading to a 
sys':.em of scintillation vials containing 3 ml of a 1:2 (v/v) mixture 
of hyamine hydro,dde and ethanol, a mixture which effect1 vely trapped 
co2 . At precisely timed Intervals, air was sequentially bubbled 
F!GURE 5-1 APPARATUS FOR THE COLLECTION OF 
14col DURING INFUSIONS WITH (1-14c)LEUCINE 
GLASS CYLINDER WITH 
RAT 
1. 
14c-LEUCINE 
IMFUS ION 
~ 
I 
OUTLET 
TO 
FUME CABINET 
-
H2O BYPASS 
HYAMINE 
TRAPPING 
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TO V DUPLICATE 
SYSTEM 
l 
AIRFLOW TO 
PUMP 
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through the two vials for exactly 60 seconds. The air pump was a 
Charles Austin diaphragm pump (Type MU 19/26) with a free air di s-
placement of 16 litres per minute and 500 11111 Hg vacuum capacity. Air 
was drawn through the scintillation vials via resistant thick walled 
polythene tubing (ID 2m x OD 3nm) which passed through the vial caps. 
Two vials were used sequentially, since the first vial was 98 to 99% 
efficient in trapping 14co2. The second vial functioned as 'spillover' 
trap. Between the actual collection periods of 60 seconds, air was 
drawn through an identical bypass system of vials containing water, 
which maintained a constant flow of air from the glass cylinder and 
effectively prevented 14co2 accumulation in the system. Expired air 
was pumped directly to a fume cabinet to prevent 14co2 contamination of 
room air. 
The radi oacti vi ty of the trapped 14co2 was determined by counting 
in a Beckman LS 150 liquid scintillation counter, with 10 ml of 0.4% 
2,5 dinitrophenyloxazole in toluene as scintillant. 
The final apparatus included a duplicate system which enabled 
14 simultaneous infusion and co2 collection of two animals. The 
efficiency of the apparatus in recovery of 
14
co2 was tested with 
Na H14co3 and [1-
14cJ leucine infusions. 
Bicarbonate infusion: Oxidation of 14c amino acids or Na H
14
co3 
produces 14co
2 
which rapidly exchanges with the body bicarbonate pool 
from 1111hich it is released and excreted in expired air. [n man, 
infusion of Na H14co 3 results in only 80% of the label being excreted 
as 14co
2
, with a 20~ retention in the body (James et al., 1976), 
Sketcher (1976), using a closed system of 14co2 collection, established 
• 1 • "' h " H14'.:03 that 1n rats the label was quint, tat ve 1y excrete .. w •n na s. wt~ 
infused. 14 
The present system was tested with Infusing Na H co 3 directly 
i nto a beaker containing 1 N HCl placed in the gins tube. 100% of 
the label was recovered as 14co2• However when Na H 
14c0:3 (2 1JCi/ml) 
was infused into animals, each rat quite surprizingly and consistently 
14 . produced a CO2 output of 150 - 249% of the , nfused dose: This 
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indicated that 14co2 was accumulating in the glass tube between periods 
of 14co2 collection. At this stage of development the system did not 
include the bypass vials, hence airflow was restricted to a minimum 
between each collection period of 60 seconds. Therefore a change was 
made by building into the collection system two bypass vials containing 
water. Between 14co2 collection periods air would thus flow uninter-
rupted frora the rat to the pump via these vials and so prevent 
accumulation. As a last precaution the pump-outlet was led directly 
to a fume cabinet to prevent any re-circulation of 14co2 in the room 
air. 
With these adjustments made,further infusions of Na H14co3 
(2 1JCi/ml) into control male albino Wistar rats of 100 - 1209 1 gave 
the expected result of 100% excretion of the label (Figure 5-2). 
14co output reached a plateau value within 60 minutes and was main-2 
tained throughout 2- 3 hours of infusion. With no retention of 14c in 
the bicarbonate pool, it was assumed that no correct1on factor would 
be required to estimate the absolute oxidation rate with [ 14cJ leucine 
infusions. The calculated half-life of the bicarbonate pool was 12 
minutes (Figure 5-2) which agrees well with the 15 minutes reported 
by Sketcher (1976) and the 12.5 minutes of Millward (1970). 
Leucine infusion: The objective of this pilot study was to determine 
(a) the rate of 14co2 excretion and (b) the time in which a plateau 
would be reached in 14co2 output in diabetic and control rats. Six 
days after diabetes was induced wf th streptozotocin, diabetic and 
control rats were infused for 4 hours with [1- 14c] leucine (5 uCi/ml, 
50 mCi/nrnol). The rise to plateau of 14co2 in expired air as ~ of 
Figure 5-2 14co2 OUTPUT A.S % OF INFUSED NaH
14
co3 
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Output of 14c0i during constant infusion by tail vein of Na H14co3 
(2~Ci/■1) at 0.5111/hour into one 100g rat. 
infused dose is shown in Figure 5-3. In control rats a plateau was 
reached within 2 hours and 12.5% of the label was recovered in co2. 
In the diabetic rats a plateau was also reached and excretion of label 
increased up to 20.4%. 
The results of the Na H14co3 and leucine infusion pilot studies 
confirmed that the apparatus was an effective system for the measure-
ment of expired 14co2 and hence oxidation rate. 
5.2.2.2 Constant infusion technique 
Each rat was wrapped in a cloth before being placed inside the 
glass tube (see Figure 5-1). This restrained movement during the 
infusion and from previous experience in this laboratory, did not 
appear to ser)ously stress the rat or impair nonnal breathing. The 
rat's tail was washed in warm water and the tail veins further dilated 
by a coating with xylene. The lateral vein was cannula ted with a 26G 
(i inch) needle without it's plastic ferrule. The needle was connected 
to a soft-walled polyvinyl cannula ([D 0.4nrnl leading to a 1 ml syringe 
containing D.9% (w/v} saline, The needle with cannula was held in 
place in the vein by adhesive tape around that section of the tall. 
The infusion was started by replacing the saline syringe with a 10 ml 
syringe containing the 14c labelled amino acid. This 10 ml syringe 
was firmly clamped onto a constant speed slow infusion pump (Scientific 
and Research Instruments Limited, Croydon, Surrey, U.K.} set at a flow-
rate of 0.46 ml per hour. 
Each infusion lasted at least 4 hours wtth 60 second periods of 
14co2 trapping every JO minutes until a plateau was reached in i
4co2 
production. Thereafter the rate of 14co2 production was measured at 
intervals of 15 minutes. 
1".od1f1cat1on of" infusion technique: Food intake data were collected 1n 
a 11 expe ri men ta 1 groups and their controls on the two days Preceding 
the constant infusion of c14cJ leucfne, whilst growth was measured 
111. 
Figure 5-3 14co2 OOTPUT AS I Of INFUSED (1 14C)LEUCINE 
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Output of 14co2 during constant infusion of L(l-
14
c)leucine (5µCi/ml) at 
0.5111/hour in 5 diabetic and 5 control rats. 
daily by weighing the rats at the same time each morning. 
Due to the severe hyperphagia observed in the 8 day diabetic and 
insulin treated rats, a modification had to be made in Experiment II 
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( Sec ti on 5. 4. 2) in the constant infusion technique. In a pilot study 
of PZI treated diabetic rats infused with [ 14cJ leucine, only 2 out of 
5 rats survived the 4 hour period in the glass cylinder without access 
to food. The surviving rats had very low plasma glucose values, ie. 
23 and 51 mg/100 ml. The absence of food combined with the still 
available PZI in the plasma was obviously responsible for severe hypo-
glycaemia which in some rats caused their death. It was therefore 
prudent to modify the existing system of 14co2 collection to enable all 
rats in Experiment II to have access to food during the infusion. 
Instead of being wrapped and restrained by a cloth inside the 
glass tube, the rats were placed in wire restraining cages with free 
access to food and water, whilst being infused via the tail vein. The 
restraining cages consisted of a cylinder formed by 15 cm long wire 
needles protruding through a movable perspex foot-plate on one end and 
immovably attached to the other end. These wires enabled changes in 
both the inside diameter and length of the cage to acco111110date the 
large control and small diabetic rats. 
By constantly monitoring the rat in the restraining cage, it was 
possible to prevent the rat from pulling or chewing the cannula from 
ft' s tail vein. It was also possible to observe and confirm that 
hyperphagic rats did in fact eat small meals at short intervals. 
After 3 hours of ( 14cJ leucine infusion, the rats were gently 
removed from the wire cage, wrapped in a cloth and placed fn the glass 
cylinder of the 14co2 collection system without dislodging the 
infusion cannulas. Having previously established that plateau 14co2 
production was reached within two to three hours, adequate measurements 
of 14co2 excretion fn this experimentweremade during only the last 
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hour of the infusion. 
5.2.2.3 Specific activity measurements 
At the end of each 4 hour infusion, rats were decapitated and bled 
from the trunk vessels. The gastrocnemius muscles were rapidly removed 
and frozen in liquid nitrogen. 
The mixed venous and arterial blood was spun at 1200 x g for 10 
minutes and part of the plasma was used to detennine plasma glucose. 
The rest of the plasma was precipitated with an equal volume of 5% 
sulphosalicylic acid and spun. The plasma supernatant containing the 
free amino acid fraction was then stored frozen and used to determine 
the specific activity of C4CJ1eucine in plasma by automated amino acid 
analysis. 
The muscle samples were prepared for amino acid analysis by 
pulverizing the frozen muscle between two aluminium blocks cooled on 
dry ice (see Section 4l and precipitated with 10% trichloroacetic acid . 
The acid was removed from the supernatant containing the free amino 
acids by three ether washes and the supematant. was then stored frozen 
for later analysis. 
All specific radioactivities were determined with a Locarte amino 
acid analyzer (Locarte Company, London W12) fitted with a column 
effluent stream splitter which enabled quantitation of both amino acid 
and it's radioactivity. The procedure followed was similar to the 
method described in Section 3 for 3-methyl histidine detenninations, but 
with some modifications. The column was eluted with 0.2 M sodium 
citrate buffer (pH 3.44) at a temperature of 65°c, with a total amino 
acid analysis running time of 240 minutes per sample and flow rate of 
30 ml per hour. Internal cal ibrat1on standards of mM norleucine and 
2 mM cycloleucine were run with each sample,and at a few days intervals, 
a Pierce-H amino ac1d calibration standard (Pierce Chemical Company, 
Rockford, Ill, U.S.A.). An internal standard equivalent could then be 
calculated and the specific activity detennined of leucine in each sample 
from the counts in each fraction collected by the co 1 umn effluents tream 
splitter. A split of 1:1 (fraction collector:amino acid analyzer) was 
used and 6 minute fractions were collected with an LKB Ul trarac (LKB 
Limited, South Croydon, Surrey, U.K.). The fractions were quantita-
tively transferred to scintillation vials and counted in a Triton 
X-100/xylene based scintillant. 
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The same system of automated amino acid analysis (.without effluent 
stream splitter) was used to detennine the leucine content of the cubed 
diet (Oxoi d). This information was required to convert food intake to 
leucine intake and from this data, calculate breakdown as described in 
the calculation section. For amino acid analysis the cubed diet was 
hydrolyzed in 6N HCl for 24 hours in sealed tubes and evaporated to 
dryness to remove the acid. The procedure of analysis was the same as 
described above. 
5.3 TREATMENT PROTOCOLS FOR EXPERIMENTS I AND II 
Experiments were planned to measure whole body protein turnover 
in rats with short and long duration diabetes and in diabetic rats 
treated with insulin to enable valid comparisons to be made with 
insulin treated diabetic patients. An outline of the protocol used is 
shown 1 n Figure 5-4. 
Male Wistar rats of 90 -100 grams were used in all experiments. 
Diabetes was induced with 13mg streptozotocin as explained in Section 
4. Food intake was monitored in all rats. 
In Experiment I rats were infused with [l-14cJ leucine after 4 
days of diabetes at which time the food intake of the diabetic rats and 
their co,,trols were equal. This experiment therefore excluded the 
effect of changes in food intake on the rate of leucine oxidation . 
In experiment II both the diabetic and insulin treated rats were 
, 
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hyperphagic compared with their controls. The diabetic rats were 
infused 8 days after diabetes was induced. at which time hyperphagia 
was well established. As shown in Section 4, insulin treatment results 
in a similar hyperphagic response as that observed in long duration 
diabetes. Ra ts diabetic for 4 days, were treated for a further 4 days 
with a single daily dose of 4 units PZI and infused on day 8 (Figure 
5-4). In this experiment the rats were allowed access to food during 
the first 3 hours of the infusion as explained in Section 5.2.2.2. 
The results of each set of diabetic or insulin treated rats were 
compared with it's own group of age controls. 
5.4 RESULTS ANO DISCUSSION 
5.4.1 Exoeriment I: The effect of 4 days of diabetes on protein 
synthesis and oxidation rates 
After 4 days of diabetes, protein synthesis rates were only 
slightly decreased (Table 5-1), whereas the rate of oxidation was 
significantly increased above that of the controls. Due to nonnal 
animal variation in resistance to a-cell destruction by streptozotocin, 
some of the rats were only mildly diabetic. This group differed from 
14 the age controls only in plasma glucose values and co2 production 
(Table 5-1). The two groups of diabetic rats showed a significant 
correlation (p < O. 05) between the degree of diabetes , 1 e. plasma 
glucose, and the rate of 1eucfneox1dat1on (Fig.5-5). No difference was 
shown 1 n rate of flux between the two diabetic groups and the control 
rats. 
5.4.2 Experiment II: The effect of 8 days of diabetes and of insulin 
treat-nt on orotein svnthesis and oxidation rates 
After 8 days of diabetes, plasma glucose and food intake were 
significantly increased above that of the control groups and growth 
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TABLE 5 - l THE EFFECT OF MILD ANO SEVERE DIABETES ( 4 days) ON 14co., 
.. 
OUTPUT AND RATES OF FLUX.OXIDATION AND SYNTHESIS 
Control Mild Severe diabetes d1 abetes 
--- .. 
.. 
--- - (5 rats) ( 5 rats) (5 rats) 
I 
Food intake (g/day) 16.6::t0.5 - 16.3:0.4 
Body weight (g) 109:!:4 101:t.6 92:!:4 
Plasma glucose (mg/lOOml) 159%6 262:!:44 453:tll 
111 ,416:!:484 14 co2 output (dpm/min) 12,720:t1148 21,656 :tl 230 
SA Leuc1ne ( dpm/ l.fflO 1 e ) 47 ,987:1:1404 55, 709 :t.6299 56 ,320:!:4430 
Fl uxt 1.677::0.000 l . 680::0. 059 l. 785:t0.097 
Ox1dat1ont 0.222:t0.018 0 . 2 31 :tO • OCB 0. 428:tO. 035* 
Synthesist 1.455:t0.064 l . 450::0. 067 l .358:t0.074 
Al 1 values mean ± SEM for age controls and diabetic groups (both 4 days post• 
streptozotoc1n 1nject1on). Leucine specific activity (SA) measured in 
plasma and used in estimating flux. Food intake mean value of 2 days 
14 preceding C .infusion. t 11moles 1euc1ne per mfn per 100 g rat. 
• significantly different from control p <0.001. 
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severely depressed (Table 5-2). The longer duration of diabetes 
resulted in a significant decrease in synthesis (p < 0.05). Oxidation 
rates were even further increased (p < 0.001) above control levels, 
most probably as a result of the combined effect of the longer duration 
of the disease and the increase in food intake. Again no change in 
flux was observed. 
The four day insulin regime successfully restored body weight to 
that of control rats by an accelerated growth rate. The insulin treat-
ment also resulted in ahyperphagic state similar to that of the long 
duration dfabetic rats, with an increase of 18% in food intake. 
Insulin effectively nonnalized the hyperglycaemia of the diabe~ic 
state . Plasma glucose values of SO± 8 mg/100 ml were much lower than 
the control values of 173 ! 6 mg/100 ml. Despite these seemingly hypo-
glycaemic conditions, no deaths occurred. This was most probably 
prevented by the rats having access to food and actually eating during 
the first few hours of the infusion. 
Table 5-3 shows the effect of insulin treatment on protein 
oxidation and synthesis rates. Protein synthesis rates were restored 
to that of the control rats, but despite a large decrease, the rate of 
oxidation was still significantly (p < 0.05) elevated above the control 
value. Flux rates, as in all previous experiments were unchanged. 
5.4.3 The effect of diabetes and insulin treatment on whole body break• 
down rates 
Although calculation of protein breakdown is possible in theory 
from the equations in Section 5.2.1, namely from either growth or food 
intake data, in practice the results are difficult to interpret. 
Ff gure 5-6 shows the rate of protein breakdown calculated from both 
growth and food intake of rats diabetic for 4 days (Section 5.4.1). 
Breakdown from growth data appears to indicate that although whole body 
TABLE 5 - 2 THE EFFECT OF LONG DURATION DIABETES (8 days) ON 14co2 
OUTPUT AND RATES OF FLUX, OXIDATION AND SYNTHESIS 
Control Diabetic 
(6 rats) (8 rats) 
Body we i gh t ( g) 151 ± 2 103 ± 4 
Plasma Glucose (mg/100 ml) 163 ± 5 507 ± 17 
Food intake (g/day) 18. 9 :t 0.9 24.6 ± 0.8 
14co2 Output (dpm/min) 11,679 ± 872 28,970 ± 1901 
SA Leucine ( dpm/\111101 e) 32,103 :t 1456 43,051 :t 1601 
Fluxt 1.913 :t 0.089 2.055 :t 0.075 
121. 
Oxidationt 0.242 :t 0.017 0.671 :t 0.056* 
Synthesist 1.671 :t 0.077 1.385 :t 0.057"'~• 
All values shown as mean± SEM. Leucine specific activity (SA) measured 
in plasma and used in estimating flux. Food intake mean value of 2 days 
preceding 14c infusion. \,moles leuc1ne per min per 100 g rat. 
* s1gnif1cantly different from control p < 0.001 and *'" p < 0.05. 
TABLE 5 - 2 THE EFFECT OF LONG DURATION DIABETES ( 8 days) ON 14co2 
OUTPUT AND RATES OF FLUX, OXIDATION AND SYNTHESIS 
Body weight ( g) 
Plasma Glucose (mg/100 ml) 
Food intake (g/day) 
14co2 Output (dpm/min) 
SA Leucine (dpm/umole) 
Control 
(6 rats) 
151 :1: 2 
163 ± 5 
18. 9 ± 0.9 
11,679 ::t: 872 
32,103 :1: 1456 
1. 913 t 0.089 
Diabetic 
(8 rats) 
103 t 4 
507 ± 17 
24.6 ± 0.8 
28,970 t 1901 
43,051 t 1601 
2.055 t 0.075 
121. 
Oxidationt 0.242 t 0.017 0 .671 t 0.056* 
Synthesist l .6 71 ::t: 0.077 1 .385 t 0.057"* 
All values shown as mean± SEM. Leucine specific activity (SA) measured 
in plasma and used in estimating flux. Food intake mean value of 2 days 
preceding 14c infusion. tumoles leucine per min per 100 g rat. 
• sign1f1cantly d1 fferent from control p < 0.001 and ** p < 0.05. 
TABLE 5 - 3 THE EFFECT OF INSULIN TREATMENT OF DIABETIC RATS ON RATES 
OF FLUX, OXIDATION AND SYNTHEsrst 
Flux 
Oxidation 
Synthesis 
Control 
(6 rats) 
1.671:1:0.139 
0. 230 ± 0.021 
1 • 441 ± 0. 129 
Insulin treated 
diabetics 
( 6 rats) 
1 .698 ± o. 104 
0.314 :1: 0.028* 
1 • 384 :1: 0 . 091 
All values meant SEM calculated from plasma leucine 
specific activity. 
* significantly different from control p <0.05. 
tumoles 1euc1ne per mfn per 100 g rat. 
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protein synthesis was not affected by 4 days of diabetes. protein 
breakdown was significantly increased. However, if we consider break-
down rates calculated from food intake data from these non-hyperphagic 
diabetic rats. the total picture is changed, with both synthesis and 
breakdown unaltered by diabetes. 
The interpretation of breakdown rates becomes even more obscure 
if one considers the effect of 8 days of diabetes combined with hyper-
phagia (Figure 5-7). From growth data, breakdown is not significantly 
changed by diabetes, whereas from food intake data breakdown rates are 
now severely depressed. In the insulin treated rats, the accelerated 
growth rate and enhanced food intake resulted in very low breakdown 
rates as calculated from either growth or intake. 
In humans the estimation of breakdown from Q,. Z+E,. B+I is valid 
since the intake of food can be regulated to coincide with the time 
(9 or 12 hours) over which protein turnover measurements are made (see 
Section 3.3.1). In the animal experiments however, whole body protein 
turnover is measured during a 4 hour infusion and compared with the rate 
of whole body growth over 24 hours or the intake of food over 24 hours. 
Therefore, a mean value of food intake is applied in the calculation 
without knowledge of the rate of absorption of protein from food 
during the 4 hour infusion period. Furthermore, the actual measure-
ment of growth and food intake cannot be exact and is highly variable, 
for example it is influenced by the time of day at which the rats and 
food are weighed or even conditions in the animal house such as lesser 
disturbance over weekends than during the week. The results of this 
study suggest that calculation of whole body breakdown rates are not 
valid in the animal model. 
5.4.4 Flux measurements from plasma and tissue free precursor pools 
The results presented to date were based on flux measurements 
from the spe cif ic activity of 1eucine 1n the plasma precursor pool. 
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Waterlow et al.(1978a) have suggested that since the precursor pool is 
not homogenous and possibly compartmented, the pool probably lies some-
where between the intracellular (free tissue) and extracellular (plasma) 
pools. 
The intracellular free amino acid pool (from gastrocnemius muscle) 
is therefore an equally valid choice and, as precursor pool for protein 
oxidation, probably more realistic since muscle is not only a major 
site of oxidation of leucine but also comprises about 50% of body 
weight in the rat (Odessey & Goldberg, 1972). 
In Figure 5-8 the rates of oxidation are su11111arized for all the 
experiments as calculated from either the plasma or intracellular 
specific activities of leucine. Since the specific activity of leucine 
in plasma will always be higher, the calculated oxidation rate will be 
the lowest value possible. From Figure 5-8 it is clear that the choice 
of precursor pool does not change the in~erpretation or statistical 
significance of the results. 
This is rather less apparent in Figure 5-9 which shows a su11111ary 
of all whole body protein synthesis rates as calculated from either 
plasma or intracellular specific activities. Whereas synthesis rates 
appear to be non11alized by insulin treatment with plasma as precursor 
pool, the synthesis rates of diabetic rats calculated from the intra-
cellular pool are not brought back to the age control values, although 
the difference 1s not statistically significant. 
The error involved in deciding on the correct pool can be 
minimized by giving a large dose of amino acid which would flood and 
nearly equalize the specific activities of all possible precursor 
pools (Henshaw et al., 1971; McNurlan et al., 1979) . This approach ..,as 
used in Section 7. 
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5. 4.5 The effect of diabetes and insulin treatment on leucine pool 
size 
The size of the free amino acid pool (plasma or intracellular) is 
influenced by the influx of amino acids from either recycling via 
breakdown or from dietary input, or by a block in protein synthesis 
and thus decreased outflow (Waterlow et a1.,1978a). Millward et al. 
(1976) showed increased leucine levels in muscle of energy restricted. 
starved and diabetic rats. They suggested that this is not necessarily 
a consequence of breakdown only but also from decreased synthesis. In 
diabetes the results of Experiment II show that there is an expanded 
leucine pool (_Table 5-4). This could possibly result from the decrease 
in protein synthesis combined with the increased dietary inflow into 
the pool in the hyperphagic state. It is possible that the expanded 
pool could enhance oxidation rate in an attempt to regulate the pool 
size . Changes in oxidation with starvation have been demonstrated by 
Goldberg & Odessey (1972) and similarly, Meikle & Klain (1972) showed 
that increases in in vivo oxidation rates were paralleled by elevated 
plasma leucine concentrations (from 0.19 to 0.75 wnoles/ml). On 
refeeding and therefore stimulation of insulin release, oxidation 
rates declined, but plasma leucine remained elevated, suggesting that 
the rate of dietary leucine intake exceeded the outflow or utilization 
of leucine by protein synthesis, oxidation or 11pogenesis. In the 
present study the near-control values of protein oxidation in insulin 
treated rats (Table 5-4) and the drop in leucine concentration, appear 
to indicate that the increased rate of protein synthesis was probably 
suff ici ent to regulate the size of the plasma leucine pool. 
5. 5 SUMMARY AND CONCLUSION 
The results of who 1 e body oxi da ti on rates appea rs to con f i nn the 
in vi tro studies of Buse and co-wo rk ers on diabetic rats. The i ncreased 
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TABLE 5 - 4 PLASMA LEUCINE CONCENTRATION AND OXIDATION RATES IN DIABETIC 
ANO INSULIN TREATED RATS 
Control a 
Diabetic 
(8 days) 
Plasma free leucine pool 0. 149 ~ 0.005 b 0.256 :t0.017 
(~moles/ml plasma) 
Oxidation rate 0.236 t 0.013 0.671 ; 0 .056 
(jJ1110les leu/min/100 g rat) 
All values meant SEM. 
a - mean control values from Experiments [and [I. 
b - significantly different from control p < 0.005. 
c - significantly different from control p <0.001. 
Insulin 
treated 
0. l 36 t O . 024 
0.314:t: 0.028 
131. 
oxidation rates observed with incubation studies in hemidiaphragms 
(Buse et al., 1976a), retina (Frayser & Buse, 1978), sciatic nerves 
(Buse et al., 1976b) and in 1 iver, kidney and gastrocnemius muscle (Paul 
& Adibi, 1978) could all be decreased to near normal values by prior 
treatment of the rats with insulin. The present work confinns that 
whole body protein oxidation rates are greatly enhanced in diabetes and 
also normalized by insulin treatment. 
Buse et al. (1976a) furthermore suggested that in diabetes the 
increase in oxidation was paralleled by enhanced breakdown. Due to the 
inherent practical problems in calculating valid protein breakdown 
values, it is difficult to evaluate this suggestion. Although it 
should be possible in theory to calculate protein breakdown from this 
method, the results in the preceding section show that this is not 
feasible in the present animal model. A possible approach would be to 
maintain feeding via an intragastric tube throughout the 4 hour 
measurement of protein tumover. 
The decrease in whole body protein synthesis rate caused by 
diabetes confinns the in vivo tissue measurements in diabetic rats 
(Pain & Garlick, 1974, Millward et al., 1976). Similarly, the nonna1-
iz1ng effect of insulin treatment on whole body protein synthesis has 
also been reported for tissue synthesis rates (Pain & Garlick, 1974). 
However, considering that these rats were severely diabetic, the 
dropof17%inwholebodysynthesis was rather small compared to the 
60-70% decrease measured in tissue synthesis (Sections 6 and 7). 
This may explain why the changes observed in whole body protein 
synthesis in humans (Section 3) could not be detected when measured 
before or after insulin treatment, since in these patients the severity 
of the diabetic state was much less than in the rats studied here. 
The next investigations were therefore to detennine the effect of 
diabetes on individual tissues from rats with acute and chronic diabetes . 
SECTION 6 
T!SSUE PROTEIN SYNTHESIS [N O[ABETIC RATS INFUSED WITH cl4cJ-
TYROSINE 
6.1 INTRODUCTION 
In diabetic rats the 17% decrease observed in rates of whole body 
protein synthesis {Section 5) was much smaller than the effect which 
had been demonstrated in some tissues of diabetic rats. Pain & Garlick 
(1974) reported a drop in synthesis of 69% in skeletal muscle and 44% 
in heart muscle. Similarly, Millward et al. {1976) demonstrated a 
decrease of 63% in synthesis rates of gastrocnemius muscle in rats not 
even severely diabetic (8 11Units insulin per ml plasma were still 
present in the diabetic group). In contrast to muscle, protein synthesis 
in 1 i ver was found to be unaffected by diabetes as measured by the 
constant infusion technique (Hay & Waterlow, 1967; Pain & Garlick, 
1974). 
These studies were at the time the only published data on the 
in vivo effect of diabetes on protein synthesis in skeletal muscle, 
heart and liver. 
The aim of this experiment was therefore to i nves ti gate protein 
synthesis in the liver, gastrocnemius muscle and kidney in rats (a) 
in the acute phase of the disease, ie. 5 days after injection with 
streptozotocin, (b} in the chronic phase, 56 days post-streptozotocin 
and (c) to follow the severity and progress of diabetes in rats with 
different initial body weights. 
132. 
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6.2 METHOD 
Two groups of male Wistar rats weighing 70 and 100 grams were 
purchased from Charles River. They were housed individually and 
allowed free access to food and water until their body weights reached 
90 and 120 grams respectively. 
The animals were then divided into three experimental groups : 
(a) Acute diabetic group, initial weight 90 gram, infused 5 days post• 
streptozotocin (6 rats). 
(b) Acute diabetic group, initial weight 120 gram, infused 5 days post-
streptozotocin (6 rats). 
(c) Chronic diabetic group, initial weights 90 and 120 gram, infused 
56 days post-streptozotocin (7 rats). 
The results of the three experiments were compared with three groups 
of age controls (6 rats each). Diabetes was induced by streptozotocin 
as described previously. 
The constant intravenous infusion technique was similar to that in 
Section 5.2.2.2 with the following changes. cu- 14cJTyrosine (The 
Radiochemical Centre, Amersham, U.K.} was infused for 6 hours at a 
concentration of 4 uCi per ml at a rate of 0.5 ml per hour. During 
this time the rats were restrained by being wrapped in a cloth. 
6.2.1 Sample collection 
After 6 hours the cannula was removed, the rats decapitated and 
mixed arterial and venous blood collected from the severed trunk 
vessels. The liver and both kidneys and gastrocnemius muscles were 
rapidly removed and weighed. Part of the liver, one gastrocnem1us 
muscle and one kidney were i1T111ediately frozen in liquid nitrogen for 
subsequent analysis of protein, RNA and ONA content, by the procedure 
previously described (Section 4.6.1) . Plasma was prepared by centri-
fugation of the heparinized blood collected at sacrifice. Aliquots 
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were taken for later analysis of glucose and insulin (Section 4). 
Approximately l gram of tissue was homogenized in ice-cold 10% (w/v) 
trichloroacetic acid (TCA) (liver 3 ml, kidney and muscle 2 ml). All 
the homogenized samples were then centrifuged and the supernatant 
containing the free amino acid removed and reserved. The protein pre-
cipitates were washed twice with 1 ml 10% TCA to further extract free 
radioactivity, with each wash being combined with the first supernatant. 
TCA was removed from these supernatants by three ether washes. ThP-re-
after each supernatant was made up to a standard volume of 5 ml and 
stored frozen at -1s0 c for later analysis of specific radioactivity of 
free tyrosine. The protein preci pi ta tes were hydrolyzed 1 n sea 1 ed tubes 
for 20 hours at 11 o0 c with 5 ml 6N HC 1 ('constant boiling'), p 1 us 3 drops 
of mercaptoethanol to prevent amino acid oxidation. The hydrochloric 
acid was removed by repeated heat evaporation and the hydrolyzed 
protein was subsequently taken up in 5 ml distilled water and stored 
frozen. 
6.2.2 Tyrosine specific activity 
The specific radioactivity of free and protein tyrosine was 
estimated as described by Garlick & Marshall (.1972). Tyrosine in the 
samples was converted to tyramine by L-tyrosine decarboxylase (acetone 
powder of Streptococcus faeca 1 is, Type 1 , Sigma Chemical Company, 
London). The enzyme was first washed with citrate buffer (.0. SM, pH 
5.5) and then suspended at a dilution of 2 mg/ml in citrate buffer. 
l ml of each sample was incubated for 1 hour at 37°c with 1 ml of 
citrate buffer and 1 ml of buffered enzyme. The resulting tyram1ne was 
extracted from the enzyme sol ut1 on 1 nto 10 ml ethy 1 acetate 1 n the 
presence of lg anhydrous sodium carbonate and lg sodium chloride. The 
organic phase was removed and 5 ml chloroform plus 4.5 ml (3.0 ml for 
protein samples) sulphuri c acid (1:2000) added, mixed and centrifug~d 
at low speed. Al iquots (2 x 1 ml) of the upper aqueous phase containing 
the tyramine were counted for radioactivity in a Beckman LS 150 liquid 
scintillation spectrometer using a Triton-XlOO/xylene based scintillant. 
Duplicate 1 ml samples (10 - 20 ul for protein hydrolysates) were 
assayed by the fluorimetric method of Waalkes & Udenfriend (1957). The 
tyramine in the sample was reacted with 1 ml 1-nitroso-2-naphtol 
(0. 1% in ethanol} in the presence of 1 ml nitric acid reagent (0.05% 
sodium nitrite in 1 :5 nitric acid), which formed a stable yellow com-
pound during a 30 minute incubation at ss0 c. Unchanged nitrosonaphto1 
reagent was extracted with 10 ml dichloroethane and after centri-
fugation, the supernatant aqueous layer was transferred to cuvettes. 
Fluorescence was measured at 570 m~ using a Locarte fluorimeter, 
(Locarte Company, London). Appropriate standard solutions of tyramine 
hydrochloride (0.01 nt,!J were assayed wtth each set of samples. 
6.2.3 Calculation of protein synthesis rates 
The results were calculated by the method of Waterlow & Stephen 
(1968), as roodified and described by Garlick et al. (1973). As 
discussed in Section 1.1.3 fractional synthesis rate (k 5 ) for 1 iver 
and kidney was obtained from 
>.P ( 1 - e -ks t ks 
( >.P - k
5 
) (_1 - e •>.pt 
and for tissues such as skeletal and cardiac muscle , 
from 
R - e -k st ) 
( R • 1 ) • e -Rks t ) ( R - 1 ) 
( 1 ) 
(2) 
The value of ks was derived by plotting curves of s8 / Si and ks at 
fixed values of t and R and >.P. An approximate value of >.P • 80 days· 1 
was used in eqn . 1 and R • 400 in eqn. 2 (Waterlow et al., 1978a) , 
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6.3 RESULTS AND DISCUSSION 
6.3.l Effect of diabetes on tissue compositions 
Table 6-1 shows that acute diabetes was characterized by low 
growth rates, high glucose and low insulin concentrations and increased 
water intake. The same symptoms were present in the chronically 
diabetic rats with more severe weight loss and lower insulin values. 
The difference in initial body weight had no apparent effect on the 
outcome and symptoms of acute diabetes. All the results shown for the 
chronic diabetic groups are in fact mean values for rats who had 
initially weighed 90 or 120 grams. Since there was hardly any 
difference in body weight and in tissue composition between the two 
chronic diabetic groups and the two control groups after 56 days, the 
results were combined to facilitate discussion and to enlarge the 
number of rats per group. 
Tab le 6-2 documents the effect of acute and chronic diabetes on 
tissue weight and composition of the liver. The total weight was 
reduced by acute and chronic diabetes, but total liver protein was not 
significantly affected, as reported previously (Pain et al., 1978b). 
The reduction in RNA to protein ratio in the livers of diabetic rats 
resulted from greater decreases in the total RNA content of the ltver. 
No significant change could be detected in DNA content or protein to 
DNA ratios between diabetic groups compared with their own age controls. 
Increases in total DNA or number of cells were observed in the older 
age controls compared with the 90 and 120 gram controls and in chronic 
diabetic rats versus acute diabetics. 
Severe muscle wasting was present in the acute diabetic rats and 
th1s was even more pronounced in the chronic state ( Table 6-3). 
Protein and RNA content was significantly reduced in all three diabetic 
groups as compared with their controls . The RNA to protein ratio was 
TABLE 6 - 1 EITTCT Of ACUTE AND CHRONIC DIABETES ON GRIMTH AND PLASMA CONCENTRATIONS OF <iLUCOSE 
AND INSIA.IN 
NUlllber of Final Growth* Plasaa Plasaa Food 
Rats per Body .eight Rate Glucose Insulin Intake 
group (g) (g/d) (119/lOOlll) (11U/■l) (g/d) 
Acute diabetic 90g 6 107 t 3 4.3 450 t 36 4.2 t 0.7 25 t 2 
control 90g 6 123 :t 3 6.7 148 t 4 10.7tl.9 24 :t l 
Acute diabetic 120g 6 141 :t 4 3.5 484 t 25 3.0 :t 0.7 28 t 2 
control 120g 6 168 t 3 7.8 171 t 4 19.4 :t 3.8 26 t 1 
Chronic diabetic 7 247 t 15 2.4 501 t 12 1.9 t 0.7 
-
control 7 427 t 12 5.6 145 t 4 38.4 t 1.6 -
• Growth rate mean value of two days preceding infusion. All other values mean! SEM. 
Water 
Intake 
(■1/d) 
100 
28 
123 
35 
-
-
TABLE 6 - 2 EFFECT Of ACUTE AND CHRONIC DIABETES ON LIVER TISSUE WEIGHT AND COft>0SITI0N (IU.N ! SEM) 
Total Total Total Tota 1 RNA/Protein Protei n/lJCA 
weight (g) Protei n(ag) RNA(119) i.tA( 119) (119/9) (119/ 119) 
Acute di abeti C 90g 3.98 t 0.21 837 t 62 17.9-f t 3. 46 12.04 t 1 .40 21 .6at 3.8 72.4 t 7.9 
control 90g 4.85 t 0.15 748 t 27 27.36 t 2.40 11.74 t 1. 73 36 .5 t 2.6 73 .6 t 2 .5 
Acute diabetic 120g 5.61 t 0 .20 1186 t 56 27.16 t 2.67 12. 95 t 1 .18 23.1 t 2.4 94.5 t 8 .5 
control 120g 6.75 t 0 . 20 1288 t 51 3138 t 4 .00 1189 t 1.06 27 .7±3.8 82 .9 t 4.1 
Chronic diabetic 11.87 t 0. 54 2993 t 161 52 t 8 27 t 1 17.3 t 2.3 112 t 5 
control 14.68 t 0. 86 3260 t 160 69 t 10 31 t 1 21.9 t 4.0 106 t 6 
a - signifiuntly different froa control p <0 .05 
TABLE 6 - 3 EFFECT OF ACUTE ANO CHRONIC DIABETES ON GASTROCNEMIUS TISSUE WEIGHT ANO CO~OSITION (lt:AN ± SEH) 
Total Total 
weight ( g) Protein(119) 
Acute diabetic 90g 0.90ct .08 l40at 7 
control 90g 1.25 t 0.07 169 t 9 
Acute diabetic 120g 1.24ct 0.15 178at 9 
control 120g 1.66 t 0. 12 244 t 10 
Chronic diabetic 1.98ct 0. 25 351ct 37 
control 5.44 t 0.59 913 t 71 
a - significantly different froa control p c 0.05 
b - significantly different fl"OII control p <0.01 
c - significantly different fro. control p < 0.001 
Total Total RNA/Protein Protein/00 
RNA(119) IJCA(119) (119/9) 119/119) 
b 0.99 t 0 . 11 0.82 t 0.04 7 .Oat 0 .6 l 70at 6 
1.58 t 0. 11 1.18 t 0.06 9.3 t 0.5 144 t 7 
1.29bt 0.84 1 .07 t 0.04 7.3t0.5 167 t 7 
1.95 t 0.16 1.36 t 0.04 8.0 t 0.5 180 t 7 
1.26ct 0.21 0.92ct 0.10 3.5 t 0.3 382 t 19 
3. 39 t 0.51 2.l2t0 . 12 3.8 t 0.4 433 t 33 
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decreased in the 90 gram acutely diabetic rats, but not in the other 
two diabetic groups. Total DNA in muscle was higher in controls than 
diabetic aroups and the DNA content of muscle in the chronic diabetic 
controls were higher than in the acute diabetic controls. Similarly 
the protein to DNA ratio was increased in the chronic diabetic control 
group, indicating increased cell size. 
Total kidney weights were increased by approximately 10% in the 
diabetic rats. After 56 days the total kidney weightswereno different 
from those of age controls, but expressed per 100 gram body weight, 
kidney weights of chronic diabetic rats were nearly 42% higher. 
Tissue composition data on the kidneys from these rats were unfort-
unately not available due to an experimental error, but there is no 
reason to believe that the kidney RNA, DNA and protein concentrations 
as measured previously (Section 4, Table 4-3) would not be applicable 
here. 
6.3.2 Effect of diabetes on synthesis rates of liver, gastrocnemius 
and kidney 
Fractional synthesis rate (ks) defined as that percentage of 
tissue protein which is replaced daily by protein synthesis, is shown 
in Table 6-4 for liver, gastrocnemius and kidney. The fractional 
synthesis rates of 14.7 and 13.2% per day for gastrocnemius muscle in 
control rats (90 and 120 gram groups) compare well with the published 
rates of 13.6% per day for animals of the same strain and weight range 
(Pain & Garlick, 1974). Similarly, the decline in fractional synthesis 
rate with age as seen in the 56 day control rats has been reported 
(Millward, 1978). The rate of protein synthesis in gastrocnemius 
muscle was significantly decreased (40- 50%) by diabetes, in confirm-
ation of the 69% drop in synthesis reported by Pain & Garlick (1974) 
and the 63% observed by Millward et al. (1976). 
The synthesis rates of l i ver appeared to be unaffected by diabetes 
TABlf 6 - 4 THf fff£CT OF ACUTE AND CHRONIC DIABETES ON THE RATE OF PROTEIN SYNTHESIS IN THE LIVER, 
MUSCLE AND KIMY 
S8/Si x 10 
-3 k s (percent per day) 
Liver Muscle Kidney Liver Muscle Kidney 
Acute diabetic 90g 114 t 6 15.5 t 1.6 101 t 7 51.l't 2.7 7.3at 0.7 44. 7 t 3.1 
control 90g 167 t 14 33.7 t 2.4 100 t 3 77.4t7.2 14.7 t 1.0 44.5 .t 1.6 
Acute diabetic 120g 111 t 4 11.0 t 1.0 108 t 6 49.7 t 2.0 5.4at 0.4 48.3 t 3.0 
control 120g 120 t 3 30.0 t 2.3 107 t 5 53.8 t 1.5 112 t 1.0 47.7t2.2 
Chronic diabetic 114 t 5 5.3 t 0.5 159 t 11 51.0 t 2.1 b 2.9 t 0.3 73.3 t 5.4 
control 131 t 5 11.8 t 1.8 178 t 15 58.9 t 2.3 5.7 t 0.8 82.8 t 7.6 
All values aean ! SOIi, statistically different fr011 controls a= p< 0.001; b = p< 0.005; c = p< 0.05 
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(Table 6-4), substantiating the findings of Pain & Garlick (1974) who 
used the same method of constant infusion. The difference in liver 
synthesis rate between the 90 gram acutely diabetic rat and it's age 
control is difficult to interpret. The control value of 77"/o is 
probably wrong since it is very high compared to published data (Pain & 
Garlick (1974) and, furthennore, the individual ks values in this grol.4) 
were highly variable. In contrast to the absence of an effect of 
diabetes on the fractional synthesis rate of liver proteins. the ratio 
of RNA to protein was decreased in all diabetic groups. Since the 
constant infusion method measures only fixed or cellular proteins and 
not secreted proteins, the results of this study do not exclude the 
possibility of diabetes affecting synthesis of other hepatic proteins. 
The effect of diabetes on rates of protein synthesis in the kidney 
is also documented in Table 6-4. Despite an increase in total protein 
content, acute or chronic diabetes did not appear to have any ef~ect a, 
protein synthesis. The control values of 45 and 48% protein per day 
compare well with the 50% quoted by Waterlow et al. (1978a) and the 55% 
per day reported by Garlick et al. (1975) in rats of the same age and 
weight range. The very high rates of kidney protein synthesis, ie. 73% 
and 83% in chronic diabetic rats and their age controls have not been 
reported before. 
6.4 SUt+tARY AND CONCLUSIONS 
Fractional synthesis rates of skeletal muscle responded markedly 
to insulin deficiency with decreases of 40- 50%. The magnitude of 
the decline in synthesis was unaffected by the duration of diabetes or 
any difference in initial body weight when diabetes was induced. In 
contrast, synthesis rates in the kidney and the liver appeared to be 
relatively unchanged by either the acute or the chronic state of 
diabetes. 
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Since the constant infusion method could only give an estimate of 
changes in cellular hepatic proteins, a more appropriate method was 
used in the following experiment, which enabled determination of 
synthesis rates of total (cellular plus secretory) hepatic protein. 
In addition, rates of protein breakdown were estimated by the change 
in protein mass at the time at which synthesis was measured. Apart 
from the liver, kidney and gastrocnemius studied in this experiment, 
four other muscles were additionally investigated in the following 
experiment. 
SECTION 7 
SYNTHESIS ANO BREAKDOWN RATES IN TISSUES OF DIABETIC AND INSULIN 
TREATED RATS AS MEASURED BY A LARGE DOSE OF LABELLED AMINO ACID 
7. l INTRODUCTION 
144 . 
The constant infusion technique used in the preceding study was an 
inappropriate method to measure both cellular and secretory hepatic 
proteins. Secondly, in that method the precursor of protein synthesis 
was assumed to be the free amino acid pool of the tissue. However, 
this pool is not homogenous; it is probably compartmented and during a 
constant infusion receives amino acids not only from intracellular 
proteolysis but also from the extracellular fluid. 
In the present study a method was therefore employed which 
minimized the error involved in choice of precursor pool and secondly, 
enabled measurement of both cellular and secretory proteins. This 
method involved the use of a large dose of labelled amino acid and 
measuring incorporation of label over 10 minutes. 
The aim of this study was 
(a) to determine the effect of diabetes on synthesis of total (cellular 
and secretory) hepatic proteins. 
(b) to determine the effect of diabetes on the rates of protein break-
down in tissues. 
(c) fn particular, to study rates of protein synthesis and breakdown 
within the first 24 hours of the onset of diabetic symptoms and to 
follow the changes in protein turnover as the disease progressed. 
145. 
The large dose method employed/ was first described by Henshaw etal. 
(1971) and more recently was modified by McNurlan et al. (1979). It 
has the following advantages 
(a) the amount of labelled amino acid injected is much larger than the 
normal free amino acid pool of the rat. Hence the specific activity of 
the intracellular and extracellular pools are approximately equalized 
during the short time of measurement. Furthermore, the decline in 
specific activity in plasma and tissue is very slow and can be assumed 
to be linear. 
(b) the short time of measuring incorporation (10 minutes) enables 
determination of rates of synthesis of cellular and secretory proteins 
before they are transported from the liver. 
(c) this short period of measurement also prevents retum of label to 
the intracellular pool via recycled amino acids, a particular problem 
when tissues with rapid turnover (i.e. liver and gut) are measured by 
constant infusion. 
The rate of protein breakdown in tissues was estimated by an 
indirect method, i.e. as the difference between rates of synthesis and 
rates of change of protein mass of the tissue. 
To accomplish the third aim of the study, i.e. to measure changes 
in protein turnover within 24 hours of onset of diabetes, the animal 
protocol as used in the previous experiments was modified. Strepto-
zotocin diabetic rats were treated with insulin for 3 days and protein 
measurements were made after one or more days of insulin withdrawal. 
The results were compared with age control rats, which were diabetic 
rats receiving insulin treatment throughout the experiment. 
Since large groups of rats were to be killed at various time 
points, a pilot study was planned to identify the rapidity andmagnitude 
of response 1n different tissues as the severity of diabetes increased. 
In the pilot study, a large dose of c3HJ 1eucine was injected and 
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incorporation of label into tissue was measured over 10 minutes without 
taking into account the specific activity of the free amino acid. 
Since the large dose would tend to flood the free amino acid pool, 
incorporation rates of amino acids from this pool into protein would 
reflect a relative rate of synthesis. 
In the actual study a large amount of [¾]phenylalanine was used 
and incorporation measured also over 10 minutes. Fractional synthesis 
rates were obtained by measurement of specific activity of the free and 
of the protein-bound amino acid. c3HJPhenylalanine was used instead 
of c3HJleucine since an enzymatic method had recently been developed 
in this laboratory for the determination of the specific activity of 
this amino acid (P.J. Garlick, M.A. McNurlan and V.R. Preedy, to be 
published). This method therefore did not require the time consuming 
and expensive use of an automated amino acid analyzer. 
7.2 METHODS 
7.2. l Animal treatment protocol 
Male Wistar rats (90-lOOg) were housed and fed as described 
previously. The experimental protocol followed after the strepto-
zotocin injection is outlined in Figure 7-1. Two days after induction 
of diabetes, blood samples from the tail vein were analyzed for 
glucose. Those with glucose values less than 400 mg/100 ml were 
excluded from the study. The rest of the animals were treated with 
4 Units PZI per day. After 3 days of insulin, the animals were 
randomly divided into a control group, which continued on insulin 
treatment and a diabetic group, in which insulin was withdrawn. 
Measurements were made at various days after insulin withdrawal or 
continued insulin treatment, as will be indicated later for each study. 
7.2.2 Measurements of incorporation of c3HJl eucine 
Leucine incorporation measurements were made in diabetic (insulin 
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withdrawn) and in control (insulin treated) groups of rats (5 rats 
per group). [ 3H]Leucine was injected into the tail vein {100 umoles 
unlabelled leucine and 40 uCi [ 3H]leucine per 100 gram body weight). 
After 10 minutes the rats were decapitated, bled and the liver, heart, 
kidneys and gastrocnemius muscles rapidly removed. The tissues were 
then blotted, weighed and frozen in liquid nitrogen. 
The protein and RNA content was detennined in each tissue by the 
procedure described in Section 4-6. Incorporation of the label into 
tissue was measured by counting 100 ul of the protein aliquot (see 
Figure 4-5) in a Triton X-100/xylene based scintillant. 
7.2.3 Measurement of incorporation of c¾Jphenylalanine and 
calculation of rates of protein synthesis and breakdown 
7.2.3. l Injection procedure and sample collection 
Diabetes was induced with streptozotocin in 80 rats, of which only 
60 were used in the actual study. (Mildly diabetic rats were rejected 
from the study and some died in hypoglycaemic coma following insulin 
treatment). 
L-[4- 3HJPhenylalanine (27 Ci/1111101) was combined with unlabelled 
phenylalanine to a concentration of 150 umoles and 55 uCi per ml. Rats 
were injected by tail vein with 1 m1/100g body weight. Groups of rats 
were killed at 2 minutes (4 rats) and 10 minutes (6 rats) after isotope 
injection. At sacrifice blood was collected for glucose analysis and 
several t1 ssues were removed rapidly but quantitatively. These were 
the liver, kidneys, heart, gastrocnemius, soleus, extensor digotorum 
longus (EDL) and diaphragm. The tissues were cooled rapidly tn ice 
water, blotted, weighed and frozen in liquid nitrogen. The time 
between killing and cooling in ice water of each tissue was noted. 
7. 2 . 3 . 2 Samole preparation and analysis 
Approximately 200 mg of tissue wa s homogenized in 2 ml of 2i 
(w/v) perchloric acid (PCA). The supernatant containing the free amino 
acid was removed after centrifugation, and the precipitate was further 
washed with 2% PCA. Protein and RNA were separated and analyzed as 
described in Section 4-6, Figure 4-5. The PCA was removed from the 
supernatant by precipitation in the cold with 100 ~l of SH KOH in a 
lH potassium citrate buffer (pH 6.0). The supernatants were then 
frozen for later analysis of free phenylalanine specific activity. The 
precipitate containing the protein-bound amino acid, obtained after 
RNA extraction was hydrolyzed as described in Section 6.2.l. 
The protein fraction was resuspended in 2 ml sodium citrate buffer 
(0.5M, pH 6.3) and stored frozen. 
7.2.3.3 Specific activity of phenylalanine 
The specific activity of free and protein-bound phenylalanine was 
estimated by the enzymatic method described by P.J. Garlick, 
M.A. Mc:Nurlan and V.R. Preedy (to be published). 
Phenylalanine was converted to phenylethylamine by incubating 
0.5 ml of sample with 0.5 ml of buffered enzyme for 20 hours at so0c. 
The enzyme solution contained per sample: 250 mUnfts L-tyrosine 
decarboxylase (Type I, Sigma Chemical Company Limited, Poole, Dorset, 
U.K., containing phenylalanine decarboxylase as an impurity), 0.2S mg 
pyridoxal phosphate and 0.5 ml citrate buffer (O.SM, pH 6.3). 1.0 ml 
of 3M NaOH was added after the incubation and the phenylethylamfne was 
extracted into 10 ml of a heptane:chloroform CJ:1) solution. This 
procedure does not extract tyramine formed by reaction of tyrosine with 
tyrosine decarboxylase. The organic phase was then added to 4 ml 
sulphuric acid (1 :2000) and 5 ml chloroform, shaken and centrifuged at 
low speed. An aliquot of the upper aqueous layer containing the 
phenylethylamine was counted in a Triton X-100/xylene scfntillant. 
Phenylethylamine in this aqueous layer was assayed by the fluori-
metric method of Suzuki and Yagi (1976) as modified by Garlick et al. 
(unpublished}. 1.0 ml of sample was incubated for 60 minutes at 6o0 c 
with 2.5 ml phosphate buffer (0.5M, pH 8.8), 1.0 ml 50mM ninhydrin and 
0.5 ml 2mM L-leucyl-L-alanine (Sigma Chemicals). This incubation 
yielded a highly fluorescent compound which was unstable in light and 
sensitive to changes in temperature. The 60 minute incubation and 
subsequent measurements of fluorescence were therefore carried out in 
a dark room. Samples were cooled on ice for 5 minutes after 
incubation and then kept at room temperature in a waterbath for a 
further 15 minutes. Fluorescence was measured using a Locarte fluori-
meter with a flow cell. This enabled very rapid reading of samples, 
thus avoiding decay of fluorescence during the measurement. Standard 
solutions of S-phenylethylamine, ranging from 2 to 20 nmoles/ml were 
assayed with each set of free (0.5 to 1.0 ml) and protein-bound 
(20-50 ~l) samples. 
7.2.3.4 Calculations of fractional rates of synthesis and 
breakdown 
Fractional synthesis rates (k5 ) in percent per day, were 
cal cu lated as described by McNurlan et al. (1979) and as discussed in 
Section 1.1.3. The following equation was used : 
ks • x l 00 
where s8 is the specific activity of phenylalanine in protein at 10 
minutes, 'S'A the mean specific activity of the free phenylalanine 
pool between zero and 10 minutes and t, time in days. 
The arithmetic average of SA at zero and 10 minutes was determined 
by measuring the free phenyhlan 1ne spec! fie activity 1n tissues of 
groups of rats killed at 2 and 10 minutes after injection. The results 
were plotted against the exact time at which each tissue was removed 
and cooled in Ice water, 1.e. when label incorporation was stopped . 
After killing. these times to cooling were: for liver, 40 seconds; for 
all skeletal muscles, 30 seconds (the whole hind leg without skin was 
placed in ice water); for kidneys, 60 seconds; heart 90 seconds and the 
diaphragm, 120 seconds. The value for SA at zero time was obtained by 
extrapolating the decline between 2 and 10 minutes back to zero. 
Fractional breakdown rates (kd) were estimated from the equation 
where kg is the fractional growth rate of the protein mass (see Section 
1. 1.4). Growth was determined by measuring the mean rate of change in 
total protein mass of the tissue in diabetic and control animals on the 
days irrmediately before and after the time at which c¾Jphenylalanine 
was injected to measure fractional synthesis rates. The fractional 
growth rate (as percent per day) was obtained by dividing the mean 
change in protein mass per day by the total protein mass of the tissue 
on the day that synthesis was measured. To define the change in 
protein mass more accurately, a group of diabetic rats was measured 
after 6 days of insulin withdrawal and a group of controls after a 
further 6 days of insulin treatment (see general protocol, Figure 7-1). 
These latter two groups of 5 rats each were used for analysis of tissue 
protein content only. The growth rate of protein in tissues of the 
insulin-treated rats at day 3 was therefore calculated from the mean of 
growth between days Oto 3 and days 3 to 6. For growth at day O of 
insulin treatment, only the growth rate between 0-3 days were used. 
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The calculation of liver breakdown rate from a change in protein mass 
requires additional information, since the measured rate of fractional 
synthesis ts that of both cellular and secretory proteins. By contrast, 
fractional growth rate represents changes in only the cellular protein 
mass. The rate of cellular protein synthesis was estimated from 
measurements of rates of albumin synthesis. Albumin synthesis as a 
proportion of total hepatic protein synthesis was determined in liver 
homogenates in all the groups of rats.as described by Pain et al. 
(1978a). By assuming that the proportion of total hepatic protein 
synthesis devoted to the production of plasma proteins other than 
albumin(! 20%) was unaffected by diabetes (Pain & Garlick, unpublished 
data), a rate of synthesis of cellular protein could be calculated. 
With this correction, fractional breakdown rates of liver protein were 
calculated as the difference between the rates of synthesis and growth 
of cellular proteins. An investigation is presently in progress to 
confirm the assumption that syn thesis of plasma proteins other than a 1 bumi n 
is not changed in diabetes, with rats subjected to the same protocol of 
insulin withdrawal. However, time does not permit the inclusion of 
results of this experiment in this study. 
7.3 [ 3HJLEUCINE PILOT STUDY 
7 .3.1 Protocol 
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The general protocol is shown in figure 7-1. The incorporation of 
[ 3HJ1eucine and content of RNA and protein were determined in tissues 
from control (insulin treated) rats measured on day 0, 1, 2 and 5. 
Diabetic rats were measured at 1, 2 and 5 days after insulin withdrawal. 
Each group contained 5 rats. 
7.3.2 Results and Discussion 
Hyperglycaemia was well established in the diabetic rats one day 
after insulin withdrawal as shown in Figure 7-2. 
Gastrocnemius muscle: The effects of insulin withdrawal and insulin 
3 treatment on protein and RNA content and on ( HJleucine incorporation 
are illustrated in Figure 7-3. Both protein and RNA are shown as a 
percentage change in the content of the tissue from the value on day 0, 
the day on which insulin was withdrawn in the diabetic group. Both RNA 
and protein mass increased during the first day of insulin withdrawal 
FIGURE 7-2 PLASMA GLUCOSE CONCENTRATIONS IN CONTROL 
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despite an increase in blood glucose from 123 ± 24 to 321 ± SO mg%, 
but the increase in mass was lower than that in the insulin treated 
groups. Similarly, the relative rate of synthesis, expressed as the 
c3HJleucine incorporated into protein over 10 minutes, was slightly, 
but insignificantly lower in the withdrawn group. However, the 
relative synthesis rate decreased rapidly after 2 days of diabetes. 
Protein mass of the gastrocnemius declined slowly after 2 days without 
insulin, but at 5 days of diabetes had reached a value 40% lower than 
that of the 5 day control group. In contrast to the decline in protein 
mass, RNA content decreased rapidly after the first day of diabetes and 
at 5 days the value was 62% lower than that of the controls. 
Cardiac muscle: The decline in protein mass in the heart (Figure 7-4) 
followed the same pattern as in the gastrocneraius, i.e. an increase in 
protein mass in the diabetic group which was slightly less than that in 
the control group during the first day of insulin withdrawal followed 
by a s 1 ow decline. At 5 days a difference of 32% between control and 
diabetic protein mass was observed. Although the decrease in the RNA 
content of heart muscle from diabetic animals was similar to the decline 
in the gastrocnemius, the final RNA content differed from the controls 
on day 5 by 47%. This less marked response of heart RNA and protein 
mass to diabetes was also seen in the rate of c3HJ1eucine incorporation 
i.e. a decrease after 2 days of diabetes. At 5 days,synthesis in the 
diabetic cardiac muscle was not so low as observed in the gastroc-
nemius. This relative resistance of heart muscle to the effect of 
diabetes was also reported by Pain & Garlick (1974). 
Liver: In contrast to muscle, the liver responded inwnediately to 
insulin withdrawal (Figure 7-5). Despite the presence of only a 
mildly hyperglycaemic state at day 1, protein mass decreased slightly 
but increased again after 2 days. Thereafter the growth of protein 
mass was approximately parallel to that of the controls. RNA mass 
FIGURE 7-4 [ 3H]LEUCINE INCORPORATION ANO PROTEIN ANO 
RNA CONTENT IN CARDIAC MUSCLE OF DIABETIC ANO INSULIN TREATED RATS 
V, 
V, 
~ --.... 
< z 
01:: 
~ 
-
-N 
~ I ~ ~ 
0 
"" Cl. 
~ ..; 
I.J e ~ Q, 
::, r .... 
~ l ~ 
~ ~ 
-
180 
+ INS. __ I 
--
--
--140 
- INS. 
100 
~--L---.1---.J....--""---.,.._ __ .,.._ __ 
150 
100 
50 _ 
-
4 
-
2 
-
0 
0 
,, 
+ INS . 
.i---- --------i 
□ + INSlLIN 
I ~- INSlLIN 
.z. 
~ 
~ 
' 
~ . 
~ 
~ 
~ 
' 
' 
I 
2 3 4 5 
DAYS AFTER INSULIN WITHDRAWAL 
(See legend Figure 7-3) 
FIGURE 7-5 [3HlLEUCINE INCORPORATION ANO PROTEIN AND RNA CONTENT 
!N LIVER OF DIABETIC AND INSULIN TREATED RATS 
150 
50 
150 
V, 
V, 
~- 100 
l4 
c:--
z 
a: 
50 
~~ 20 
- I s ~ 
~ . ! .. ~ [ 10 
:::, i' 
~ ! 
+ INS. 
T -- _ _. 
.----.---- -- - -- ~ 
L---~ ,J....... 
·INS. 
L-,......,..__ _ __. __ .....1,, __ ....r.,. __ ....., __ .:.,_ __ 
+ INS. i.:_:---i T - ___ _. 
~----;------- 0 
- INS. 
□ + INSll.lN 
~ - INSll.lN 
"'":' .,, ~ -- 0 L.......L..L-.-....i .... _,1,,,,1;1J.,.._...:., __ _._ __ ,1Wo __ 
0 2 3 4 
DAYS AFTER INSULIN WITHDRAWAL 
(See legend F'1gure. 7-3) 
5 
158. 
declined within the first 24 hours without insulin and this lower level 
was maintained up to 5 days of diabetes. In contrast to the findings 
of other studies (Hay & Waterlow, 1967; Pain & Garlick, 1974, and 
Section 6) where rates of liver protein synthesis appeared to be 
unaffected by diabetes when measured by constant infusion, incorp-
oration from the single large dose of c3HJleucine was reduced by 
diabetes. This decrease suggests that total liver protein synthesis 
was reduced. 
Kidney: Figure 7-6 illustrates the relative lack of effect of diabetes 
on protein and RNA mass of the kidney and on the rate of C3HJleucine 
incorporation. The relative rate of protein synthesis after 5 days of 
diabetes was however lower than that of the control insulin treated 
rats. In the c14cJtyrosine constant infusion study (Section 6), no 
change in kidney synthesis rates could be observed after a similar 
period of diabetes. 
Conclusions from the pilot study: The results of this pilot study 
demonstrated that in muscle, changes in protein mass and in the 
relative rates of synthesis appear after at least 48 hours of insulin 
withdrawal, whereas in liver these changes are already apparent within 
the first 24 hours after the onset of diabetes. In a 11 four tissues 
studied the largest differences between diabetic and control rats were 
present 4 or 5 days after insulin withdrawal. 
The results of this study therefore indicated the most appropriate 
days on which rates of protein synthesis should be measured and when 
changes in protein mass should be determined to enable estimations of 
protein breakdown. For measurements of changes in muscle protein turn-
over, the most important periods were from day 2 to day S. For liver, 
the initial 24 to 48 hours of insulin withdrawal was the essential time 
for measurements. 
FIGURE 7-6 [3H]LEUCINE INCORPORATION AND PROTEIN AND RNA CONTENT 
IN KIDNEY OF DIABETIC AND INSULIN TREATED RATS 
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7.4 c3HJPHENYLALANINE STUDY 
7. 4. 1 Protocol 
c3HJPhenylalanine was injected as a large single dose in control 
(insulin treated) rats on day O and day 3 (see Figure 7-1 for genera 1 
protocol). In diabetic (insulin withdrawn) rats, injection was on 
days 1, 2 and 4. Each group consisted of 10 rats, of which 4 rats were 
killed 2 minutes after the isotope injection and 6 rats after 10 
minutes. One group of 5 control rats and another of 5 diabetic rats 
were studied on day 5 for measurement of changes in protein mass. 
7.4.2 Results and discussion 
Insulin treatment of the diabetic rats maintained normal glucose 
concentrations throughout the study (Table 7-1). The growth rate of 
10.7 ± 0.7 g/d (mean rate between day Oto day 3} in these insulin 
treated controls was higher than that observed in previous experiments 
with nonna l controls. The diabetes resulting from withdrawal of insulin 
was characterized by a fal 1 in growth rate and an increase in plasma 
glucose within 24 hours. Marked hyperglycaemia was present only after 
48 hours and blood glucose was maintained at this high level throughout. 
The effect of diabetes on each of the 7 tissues studied will be 
discussed separately. Complete data for each tissue on changes in 
composition and rates of protein turnover will be shown in a table, 
followed by a sunrnary of changes in protein synthesis and breakdown 
shown graphically. 
Gastrocnemius muscle: The total weight of the muscle continued to r1se 
during the f1rst day of insulin withdrawal, but decreased subseQuently 
(Table 7-2). There was a small decrease in the protein concentration 
and a much larger decrease in RNA concentration, resulting in a 23-261 
fall in RNA to protein ratio after 4 days of diabetes. This was not 
as marked as the 32i decline reported by Pain & Garlick (1974) in 
160. 
TABLE 7 - 1 lliE EFF£CT OF DIA8El£S AND INSULIN TREATll:NT ON BODY WEIGH AND PLAS~ GLUCOSE 
ClltCENTRA TI ON 
CONTROL D I A B E T I C 
Day 0 Day 3 Day 1 Day 2 Day 4 
Initial body wight (g) 
on day 0 112 t 6 109 t 5 11l t 4 101 t 6 9913 
Final body wight (g) 112 t 6 138t 5 118 t 3 110 t 6 107 t 5 
at kill 
Plasaa Glucose (119/100.l) 106 t 10 98 t 11 275 t 44 581 t 35 644 t 35 
(a} All values 11ean ~ SEN for 10 rats in each group. 
(b) CONTROL: These -.ere diabetic rats pre-treated with PZI (4 U/d) for 3 days. Protein turnover 
was aeasured after these 3 days of pre-treat:aent ( day O control) and after a further 3 days 
on insulin (day 3 control). 
(c) DIABETIC: These wre diabetic rats pre-treated with PZI (4 U/d) for 3 days and aeasured on 
day 1, day 2 and day 4 of insulin withdrawal. 
(d} In all the following tables, total tissue weights are the contiined weights of two gastrocnemius, 
soleus and EDL 11Uscles and two kidneys. Synthesis/RNA (mg prot/mg RNA/d} was derived from 
dividing ks by RNA/protein. 
TABLE 7 - 2 TH£ EFFECT OF DIABETES AND INSULIN TREAHENT ON GASTROCNEMIUS COfollOSITION AND 
PROTEIN TURNOYER 
CONTROL D I A B E T I C 
Day 0 Day 3 Day 1 Day 2 Day 4 
Total tissue wight (g) 1.019 t 0.055 l.266t0.063 1.134 t 0.042 1.095 t 0.069 0.990t 0.062 
Protein (119/g wt tissue) 153 t 4 174 t 5 160 t 3 150 t 5 14 7 t 2 
lltA (119/g wt tissue) 1.497 t 0.028 1.772 t 0.087 1.6281 0.032 1.462 t 0.032 1.104 t 0.045 
MA/Protein (119/g) I 9.8t0.3 10.2 t 0.4 I 10.2±0.3 9.8t 0.5 7.510.3 Si (dpa/nmle) 503t 4 472 t 8 487 t 8 4701 3 458 t 7 
5a (dpa/nmle) I 0.7310.05 0.59 t 0.06 I 0.62 t 0.02 0.35 t 0.04 0.21 t 0.05 ks (l/d) 18.6t 1.1 16.811.7 16.2t0.5 9.8tl.1 5.911.3 
Synthes is/lltA I 18.3t 1.0 16.ltl.7 I 16.2±0.4 10.210.9 7.8tl.4 (119 prot/119 lltA/d) 
kg (Sid) I + 14.8 + 6.7 I + 6.8 - 2.9 - 9.1 
ltd (:/d) I 3.8 10. l I 9.5 12.7 15.0 
-
See legend Table 7-l. ..... 
a, 
N 
gastrocnemius muscle of 5 day diabetic rats. 
The fractional synthesis rates of the day O insulin treated 
control rats are slightly higher than reported by others (Pain & 
Garlick, 1974; Millward et al., 1976) for normal controls (Table 7-2 
and Figure 7-7). This higher synthesis rate most probably reflects a 
period of catch-up growth after induction of diabetes and treatment 
with insulin. The growth rate of 14.8%/day at day O is very rapid 
indeed, but by day 3 it had fallen to 6.7%/day which is similar to that 
observed in normal rats of this age (Section 6). 
In the diabetic rats, fractional synthesis rates fell rapidly 
after 2 days without insulin and at 4 days reached a value only 32 to 
35% of the synthesis rates in controls. This confirms the results of 
Pain & Garlick (1974) and those obtained by constant infusion (Section 
6). The reduced rate of synthesis in the 4 day diabetic rats resulted 
from a small decrease in the number of ribosomes, as shown by the 
decrease in the RNA/protein ratio, and a much greater fall in the 
activity of those ribosomes remaining, as indicated by the low rates of 
syn thesis expressed per mg RNA. However, the 1 a tter effect was 
observable almost immediately, while the former did not appear until 4 
days of diabetes. 
Figure 7-7 illustrates the change in total protein mass, the 
163. 
change in the fractional rate of protein synthesis and also the rates of 
protein degradation derived from these. The protein mass 1s the total 
protein content of two gastrocnemius muscles, expressed as mg protein 
per 100g initial (_day 0) body weight, to take account of the fact that 
the different groups of rats began the experiment on day O with slightly 
different mean body weights. Each value was then expressed as a percent 
of the mean value for day O. Growth rates obtained from the change fn 
protein mass (kg fn Table 7-2) were initially depressed in the diabetic 
FIGURE 7-7 
PROTEIN TURNOVER IN GASTROCNEMIUS MUSCLE OF DIABETIC 
AND INSULIN-TREATED RATS 
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(1 nsu11n withdrawn) rats. Protein mass (mg protefn/100g 1n1t1al cccy 
we ight on day 0) as \ change from mean protein content at day 0. 
rats and then became negative as protein was lost. The calculated 
rates of breakdown showed a progressive increase with onset of severe 
diabetes. This increase in protein breakdown rates measured in vivo 
in the diabetic animal has not been reported before. These results 
contrast with the 45% decrease in in vivo breakdown rates of diabetic 
ske l eta 1 muscle reported by Millward et a 1. ( 1976). However. the 
increase in breakdown rates observed in the present study does sub-
stantiate the in vitro work of Jefferson et al. (19741 and Fulks et al. 
( 1975). 
Cardiac muscle: The changes in composition and protein turnover of 
cardiac muscle are shown in Table 7-3 and Figure 7-8. The effect of 
diabetes on this muscle was less marked than in the gastrocnemius. 
Again there was a lag period of 2 days before tissue mass and protein 
content started to decrease. There was a decline in RNA concentration 
and RNA/protein ratio after l day of diabetes. 
The higher tumover rate of cardiac muscle of control rats com-
pared to skeletal muscle such as the gastrocnemius has been reported 
before (_Garlick et al., 1975). The results in these diabetic rats 
further confirm that protein tumover in cardiac muscle is more 
resistant to change than the gastrocnemius (Pain & Garlick, 1974), 1.e. 
the fractional synthesis rates fell to a value of 46% of the control 
rates by 4 days. The amount of protein synthesized per mg RNA was not 
markedly affected by diabetes, hence the decline in fractional synthesis 
rates were probably due to the decrease 1n amount of RNA. The present 
results confirm those obtained in vivo by Pain & Garlick (1974) and 
the more recent results of Chua et al. (1979), who observed a 38% 
reduction 1n protein synthesis by perfused diabetic hearts. 
At one day of diabetes neither growth rate nor synthesis rate of 
protein were different from control values, but thereafter both rates 
fell. S1m1 larly the derived breakdown rate at one day was very low, 
TABLE 7- 3 THE EFFECT OF DIABETES ANO INSULIN TREATMENT ON HEART COMPOSITION AND PROTEIN TURNOVER 
CONTROL I 0 I A B E T I C Day 0 Day 3 Day 1 Day 2 Day 4 
Total tissue weight (g) 0.43t0.02 0.53t 0.02 0.47 t 0.01 0.44 t 0.03 0.38t 0.02 
Protein (ag/g wet tissue) 108t 2 118t 2 107 t 2 129 t 2 128 t 3 
MA (ag/g wet tissue) 2.227 t 0.031 2.383t 0.068 2.326 t 0.049 l .893t 0.041 l .645:t 0.051 
MA/Protein (ag/g) 20.7:t0.3 20.2 t 0.5 22. 9 t 0. 7 14.7t0.4 12.9 :t 0.4 
S1 (dpa/iaole) 482 t 11 472:t 5 469 :t 3 462 t 5 434 t 4 
58 (ctc-/iaole) 0.83t 0.03 0.81 t 0.04 0.86 t 0.03 0.63 :t 0.04 0.45t0.03 
ks (1/d) 20.9:t l.O 20 .4 t l.1 21.2t0.7 15.7t0.9 12.0:t 0.7 
Synthesis/RNA 10.2 t 0.4 9.9t0.4 9.5t0.5 10.6 t 0.4 9.3 t 0.2 (ag prot/ag AIIA/d) 
kg (1/d) + 12.9 + 8.6 + 14.1 ♦ 5.1 - 6. l 
kd (S/d) 8.0 11.8 7 .1 10.6 18.1 
See legend Tihle 7-1. 
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FIGURE 7-8 
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PROTEIN 
MASS (~) 
0.20 
SYNTHESIS 
-1 (days ) 0.10 
BREAKDOWN 0. 10 
-1 (days ) 
., 
, 
, 
., 
□+INSULIN 
~-INSULIN 
o L.J..J.o.L--'~--~'---~3:-'----(.,,14:---
oAYS AFTER INSULIN WITHORAWAL 
(See legend Figure 7-7) 
168. 
comparable to that in the day O control. Subsequently breakdown 
increased so that by day 4 it was 53% higher than the day 3 control. 
This increase in breakdown rate contrasts with the 17% reduction in 
degradation reported by Chua et al (1979}. However. they used cardiac 
muscles obtained from alloxan-insulin treated rats. They perfused 
these muscles after 3 days of insulin withdrawal, at which time, 
according to the present study. breakdown rates would not be detectably 
different between control and diabetic groups. 
Diaphragm: The results shown in Table 7-4 and Figure 7-9 confirm the 
suggestion of Pain & Garlick (1974} that the rate of protein turnover 
of the diaphragm muscle would be intermediate between that of the heart 
and gastrocnemius in it's response to diabetes. After 2 days of 
diabetes, the weight of the diaphragm declined, protein concentration 
was unchanged and RNA concentration and the RNA to protein ratio were 
decreased. Similarly, as fractional synthesis rates declined, 
fractional breakdown rates were enhanced. Again, as in gastrocnemius, 
the number as well as the activity of remaining ribosomes were 
decreased. 
Soleus and EDL: The total tissue weights of the soleus and EDL both 
declined with diabetes (Table 7-5 and 7-6 respectively). However, the 
actual weights shown are probably not quantitative and accurate enough 
and therefore changes in protein mass, protein growth and protein 
breakdown rates are not shown for these two muscles. 
In both muscles.protein concentration was unaffected by diabetes 
and the decreases in RNA to protein ratios seen in these two muscles 
were brought about by the drop fn RNA concentration. Fractional syn-
thesis rates in both muscles declined at a steady rate after 2 days 
without insulin. These decreases in synthesis rates were probably due 
to the loss in number and activity of ribosomes as shown by the decline 
1n synthesis rate per mg RNA in Tables 7-5 and 7-6. However, the 291 
TABlE 7 - 4 TltE EffiCT OF DI AD£TES AND INSULIN TREATMENT ON DIAPHIW.M C01f)OSITION AND PROTEIN TURNOVER 
CONTROL D I A B E T I C 
Day 0 Day 3 Day 1 Day 2 Day 4 
Tout tissue wight {g) 0.312t0.019 0.415t 0.015 0.370t0.024 0. 382t 0.072 0.346 t 0.018 
Protein (119/g wt tissue) 113 t 3 124 t 3 117t 2 116 t 2 114t 2 
ANA (119/9 wet tissue) 1.377 t 0.039 1.501 t 0.063 1.417 t 0.036 1.213t 0.053 0.975t0.048 
ANA/Protein (ag/g} 12.2t0.3 12.2t 0. 7 12.lt0.3 10.5t0.4 8.5t0.3 
s1 (dpa/nmle) 440t 2 455 t 4 441 t 3 449t 6 431 t 7 
s8 (dpa/nmle) 0. 74 t 0.05 0.60t 0.05 0.68t 0.03 0.46 t 0.05 0.33t0.04 
Its (S/d} 19 .ltl.2 15.4 t 1.2 17.St0.8 11.St0.4 8.6 t 0.9 
Synthesis/ANA · 16.0 t 0.8 13.0t 0.3 15.2 t 0.9 1l.3t0.8 9. 7t0.7 (119 protAlg ANA/d) 
1t
9 
(S/d) -t 15.6 + 6.9 -+ 14 .1 + 2.9 - 5.6 
ltd (S/d} 3.5 8.5 3.7 9.0 14.2 
See legend Table 7-1. 
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FIGURE 7-9 
PROTEIN TURNOVER IN DIAPHRAGM OF DIABETIC AND 
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TAB LE 7 - 5 THE EFFICT Of DIABETES ANO lNSll.lN TR£All£HT ON SOLEUS CCJl>OSITION AND PROTEIN TURNOVER 
C 0 N T R 0 L D l A 8 E T I C 
Da1_ 0 Day 3 Day 1 Day 2 Day 4 
Total tissue -,eight (g) 0.1 01 1 0 .003 0 .1 24 ± 0.004 0.1101 0.003 0. 1011 0 .006 0 .0921 0 .005 
Protein (119/9 -,et ti ssue) 120± 3 11 81 4 127 t 5 142 t 3 152 ± 2 
RNA (119/ 9 wet ti ssue) 1.574 :!: 0 .032 1.480± 0. 023 1. 5421 0 .056 1 .341±0. 023 l . 288± 0. 051 
RNA/ Protein (119/g ) 13. 2± 0 .4 12.6 ± 0. 2 12. 3± 0 . 5 9. 5± 0. 3 8 . 5± 0 . 5 
Si ( di;a/ mao l e ) 53h 14 503:!: 3 525 ± 12 496± 8 502± 2 
s8 ( di;a/1110 le ) 0 . 75± 0 .04 
0 .63± 0 .02 0.65 t 0 .04 0. 56 ± 0 .06 o. 37t 0. 04 
k
5 
(1/d) 19.3tl .O 16.5±0. 6 15.610 .8 13. 5±1.2 9.6 ± 0 .9 
Synthesis/RM 
(119 protlagRNA/d) 15. l± 0. 8 13. 2 t 0 . 2 
13 .0±0. 5 14.0± 0 .9 11. 4±0. 5 
See legend Table 7-1. 
TABLE 7 -6 THE Eff£CT OF DIA8ET£S AND INSUl.IN TREATKNT ON EXTENSOR DIGITORUH LONGUS COtt>OSITION AND 
PROTEIN TURNOVER 
C O N T R O L DIABETIC 
Day 0 Day 3 Day 1 Day 2 Day 4 
Tot•l tissue weight {g) 0.090t 0.004 0.113t 0.004 0.0931 0.003 0.104 t 0.005 0.0901 0.007 
Protein (119/g wet tissue) 121 t 4 112 t 4 125 t 4 127 t 3 134 t 6 
RNA (ag/g wet tissue) 1.3101 0.025 1.292:t0.062 1.296± 0.030 1.0711 0.057 0.881 :t 0.046 
ANA/Protein (ag/g) 10.710 .7 11.7:t0.6 10.5:t0.4 8.41 0.4 6.7 :t 0.5 
S1 {dpa/nmle) 4861 7 
500:t 3 496:t 6 498t 2 506:t 9 
5s (dpa/nmle) 0.59 :t 0.01 0.671 0.04 0.61 t 0 .02 0.401 0.04 0.26 :t 0.05 
ks (1/d) 15.7t 0.2 17.St 1.1 15.81 0.6 10.3:t0.9 6.81 1.3 
Synthes i s/AIIA 14.210.8 14.4:t0 .6 I 16 .1 t 0.7 11.81 1.0 10.0:t 1.5 (ag prot,IIJ IIWd) 
See legend Table 7-1 . 
decrease in activity of the EDL synthesizing mechanism and the 14-16% 
decrease shown in that of the sol eus is much 1 ess pronounced than the 
reduction of 51% observed in the gastrocnemius. 
Kidney: Tab 1 e 7-7 and Figure 7-1 O i 11 us trate the response of the 
kidney to insulin withdrawal and insulin treatment. As diabetes pro-
gressed, so tissue weight and total protein mass increased relative to 
the values for control animals. There was a small decrease in RNA 
concentration and RNA to protein ratio after 4 days of diabetes when 
compared with the day O and day 3 control values. 
The fractional synthesis rates of 47 and 42% demonstrated in the 
control, insulin treated rats are very comparable to the values of 47¾ 
obtained by constant infusion with c14CJtyrosine (see Section 6.3.2) 
in nonnal control rats. Similarly, the kidney again appeared to be 
relatively unaffected by diabetes. The fractional synthesis rates of 
173. 
4 day diabetic rats were lower only if the values are compared to that 
of the day O controls, i.e. the group assumed to be in a phase of catch·· 
up growth. The protein synthesis rates shown here and in Section 6 are 
to our knowledge the first published indication that synthesis rates of 
diabetic kidneys do not increase in a similar fashion as do kidney 
weight and glomerular filtration rates in response to diabetic hyper-
glycaemia, polyuria and glycosuria. The work of Seyer-Hansen (1976, 
1977 and 1978) on the diabetic kidney described hypertrophy only in 
terms of increased protein, RNA and DNA content. In contrast, Peterson 
et al. (1971} reported that kidney rii:>osomes incorporated more amino 
acids into protein in vitro. 
Protein breakdown rates in the kidney were depressed only on the 
initial day of insulin withdrawal. Thereafter breakdown rates 
increased so that by 4 days of diabetes there was little difference 
between the control and diabetic values. 
TABL[ 7 - 7 THE £FF£CT Of DIABETES AND INSULIN TRfAHENT 00 KI1~£Y COlflOSITION AND PROTEIN TURNOVER 
C 0 N T R 0 L I D I A B E T I C Day 0 Day 3 Day 1 Day 2 Day 4 
Total tissue wei91t (g) I 1.25 t 0.05 1.49 t 0.05 I 1.40 t 0.05 1.45 t 0.06 1.58 t 0.06 Protein (119/9 wet tissue) 91t 3 101 t 2 95 t 7 104 t 5 97 t 2 
RNA (119/9 wet tissue) 4.076 t 0.127 4 . 027 t 0. 052 4.137t:0.105 3.919 t 0.060 3.655 t 0.068 
RNA/Protein (119/9) 45.0 t 0.8 39.7 t 0.5 41.6 t 1.4 38.4 t 1.6 37.9t0.7 
Si (dpa/nmle) 520 t 11 525 t 4 513 t 7 510 t 13 494 t 12 
s8 (dpa/na>le) I 1.92 t 0.04 1. 70 t 0.02 I 1.67 t 0.04 1.74t0 .03 1.58t 0.08 
k5 (1/d) I 46.7tl.2 42 .0t 0.4 I 41.Jt 1.1 43 .2t0.7 39 .2t 1.8 
Synthesi s/lllA 
I 10.Jt 0.2 10.5 t 0.2 I 10.3t0.7 11.3t0.7 10.2t:0.4 (119 prot/119 IIIA/d) k9 (S/d) ♦ 12 .1 ♦ 5.5 t 18.9 t 8.3 + 1.5 
ltd (S/d) I 34.6 36.5 I 22.4 34.8 37.7 
-
See legend lib le 7 - 1. 
-
..... 
• 
FIGURE 7-10 
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Liver: The changes brought about by diabetes on liver composition and 
protein metabolism are shown in Table 7-8 and F'igure 7-11. Total liver 
weight decreased within the first day of insulin withdrawal and then 
remained more or less constant. There was little change in composition. 
The fractional synthesis rate of total (cellular plus secretory) 
hepatic protein also responded i11111ediately to insulin withdrawal, 
despite the fact that this group of rats was only mildly hyper-
glycaemic after only 24 hours without insulin. The synthesis rate of 
total protein thereafter fell slowly and consistently as insulin with-
drawal was prolonged. This decrease in total protein synthesis rates 
confirms the results of McNurlan & Garlick(l980a) who used the same 
1 arge dose method and reported an even 1 arger decrease in syn thesis 
after 10 days of diabetes. 
Albumin synthesis as a proportion of total liver protein synthesis 
showed a disproportionate fall, in confirmation of the results of Fain 
et al .(1978a) and Peavy et al. (1978) This decline in albumin 
synthesis was on it's own however insufficient to account for the over-
all drop in total hepatic protein synthesis. 
Pain & Garlick (unpublished data) have previously shown that the 
proportion of total hepatic protein synthesis devoted to the production of 
pl asmaproteins other than albumin (approximately 20%) was not changed by 
diabetes. The synthesis rate of cellular proteins could then be 
calculated from the rate of synthes 1s of a 1 buru1 n and that of tota 1 
hepatic proteins (Table 7-8). In diabetic rats a decrease fn cellular 
synthesis rate was observed, but this was less marked than the decrease 
in rates of synthesis of total liver proteins. 
Degradation of liver cellular proteins was elevated above day 0 
and day 3 control values for only the first day of insulin withdrawal 
during the period of rapid protein los s (Figure 7-11). After 4 days 
of diabetes breakdown rates had however declined to levels belo~, that 
TABLE 7 - 8 niE EFFECT OF DIABETES AND INSULIN TREATMENT ON LI VER COMPOSITION 
AND PROTEIN TURNOVER 
177. 
C 0 N T R O L 0 l A 8 E T l C 
Day 0 D•y 3 Day Day 2 Day 4 
Total tissue ..eight (g) 7.41:t0.39 6.45t0.25 5.4~0.16 5 .00:0 .25 s.22:0.20 
Pr~tein [mg/g wet tissue) 162:!:6 187±3 182:t:4 -141:4 1531'4 
RNA (mg/g wet tissue) 7. 840:0. 221 8 . 238:tO. 158 8.751:t0.179 7 .675:tO. 103 7.611±0.201 
RNA/Protein [ rng/g) 48.6:tl, I 48. 1:0.a 44.0:t0.8 54. 7:tl . 5 48.6±2.0 
s, ( dpm/nmole) 487±6 467:tl l 453:t:9 461*6 434±15 
Sa [ dpm/nmole) 3. 70:0.07 3.10:t0.12 2 .B5t:O .OS 2. 72±0.10 2. 52±0. 16 
ks Tota 1 Protein [i t d) 96.4:2.7 82. S-t2. 7 75. 7:tO .8 71 .5:t2.2 65.3:t3.2 
ks Cellular- Protein ["l/dl 59.7 49.5 46, 7 47 . 2 42.8 
Synthesis Albumin 18. 1:0.6 20.0:0.6 (~ of total pr-ct.synthesis) 18.3:tl .0 14.0:t0.6 14.5:tl .5 
Syntnesi S/ RNA 19.3:tO,S 19. lt0.6 15. 7t:0,2 13.J:t0.6 14.J:t0.6 
(mg prot/m9 RNA/d) 
g [~ /d) .. 1.2 - 1.7 - 20.J - 9.8 ,. 3. l 
kd ('./ d) 58.5 51.2 67 .0 57 .0 39. 7 
( a ) ks of total pr-ot■ in includH synthesis rat■s of' cellular plus secr-etcr-y pr-ot11ns 
(b) k
1 
of cellular pr-ot■ in was c1lcullt1d f'rom synthesis of total protein minus 
synthH1S of albumin 1nd syntnu1s of othtr plasma proteins (! 20!: of total 
11 .. e,- prote 1ns fer- both control and diabetic groups ), 
(c) kg reflects growth of non-11cr-etor-y or- callular Pl'Otein only, therefor• kd NAS 
cal culated as thl difference ottwetn k1 of cellular prote1n and k9 , 
( d) SH l egend of T~ole 7 - 1 for detail on control 1no o1aoet1c groups. 
FIGURE 7-11 
PROTEIN TURNOVER IN LIVER OF DIABETIC AND INSULIN-TREATED RATS 
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7.4.3 SulTlllary and Conclusions 
The gastrocnemius muscle appears to be highly sensitive to 
changes in insulin levels and responds with a rapid and pronounced 
decline in rates of protein synthesis within 24 hours of insulin with-
drawal. Cardiac and other skeletal muscles showed a decrease in 
synthesis only after al to 2 day lag period. The magnitude of 
response to diabetes appeared to be much higher in the white glycolytic 
muscles, i.e. gastrocnemius and EDL. The heart, soleus and diaphragm, 
which contain more red muscle fibres, seemed to be less affected by 
diabetes and on the average synthesis decreased by 40-45%, whereas the 
synthesis rates in the more white muscles decreased by 60-70% after 4 
days of diabetes. 
Protein breakdown rates in all muscles were severely depressed in 
the day O insulin treated controls, since the growth rates on this day 
were extremely high. These day O values of fractional growth probably 
represents a phase of catch-up growth in the muscles resulting from 
only 3 days of pre-treatment with insul fn. After a further 3 days on 
insulin,the growth rates of day 3 insulin treated controls were 
comparable to that of normal controls of the same age in other 
experiments. In all muscles the effect of diabetes was shown as a 
steady elevation in protein breakdown as protein synthesis declined. 
In contrast to muscle, the diabetic kidney increased in weight 
and protein content whilst rates of synthesis and breakdown were 
relatively unchanged. 
Liver proteins responded inrned1ately to insulin withdrawal with a 
decrease 1n rates of synthesis in both total hepatic proteins and of 
albumin as a proportion of total protein. Protein breakdown rates in 
the liver were only transiently elevated on the ff rst day w1 thout 
insulin, thereafter rates of protein breakdown below those of the 
controls were observed. 
SECTION 8 
GENERAL DISCUSSION 
The primary aim of this investigation was to examine the 
mechanism of the negative N-balance present in uncontrolled diabetes. 
In the preceding experimental section some results were presented for 
rates of protein synthesis and breakdown in diabetic animals that were 
not only new information, but contrasted with some published data 
obtained in vivo. In addition, the results observed in rates of 
protein synthesis in the diabetic subjects appeared to conflict with 
the anabolic function of insulin. If one is to accept these results 
as being a true reflection of changes in the diabetic state, the 
following questions should be considered 
(a) did the methods that were used give reasonable results in the 
normal or control animal or human. 
(b) how were the rates of protein turnover altered by diabetes with 
these methods. 
(c) can one make any comparison between the results observed in the 
experimentally diabetic rat and the disease state as presented in 
the diabetic subjects. 
In this general discussion, consideration will be given firstly 
to the control values obtained for protein turnover in the whole body 
in man and in the rat and also in tissues of the rat. Secondly, the 
changes observed in the diabetic state on a whole body and on a 
tissue level will be compared with the control values measured and 
with other published 1n vivo and 1n vitro investigations in diabetes. 
8.1 PROTEIN TURNOVER IN NORMAL MAN AND CONTROL RATS 
8.1.1 Whole body protein turnover in man 
In the Introduction (Section 1.1 .2) various methods were 
discussed which could be used to measure whole body protein turnover . 
These methods differ from each other by: 
(a) the use of either radioactively labelled 14c amino acids or 
stable isotopes such as 15N labelled amino acids. 
(b) by administration of the labelled amino acid by either constant 
infusion (14c and 15N amino acids), or by multiple or single ~ral 
doses (15N amino acids). 
(c) by measurement of the excretion of [ 15NJ abundance in the urinary 
end products urea or amnonia if c15NJglycine was used. 
(d) by measurement of excretion. of the 14c label as 14co2 if a 
14c 
amino acid was used. 
In the present study, the stable isotope c15NJglycine was chosen 
since the age group of the patients studied excluded on ethical 
grounds the use of 14c labelled amino acids. It was more convenient 
in these patients to administer the c15NJglycine as a single oral dose. 
It was also more realistic in the non-steady state of diabetes to 
measure c15NJ abundance in ammonia as end product since this enabled 
completion of a study within 9 - 12 hours. In contrast, 24 - 48 hours 
would have been required 1 f urea had been used as urinary end product. 
Rates of orotein synthesis: In the diabetic patients the rates of 
whole body protein synthesis measured pre-insulin (3.8 t 0.4 g protein/ 
kg/day, Exp. I, Section 3) were not markedly different from the rates 
observed after 4 to 5 days of insulin treatment (3.2 ! 0.4 g protein/ 
kg/day) or even after 10 months of insulin (3.0 g protein/kg/day). 
The post-insulin values were assumed to b! representative of the 
controlled diabetic state since hyperglycaemia was reduced to near-
182 . 
normal values and the negative N-bal ance improved. 
Despite the fact that the choice of labelled amino acid, of end 
product and of route of administration all have some disadvantages as 
discussed in Section l.l .2, the synthesis rate of 3.2: 0.4 gram 
protein/kg/day observed post-insulin in the 4 patients of Exp. I are 
quite comparable to that reported by others as shown in Table a - 1. 
In this table a summary is given of results reported by various 
research groups using both 14c and 15N labelled amino acids with 
different routes of administration and with measurements on urinary 
a111110nia, urinary urea or plasma. Not only are the results obtained 
remarkably consistent between methods, but are comparable over a wide 
age-range. 
In Experiment II of Section 3, much higher synthesis rates of 
6.6 g protein/kg/d were observed in two patients. At the time of 
measurement this was thought to possibly result from the practically 
continuous feeding of protein meals at 2 hourly intervals during the 
9 hours in which 15N abundance was measured in urinary annonia. The 
absorption of food would not only have delayed excretion of label from 
the metabolic pool, but food intake in itself could have maintained a 
high rate of protein synthesis, since Garlick et al. (1980a) have 
recently shown that the absence of feeding results in an abrupt 
decrease in synthesis. However, these high values of protein synthesis 
were not observed in control subjects receiving a similar dietary 
protocol (see Table 8 - 1, unpublished data, 3.0 g protein/kg/day, 
range: l - s g protein/kg/d). The reason for the high synthesis rates 
observed in these subjects in the present study is therefore not 
clear. Although these rates were measured in only two patients, it 
was a consistent finding in each patient before and after insulin 
treatment (Table J - 6) and this high rate was again observed in one 
patient after 8 weeks of insulin (Table 3- 7). 
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Age SyftlheS Is 
20-25 l .0 t O. l 
20-65 l.81 0 . 7 
66-91 3. l t 0. 3 
66-91 2. l t 0.6 
66-91 l . 2 1 0.5 
66-91 2. 7 t o. 7 
52-75 4.0 t 0 .5 
30-65 4.6 1 0.8 
31-46 2. l 1 1.2 
20-45 l.0 t 1.1 
Rate of protein breakdown: In the 4 patients studied in Experiment 
{Section 3), rates of whole body protein breakdown of 3.0 ! 0.5 g 
protein/kg/day were measured (Table 3-4). These rates were quite 
comparable to the 3.9 and 3.7 g protein/kg/day observed pre- and post-
operatively with repeated doses of c l 5N ]glycine and measurement of 15 
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in urinary urea {Crane et al., 1977 ). Similarly, 0' Keefe et al . (1974 ) reported 
values of 299 and 302 g protein/day (approximately 4 g protein/kg/day) 
for patients pre- and post-operatively as measured by constant infusion 
of c14CJ1eucine. 
In conclusion, it would appear that the rates of protein synthesis 
and breakdown measured post-insulin in the diabetic subjects of 
Experiment I were consistent with results obtained by others using 
different methods and different labelled amino acids. 
8.1 .2 Whole body protein turnover in control rats 
Rates of protein synthesis: The rate of whole body protein synthesis 
was measured in control, diabetic and insulin treated diabetic rats 
by constant infusion of L-c1 14CJ 1eucine{Section 5). Inherent 
advantages of this method were the short time (2 hours) required for the 
specific activity of the free amino acid in the blood and in tissues 
to reach a plateau. Secondly, since the 14c label was quantitatively 
excreted as 14co2 , oxidation rates could be obtained as described in 
Section 1.1.2. 
The synthesis rates measured as \Jmoles leucine per minute per 
100g body weight could be converted tog protein per kg per day, by 
assuming that rat protein contains approximately 8% leucine (Fem, 
1975). The values of 39 g protein per kg per day for control rats in 
thi s experiment is comparable with the 31 g protein / kg/day observed by 
McNurlan & Garl ick ( 1980 b). They injected a large amount of c14cJ-
leucine , measured label incorporation ove r 10 minutes and determined 
Rate of protein breakdown: In the 4 patients studied in Experiment I 
(Section 3), rates of whole body protein breakdown of 3.0 ! 0.5 g 
protein/kg/day were measured (Table 3-4). These rates were quite 
comparable to the 3.9 and 3. 7 g protein/kg/day observed pre- and post-
operatively with repeated doses of clSNJglycine and measurement of 15N 
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in urinary urea ( Crane et al., 1977). Similarly, O' Keefe et al. ( 1974) reported 
values of 299 and 302 g protein/day (approximately 4 g protein/kg/day) 
for patients pre- and post-operatively as measured by constant infusion 
of [ 14CJleucine. 
In conclusion, it would appear that th& rates of protein synthesis 
and breakdown measured post-insulin in the diabetic subjects of 
Experiment l were consistent with results obtained by others using 
different methods and different labelled amino acids. 
8.1.2 Whole body protein turnover in control rats 
Rates of protein synthesis: The rate of whole body protein synthesis 
was measured in control, diabetic and insulin treated diabetic rats 
by constant infusion of L-c1 14CJleucine(Section 5). Inherent 
advantages of this method were the short time (2 hours) required for the 
specific activity of the free amino acid in the blood and in tissues 
to reach a plateau. Secondly, since the 14c label was quantitatively 
excreted as 14co2 , oxidation rates could be obtained as described in 
Sec ti on 1 . l . 2. 
The synthesis rates measured as umoles leucine per minute per 
100g body weight could be converted tog protein per kg per day, by 
assuming that rat protein contains approximately 8% leucine (Fern, 
1975). The values of 39 g protein per kg per day for control rats i n 
this experiment is comparable with the 31 g protein/kg/day observed by 
McNurlan & Garlick (1980b). They injected a large amount of r14cJ-
leucine, measured label incorporation ove r 10 minutes and determined 
total body protein content and the specific activity of leucine in 
free and protein-bound tissue obtained by homogenizing the total rat 
carcass. The synthesis rates of this study were also consistent with 
the 42 g protein/kg/day reported by Garlick et al. (1975) who 
calculated the rate from flux observed by constant infusion of [ 14cJ-
tyrosine and by assuming that body protein contained 3% tyrosine. 
The vast difference in absolute synthesis rates between humans 
and rats measured here, i.e. of approximately 3-4 g protein/kg/day in 
man versus 30-40 g protein/kg/day in the rat has been noted before 
(e.g. Garlick, 1979) and appears to be related to the very high 
metabolic rate of the smaller species (Munro, 1969). 
Rates of protein oxidation: The whole body oxidation rates measured 
in vivo in control rats, i.e. of 0.236 ! 0.013 ~moles leucine/minute/ 
100 g rat were very similar to the values of 0.277 ~moles leucine/ 
minute/100 g rat observed by Sketcher (1976) using a similar method. 
Rates of protein breakdown: In contrast to the measurement of protein 
breakdown in humans as the difference between flux rates and food in-
take, in the rat this method has been shown not to be applicable 
(Section 5.4.3). Since flux was measured over 4 hours, comparison with 
either food intake or growth measured over 24 hours was shown not to be 
practical. 
8.1.3 Tissue protein tumover in control rats 
Growth rate of orotein mass: The comparison between control rates of 
fractional synthesis in tissues, observed by either [ 14cJ tyrosine 
infusion or injection with a large mmount of [ 3HJphenylalanine and with 
other published data requires consideration of the fact that the 
controls of Section 7 were diabetic rats treated with insulin. In 
terms of plasma glucose values these animals were well-controlled at 
186. 
day O (after 3 de.j's pre-treatment with insulin) and at day 3 (after 
a further 3 days of insulin). At day O these rats not only had 
extremely rapid body growth rates (11 g per day), but also rates of 
growth in protein mass of 13-16%/d in skeletal and cardiac muscle 
(Section 7). These rates of growth in protein mass are extremely 
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rapid compared to the 6-8%/d observed in normal rats of similar age and 
weight (e.g. Section 6). The high rates of growth of protein mass in 
controls at day O were associated with equally high rates of fractional 
synthesis (e.g. ks of 19%/d was measured in the gastrocnemius muscle 
of day O control rats, Table 7-2). 
Similar high rates of synthesis have been observed during the 
period of rapid catch-up growth in malnourished rats following 
refeeding (Millward et al., 1974, 1975). This rapid growth during 
rehabilitation was associated with not only increased protein 
synthesis, but also increased rates of protein breakdown. High 
synthesis and high breakdown rates have also been observed in skeletal 
muscle of very young rats during the period of rapid growth (Waterlow 
et al., Ch. 16, 1978a). In contrast, in the present study, after 3 days 
of insulin treatment (day O controls) rapid growth was associated with 
high rates of synthesis, but with extremely low rates of breakdown, 
(e.g. 3%/day as measured in the gastrocnemius), a finding consistent 
with the anabolic role of insulin. 
Rapid growth of protein mass associated with high fractional 
synthesis rates have been observed in hypertrophied muscles following 
various surgical and mechanical interventions. Goldberg reported 
conpensatory growth in the soleus and plantar-is muscles after severing 
the connection of the gas trocnemf us to the Ach 111 es tendon. Th 1 s 
hypertrophy after tenotomy was shown to occur not only fn control rats, 
but also in hypophysectomized (Goldberg, 1967a)a nd i n diabetic rats 
(Goldberg, 1968), where one would expect the absence of growth honnone 
and insulin to prohibit rapid growth. Hypertrophy with high rates of 
protein synthesis and of breakdown measured in vivo has been 
demonstrated to occur in the wing muscle of the fowl fol lowing a long 
period of muscle stretch by weights attached to the wing {Laurent et 
al., 1978). Similarly, hypertrophy of the isolated diaphragm after 
denervation has been reported by Buse et al. (1965) and by Harris & 
Manchester (1966). Turner & Garlick (1974) also observed hypertrophy 
of diaphragm muscle after nerve section and by constant infusion of 
c14cJtyrosine could detennine that again both in vivo synthesis and 
breakdown rates were enhanced, a finding consistent with that of 
Millward et al. (1974, 1975) in rats during rehabilitation following 
malnutrition. 
It would appear therefore that the control rats at day O of the 
experiment reported in Section 7, were still in an initial phase of 
rapid catch-up growth in response to the insulin treatment, which 
after a further 3 days of insulin treatment (day 3 controls), had 
settled down to a state more characteristic of normal rats. In all 
the experiments to be discussed, comparisons will therefore be made 
with either normal age control rats (Section 6, rats with similar 
Initial body weight and age as experimental groups) or day 3 controls 
(Section 7, diabetic rats after a total of 6 days of 1nsul in). 
Tissue s_vnthesis rates: In Table 8-2 control values are presented 
for fractional synthesis rates in some tissues as measured in this 
study by either constant infusion of c14CJtyrosine or as a single 
injection of a large amount of c3HJphenylalanine. It is clear that 
not only do the values compare well between the two methods, but also 
with other in vivo studies usfng different strains of rats, diets, 
controls and with different days of duration of diabetes. The table 
{Goldberg, 1968), where one would expect the absence of growth honnone 
and insulin to prohibit rapid growth. Hypertrophy with high rates of 
protein synthesis and of breakdown measured in vivo has been 
demonstrated to occur in the wing muscle of the fowl following a long 
period of muscle stretch by weights attached to the wing {Laurent et 
al., 1978). Similarly, hypertrophy of the isolated diaphragm after 
denervation has been reported by Buse et al. (1965) and by Harris & 
Manchester (1966). Turner & Garlick (1974) also observed hypertrophy 
of diaphragm muscle after nerve section and by constant infusion of 
c14c]tyrosine could detennine that again both in vivo synthesis and 
breakdown rates were enhanced, a finding consistent with that of 
Millward et al. (1974, 1975) in rats during rehabilitation following 
malnutrition. 
It would appear therefore that the control rats at day O of the 
experiment reported in Section 7, were still in an initial phase of 
rapid catch-up growth in response to the insulin treatment, which 
after a further 3 days of insulin treatment (day 3 controls), had 
settled down to a state more characteristic of nonnal rats. In all 
the experiments to be discussed, comparisons will therefore be made 
with either normal age control rats (Section 6, rats with similar 
initial body weight and age as experimental groups) or day 3 controls 
(Section 7, diabetic rats after a total of 6 days of Insulin). 
Tissue synthesis rates: In Table 8-2 control values are presented 
for fractional synthesis rates in some tissues as measured in this 
study by either constant infusion of c14CJtyrosine or as a single 
injection of a large amount of c3HJphenylalanine. It 1s clear that 
not only do the values compare well between the two methods, but also 
with other 1n vivo studies using different strains of rats, diets, 
control s and with different days of duration of diabetes. The table 
TABU 8- 2 FRACTl<IW. SYNTHESIS RATES (ks as S/d) IN SM TISSUES OF CONTROL RATS ANO DIABETIC 
RATS (100-120g) 
C O N T R O L D I A 8 E T I C 
REF. 
Gastroc- Liver Liver Gastroc- Liver Liver 
netlius Heart Kidney tot.il cellular n~ius Heart 
Kidney total cellular 
a 13 - 48 - 54 5 - 48 - 50 
b 17 20 42 83 50 6 12 39 65 43 
C 14 17 - - 50 4 9 - - 50 
d 13 17 48 - 67 - - - - -
e 13 - - - - 5 - - - -
f - - - 97 - - - - 52 -
a 1 Section 6i c14c]Tyr infusion, 120g age controls and 5 day diabetic rats. 
b = Section li ( 3ti ]Phe large dose, day 3 (insulin treated diabetic) controls and day 4 
(insulin withdra"°) diabetic rats. 
c 1 Pain l Garlick (1974)i c14cJTyr infusion, age controls, 5 day diabetic rats. 
d = Garlick et al. (1975)i c14c]Tyr infusion, age controls. 
e = Millward et al. (1976); c1 4c1Tyr infusion, age controls and 6 day diabetic rats. 
f = McNurlan & Garlick (1980a);[14cJLeu large dose, age controls and 10 day diabetic rats . 
also confirms that the method of injecting a large dose of labelled 
amino acid does in fact measure synthesis of total hepatic proteins 
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as suggested by the work of McNurlan et al. (1979). With this method 
McNurlan et al. (1979) investigated the possibility of the large dose 
affecting the rate of protein synthesis. They showed equal 
incorporation of [ 14CJglycine with or without a large amount of c14cJ-
leucine. The very small differences observed in the present study in 
synthesis rates of gastrocnemius, kidney and liver in controls measured 
by either constant infusion or by the large dose method would appear to 
confinn the assumption that the large dose of labelled amino acid 
would not adversely affect protein synthesis. 
In Table 8-3 values are shown for the contribution of individual 
tissues to whole body protein turnover. Since synthesis rates were 
measured in only 5 muscles, this table does not clearly indicate that 
the contribution of skeletal muscle to -whole body protein synthesis 
is in fact quite large. Despite very slow rates of turnover, skeletal 
muscle can contribute more than 19% of protein synthesis in the whole 
body if one assumes total body muscle mass to be 36% of the body 
weight of a 100 g rat. Although it has a very rapid turnover rate, 
the liver contributes not more than about 2S% of total body protein 
synthesis, since it only contains approximately 5% of the body's 
protein mass. 
In Table 8-3, the rates of synthesis in the tissues measured in 
the present study accounts for only 1.03 g protein/day of a whole body 
protein synthesis of 3.9 g/day. Of the 2.9 g protein/day not accounted 
for, a large contribution of 0.4 g/day or 10% of whole body synthesis 
will be made by the small intestine (McNurlan et al., 1979), and the 
rest by tissues such as smooth muscle, skin, bone, brain, lung and 
other visceral organs . 
TABLE 8- 3 RATES Of PROTEIN SYNTHESIS IN TISSll:S OF CONTROL AND DIABETIC RATS (100-1209) 
C O N T R O L DIABfTIC 
ks (S/d) Absolute Synthesis Rate k5 ( S/d) 
Absolute Synthesis Rate 
g/d I of who1e 6ody g7a I of who le 6oay 
Gas trocneai us 16.8 0.034 0.94 5.9 0.009 0.27 
Ell. 17.5 0.002 0.06 6.8 0.001 0.02 
Soleus 16.5 0. 002 0.06 9.6 0.001 0.04 
Diaphraga 15.4 0.007 0.19 8.6 0.003 0.10 
Heart 20.4 0.012 0.33 12.0 0.006 0.18 
Kidney 42.0 0.058 1.61 39.2 0.060 l.82 
Liver (Total) 82.5 0.914 25.39 65 .3 0.543 16.5 
(cellulir) 49.5 0.549 15.24 42.8 0.356 10.8 
Whole body - 3.900 100 - 3.300 100 
(a) All tissue values obtained by injecting a large aaount of cltiJphenylalanine and aeasuring 
incorporation over 10 ■inutes (Section 7) 
(b) Control values are those ■easured after 6 days of insulin treat■ent (4 U PZl/d) of diabetic 
rats, i.e. Day 3 controls of Table 7-1. 
(c) Diabetic values are those ■easured after 4 days of insulin withdrawal, i.e. Day 4 diabetic 
rats of Table 7-1. 
(d) Whole body synthesis rate IIMS deter■ined by constant infusion of c1-14c11eucine (Section 5, Exp. 11) . 
(e) Absolute rates of protein synthesis as gra■ protein per day calculated by ■ultiplying the fractional 
rate of protein synthesis (ks, S/d) by the protein content of the tissue (which is approxiaate only 
for soleus and Ell. ■uscles) . ..... 
ID 
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Tissue breakdown rates: The values obtained for fractional rates of 
protein breakdown by use of the indirect method are influenced by the 
inherent errors involved as discussed in Section 1.1.2, e.g. by 
deriving these breakdown rates from measurements of changes in protein 
mass over several days. In this investigation (Section 7) the day 3 
control values of growth in protein mass (kg) were obtained as the mean 
of the changes between day O and day 3 and between day 3 and day 6. 
The day O contro 1 kg va 1 ue was measured only from day O to day 3 and was 
assumed to be linear over this period. 
At day O the control fractional rates of protein breakdown were 
extremely low in all muscles. This is to be expected since the rates 
were derived as the difference between the ks and kg values of each 
muscle, both rates which were highly elevated. The day 3 control 
rates are for reasons discussed previously more similar to those of 
normal growing rats. Rates of breakdown in gastrocnemius (1O.1%/d), 
heart (11 . 8%/d) and diaphragm (8.5%/d) were comparable to the 9.4%/d 
reported by Turner & Garlick (1974) in hemidiaphragm muscle or values 
of 8-11 %/d in skeletal muscle reported by Garlick et al. (1975) and 
Millward et al. (1976). 
In conclusion, it appears not unrealistic to accept the values 
obtained for protein synthesis and breakdown in diabetic subjects 
treated with insulin and in control animals, since these rates are 
quite consistent with values obtained by other groups using similar 
or different methods. In the following discussion, results observed 
in the diabetic state in humans and in rats will be exami ned as 
measured by these methods. 
8.2 PROTEIN TURNOVER IN DIABETIC SUBJECTS AND ANIMALS 
8.2.1 Whole bodv orote1n turnover in diabetic adults 
Rates of orote1n synthesis: The normal control rates of protein 
synthesis ~easured pre-insulin and the s l igh t ~ecrease in synthes i s 
r ates observed in diabetic patients~ days ~Ost-insulin ( Sect ion 
3.2.~ ) . not only contrasts with the r-es ults of the pilot study by 
\oiaterlow et al. ( 1977), but a l so 111ith the expected anabol i c fun ction 
of insulin. Since there was a s li ght improvement in t~e negative N-
balance in :nost patients, this cou ld have only resu l ted from the :non! 
pronounced decrease in breakd(l',,fn following insu1 in treatment. ihe 
smal l decrease in synthesis rate after 4 to 5 days of insulin was 
:oser'lea in 5 out of 6 pati!mts and was not affectea by ,ianioulaticn 
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of caloric content of the diet, the meal pattern i tself or time of 
:
1
=N ; glycine aaministration. The apparent ly higner synt~ esis rates 
before insulin in the first 4 patients might, however, by a ~tabol ic 
artifact resulting from the higher rate of NH 3 excretion in the 
diabetic state, even though there was no frank acidosis. 7he poss-
ibility exists that when the rate of urinary NH 3 excretion i s increased, 
glycine mignt contribute a smaller proportion of N to the formation of 
NH 3. The effect of this would be to lower the 
15N abundance in urinary 
NH 3, and to increase the calculated values for flux and synthesis. How-
ever, in patients Nos. 5 and 6 where rates of protein synthesis were 
also higher in the pre-insul i n period, ammonia excretion ·..ias unchanged 
in one patient and increased in the other. Th e difference between 
nor.nal and pre-insulin values measured in this study and the very low 
synthesis rates observed pre-insulin in the pilot study (Waterlow et al., 
1977) have been discussed in detail (.see Section 3.2.7}. 
Rates of protein breakdow": Th e decrease 1n rates of who le body protein 
breakdown in these subjects following 4 days, 8 weeks or 10 months of 
insul 1n therapy f1 ts with the role of insu11n in inhib1 ting prote i n 
~egr~dation . In con tr!St, no change in ,11uscle protein b,.eal(down could 
be detected in these patients after insulin as indicated by excretion 
of 3-methylhistidine. 
From the results of the present investigation in diabetic 
subjects one must conclude that large changes in whole body protein 
turnover could not be detected in these patients. It is possible that 
such changes may occur in diabetic patients with more severe bio-
chemical abnormalities, e.g. in the newly diagnosed insulin dependent 
subject with severe weight loss, hyperglycaemia and glycosuria, or 
alternatively in a well-controlled diabetic subject after one or two 
days of insulin withdrawal. 
8.2.2 Whole body protein turnover in diabetic rats 
Rates of protein synthesis: The 17% decrease in whole body protein 
synthesis observed in diabetic rats (Table 8-3 and Section 5) was not 
as pronounced as the 60-70% decrease measured in fractional synthesis 
rates in skeletal muscle (Tables 8-2 and 8-3) of rats with similar 
periods of duration of diabetes and severity of hyperglycaemia. Since 
whole body protein synthesis in the severely diabetic rat decreased 
only slightly, it may possibly be a further explanation why hardly any 
change could be detected in whole body protein synthesis in the 
diabetic patients who were not so severely ill. 
Rates of protein breakdown: Reasons have al ready been discussed 
why rates of whole body protein breakdown could not be calculated in 
control rats and therefore by implication also in diabetic rats. This 
is particularly unfortunate since no other published information is 
ava11able on in vivo whole body protein breakdown rates in the 
experimentally diabetic animal. 
Rates of crotein oxidation: The highly elevated rates of oxidation 
mea~ured in diabetic rats with either normal or increased food intake 
confirm the many observations by Buse and her colleagues of increased 
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oxidation rates in incubated diaphragms, retina or sciatic nerves from 
diabe~ic rats (Buse et al .• 1976a & b, Frayser and Buse. 1978). The 
only other published data on whole body absolute oxidation rates in 
abnonnal nutritional states are that of Sketcher (1976). who demonstrated 
decreased oxidation rates 1n protein depleted rats. Without measurement 
of the specific activity of the precursor pool, Meikle & Kla1n (1972) 
could show only an increase in proportional oxidation rate after 
starvation, i.e. as the amount of 14co2 excreted at plateau as a% of 
the infused isotope. 
In the present study the increase in whole body rate of leucine 
oxidation was observed in diabetic rats whose intake of food was 
similar to that of controls. This would suggest that leucine was being 
mobilized from other tissues and hence a change in balance of synthesis 
and breakdown could have taken place in the diabetic state. This 
possibility will be analysed in the next section. 
8.2.3. Tissue protein turnover in diabetes 
Skeletal muscle: The decrease in fractional synthesis rate of the 
gastrocnemius muscle after 4 to 5 days of diabetes was similar 
when measured by either constant infusion or a large amount of labelled 
amino acid and is also comparable with the published in vivo work of 
Pain & Garlick (1974) and M11 lward et al. (1976) as shown in Table 8-2 . 
The skeletal muscles appear to differ in their response to insulin 
deficiency (Table 8-3). Those with more white fibres such as the 
gas trocnemi us and EDL were much more sensitive to the lack of insulin. 
They demonstrated a very marked decrease of 60 to 70% in both fractional 
and absolute rates of protein synthesis. In contrast, muscles with 
more red fibres such as the diaphragm and soleus responded less with a 
33 to 47% decrease in rates of synthesis. During the course of this 
work, th is relative resistance to ins ulin deficiency by muscles with a 
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greater proportion of red fibres was also reported by Flaim & Jefferson 
(1979). . ' . In the1r perfus1on study, they showed that in diabetic muscle 
preparations the soleus with more red fibres was less susceptible to 
the development of the initiation block to peptide-chain synthesis 
which develops quite rapidly in psoas and gastrocnemius muscles which 
contain more white or mixed fibres. 
The low in vivo rates of synthesis seen in all skeletal muscles 
from diabetic rats are consistent with in vitro data of Buse et al. 
(1976a) with incubated diaphragms and of Jefferson et al. (1972) with 
perfused psoas muscle of diabetic rats. 
The increase in fractional breakdown rates measure in vivo in 
skeletal muscle after 4 days of diabetes has not been reported before. 
This steady and progressive elevation of protein breakdown was demon-
strated in the gastrocnemius, diaphragm and heart muscles (Figures 
7-7, 7-8 and 7-9). 
This increase in rates of protein breakdown with diabetes does 
not confinn the data of Millward et al. (1976). They also used the 
method of indirect measurement of breakdown with constant infusion of 
( 14cJtyrosine to detennine synthesis. They reported that both syn-
thesis and breakdown were decreased in diaJetes. The discrepancy 
between these two reports may be due to differences in measurement of 
growth rates of protein mass and of experimental diabetic models used. 
In the study of Millward et al. (1976), protein synthesis was measured 
6 days after the rats were injected with streptozotocin, at which time 
their plasma insulin levels were however not very low (8 uU/ml) . In 
the present study, protein breakdown rates were determined in insulin 
withdrawn diabetic rats which were severely hyperglycaemic. Further-
more, Millward and co-workers calculated the mean growth in protein 
mass from values of protein content obtained only on day O and day 6 
(Millward, personal conmunication). It is apparent from the figures 
in Section 7 that protein mass does not decline in a linear fashion 
over this period. In fact, there was a considerable lag period of 24 
to 48 hours in all muscles before a drop in protein mass could be 
measured. In the present study protein mass was determined on each 
day before and after the measurement of protein synthesis to obtain a 
more accurate estimate of the change in rate of growth of protein mass 
with diabetes. This lag period followed by a decline in protein mass 
of skeletal muscle was observed not only in the actual study, but also 
in the pilot study. 
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The increase in breakdown rates measured in vivo in this study does con-
firm the in vitro results of various workers, who have shown increased proteo-
lysis in hemicorpus preparations of normal rats if perfused in the absence of 
insulin (Jefferson et al., 1974, 1977; Ruderman & Berger, 1974). 
Cardiac muscle: The approximately 40% decrease in in vivo fractional 
synthesis rate as measured by the two methods (Table 8-2) resulting 
from diabetes is similar to the changes observed by Pain & Garlick 
(1974) in vivo and the recent perfusion studies of Chua et al. (1979). 
This decrease does not substantiate the suggestion of Rannels et al. 
(1970) that rates of protein synthesis in perfused diabetic cardiac 
muscle is not affected by insulin deficiency, since free fatty acids 
can substitut~ for insulin to prevent development of a block in peptide-
cha f n f ni tia ti on. Certainly the results in this study do suggest that 
the heart muscle, which contains predominantly red fibres, is like the 
soleus and diaphragm, less susceptible to the effects of diabetes. 
As demonstrated in skeletal muscle, the in vivo rate of protein 
breakdown in cardiac muscle of diabetic rats progressively increased as 
insulin was withdrawn (Figure 7-8) . Similar increases in protein 
breakdown have been observed in perfusion of diabetic cardiac muscle 
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(Chua et al., 1979) or if insulin was absent from the perfusing medium 
(Rannels et al., 1975). 
Kidney: Hypertrophy of diabetic kidney!., as demonstrated by increased 
protein mass and total weight, was not associated with enhanced 
fractional synthesis rates as measured by either constant infusion or 
a single large amount of amino acid (Tables 8-2 and 8-3). However, 
since absolute rates of synthesis are based on the total amount of 
protein present, a slight increase in the absolute rate of synthesi~ 
was observed after 4 days of diabetes and an increase of 13~ in the 
contribution of kidney protein synthesis as a~ of whole body. Data 
on in vivo synthesis rates in diabetic kidney~ have not been presented 
before. Protein breakdown rates were depressed on only the first day 
of insulin withdrawal, thereafter there was little difference 
between breakdown rates in insulin-treated or insulin-withdrawn groups 
(Figure 7-10). 
Liver: With th.e constant infusion technique which measures only non-
secretory or cellular proteins, not much of an effect could be 
demonstrated in fractional synthesis rate in diabetic livers as shown 
previously by Hay & Waterlow (1967) and Pain & Garlick (1974), (Table 
8-2) . With the large dose of labelled amino acid and measurement of 
incorporation over 10 minutes, there was no doubt that diabetes did in 
fact decrease total hepatic protein synthesis (Table 8-3) as observed 
previously by McNurlan & Garlick (1980a). Similarly the rate of albumin 
synthesis was also decreased after 4 days of diabetes as demonstrated 
by Pain et al. (1978b) and Peavy et al. (1978). However, the decrease 
in total liver protein synthesis was not nearly as marked as was seen 
in skeletal muscle. 
Results of perfusion studies have demonstrated that liver 
r:legradation 1s accelerated 1f insulin is absent from the perfusate 
~rtimore & Mendon, 1970) . [n the present Investigation breakdown 
rates were only transiently elevated after one day of insulin with-
drawal (Figure 7-11). 
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Contribution of tissues from diabetic rats to whole body protein turnover: 
In Table 8-3 absolute rates of protein synthesis were calculated for each tissue 
measured and the % contribution of each tissue to protein synthesis of 
the whole body. As discussed in the preceding chapter and as illustrated 
in Table 8-3, the effect of diabetes was much more pronounced on a 
tissue level. In terms of absolute synthesis rates, the 1.03 g protein / 
day contributed by the tissues measured in this study in control rats 
declined to 0.62 g protein per day in diabetic rats, whereas total 
body protein synthesis dropped only slightly from a value of 3 . 9 in 
controls to 3.3 g protein/day in the diabetic rats. This would suggest 
that the tissues that were not measured in this study were much less 
affected by diabetes, e.g. protein synthesis of the small intestine has 
been reported to be unchanged in diabetic rats (McNurlan & Garlick, 
1980a), and similarly, synthesis in lung as measured in vitro (Rannels 
et al., 1979). No information is available on the effect of diabetes 
on protein synthesis rates in tissues such as smooth muscle, brain, 
spleen, bone or skin. One can only speculate that protein synthesis in 
some of these tissues is either not changed by diabetes or might even 
be enhanced. The small decrease in whole body protein synthesis in 
diabetic rats could then possibly be explained by the large decrease in 
protein synthesis in skeletal muscle being balanced by a small decrease 
in liver,plus hardly any change fn kidney, gut and lung, and 
possibly, fn some of the other body tissues not measured here. 
8.3 CONCLUSION 
The changes in protein metabolism resulting from diabetes presented 
here on a whole body and on" tissue level would suggest that in experi-
mentally diabe tic rats, the negative N-balance of uncontrolled diabetes 
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is probably brought about by the combined effect of a decrease in the 
rates of protein synthesis and an elevation in rates of protein 
breakdown. Whereas these changes were not observed in the diabetic 
subjects investigated in the present study, the possibility of similar 
protein abnonnalities being present in the severely ill diabetic 
patient cannot be excluded and therefore should merit equal attention 
in criteria for establishing good control in the insulin treated 
diabetic patient. 
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